Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Tuberculosis

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 1075 articles:
HTML format



Single Articles


    January 2021
  1. AHMAD N, Baharom M, Aizuddin AN, Ramli R, et al
    Sex-related differences in smear-positive pulmonary tuberculosis patients in Kuala Lumpur, Malaysia: Prevalence and associated factors.
    PLoS One. 2021;16:e0245304.
    PubMed     Abstract available


  2. HASSUNA NA, El Feky M, Hussein AARM, Mahmoud MA, et al
    Interleukin-18 and interferon-gamma single nucleotide polymorphisms in Egyptian patients with tuberculosis.
    PLoS One. 2021;16:e0244949.
    PubMed     Abstract available


  3. MARIN AV, Rastogi N, Couvin D, Mape V, et al
    First approach to the population structure of Mycobacterium tuberculosis complex in the indigenous population in Puerto Narino-Amazonas, Colombia.
    PLoS One. 2021;16:e0245084.
    PubMed     Abstract available


  4. KIM J, Park BG, Lim DH, Jang WS, et al
    Development and evaluation of a multiplex loop-mediated isothermal amplification (LAMP) assay for differentiation of Mycobacterium tuberculosis and non-tuberculosis mycobacterium in clinical samples.
    PLoS One. 2021;16:e0244753.
    PubMed     Abstract available


  5. SHANKAR S U, Kumar AMV, Venkateshmurthy NS, Nair D, et al
    Implementation of the new integrated algorithm for diagnosis of drug-resistant tuberculosis in Karnataka State, India: How well are we doing?
    PLoS One. 2021;16:e0244785.
    PubMed     Abstract available


  6. ASEMAHAGN MA, Alene GD, Yimer SA
    Spatial-temporal clustering of notified pulmonary tuberculosis and its predictors in East Gojjam Zone, Northwest Ethiopia.
    PLoS One. 2021;16:e0245378.
    PubMed     Abstract available


  7. KHALIQ A, Ravindran R, Afzal S, Jena PK, et al
    Gut microbiome dysbiosis and correlation with blood biomarkers in active-tuberculosis in endemic setting.
    PLoS One. 2021;16:e0245534.
    PubMed     Abstract available


  8. THAYER MB, Parish T
    Phenoxyalkylimidazoles with an oxadiazole moiety are subject to efflux in Mycobacterium tuberculosis.
    PLoS One. 2021;16:e0239353.
    PubMed     Abstract available


  9. OLADIMEJI O, Adepoju V, Anyiam FE, San JE, et al
    Treatment outcomes of drug susceptible Tuberculosis in private health facilities in Lagos, South-West Nigeria.
    PLoS One. 2021;16:e0244581.
    PubMed     Abstract available


  10. ARNOLD ME, Courcier EA, Stringer LA, McCormick CM, et al
    A Bayesian analysis of a Test and Vaccinate or Remove study to control bovine tuberculosis in badgers (Meles meles).
    PLoS One. 2021;16:e0246141.
    PubMed     Abstract available


  11. CHUNG HS, Bae S, Kim I, Ahn HY, et al
    Unexpected exposure to Mycobacterium tuberculosis during bronchoscopy using radial probe endobronchial ultrasound.
    PLoS One. 2021;16:e0246371.
    PubMed     Abstract available


  12. DAGNE B, Desta K, Fekade R, Amare M, et al
    The Epidemiology of first and second-line drug-resistance Mycobacterium tuberculosis complex common species: Evidence from selected TB treatment initiating centers in Ethiopia.
    PLoS One. 2021;16:e0245687.
    PubMed     Abstract available


  13. LOPEZ K, Arriaga MB, Aliaga JG, Barreda NN, et al
    Dysglycemia is associated with Mycobacterium tuberculosis lineages in tuberculosis patients of North Lima-Peru.
    PLoS One. 2021;16:e0243184.
    PubMed     Abstract available


  14. SORSA A, Kaso M
    Diagnostic performance of GeneXpert in tuberculosis-HIV co-infected patients at Asella Teaching and Referral Hospital, Southeastern Ethiopia: A cross sectional study.
    PLoS One. 2021;16:e0242205.
    PubMed     Abstract available


  15. XIA T, Chen J, Rui J, Li J, et al
    What affected Chinese parents' decisions about tuberculosis (TB) treatment: Implications based on a cross-sectional survey.
    PLoS One. 2021;16:e0245691.
    PubMed     Abstract available


  16. GAUTAM N, Karki RR, Khanam R
    Knowledge on tuberculosis and utilization of DOTS service by tuberculosis patients in Lalitpur District, Nepal.
    PLoS One. 2021;16:e0245686.
    PubMed     Abstract available


  17. LIM RK, Semitala FC, Atuhumuza E, Sabiti L, et al
    Patient choice improves self-efficacy and intention to complete tuberculosis preventive therapy in a routine HIV program setting in Uganda.
    PLoS One. 2021;16:e0246113.
    PubMed     Abstract available


  18. SHIN HJ, Chang JS, Kim MS, Koh BG, et al
    Hypersensitivity reactions to multiple anti-tuberculosis drugs.
    PLoS One. 2021;16:e0246291.
    PubMed     Abstract available


  19. KHAN MS, Rego S, Rajal JB, Bond V, et al
    Mitigating the impact of COVID-19 on tuberculosis and HIV services: A cross-sectional survey of 669 health professionals in 64 low and middle-income countries.
    PLoS One. 2021;16:e0244936.
    PubMed     Abstract available


  20. DE MENDONCA EB, Schmaltz CA, Sant'Anna FM, Vizzoni AG, et al
    Anemia in tuberculosis cases: A biomarker of severity?
    PLoS One. 2021;16:e0245458.
    PubMed     Abstract available


  21. SOEROTO AY, Pratiwi C, Santoso P, Lestari BW, et al
    Factors affecting outcome of longer regimen multidrug-resistant tuberculosis treatment in West Java Indonesia: A retrospective cohort study.
    PLoS One. 2021;16:e0246284.
    PubMed     Abstract available


  22. YUEN CM, Millones AK, Puma D, Jimenez J, et al
    Closing delivery gaps in the treatment of tuberculosis infection: Lessons from implementation research in Peru.
    PLoS One. 2021;16:e0247411.
    PubMed     Abstract available


  23. KASSA GM, Merid MW, Muluneh AG, Wolde HF, et al
    Comparing the impact of genotypic based diagnostic algorithm on time to treatment initiation and treatment outcomes among drug-resistant tuberculosis patients in Amhara region, Ethiopia.
    PLoS One. 2021;16:e0246938.
    PubMed     Abstract available


  24. NAZNEEN A, Tarannum S, Chowdhury KIA, Islam MT, et al
    Implementation status of national tuberculosis infection control guidelines in Bangladeshi hospitals.
    PLoS One. 2021;16:e0246923.
    PubMed     Abstract available


  25. EDWARDS BD, Edwards J, Cooper R, Kunimoto D, et al
    Rifampin-resistant/multidrug-resistant Tuberculosis in Alberta, Canada: Epidemiology and treatment outcomes in a low-incidence setting.
    PLoS One. 2021;16:e0246993.
    PubMed     Abstract available


  26. ISLAM MN, Khan MK, Khan MFR, Kostoulas P, et al
    Risk factors and true prevalence of bovine tuberculosis in Bangladesh.
    PLoS One. 2021;16:e0247838.
    PubMed     Abstract available


  27. HENNEBERG M, Holloway-Kew K, Lucas T
    Human major infections: Tuberculosis, treponematoses, leprosy-A paleopathological perspective of their evolution.
    PLoS One. 2021;16:e0243687.
    PubMed     Abstract available


  28. FANG Y, Ma Y, Lu Q, Sun J, et al
    An outbreak of pulmonary tuberculosis and a follow-up investigation of latent tuberculosis in a high school in an eastern city in China, 2016-2019.
    PLoS One. 2021;16:e0247564.
    PubMed     Abstract available


  29. LAZARUS G, Tjoa K, Iskandar AWB, Louisa M, et al
    The effect of human immunodeficiency virus infection on adverse events during treatment of drug-resistant tuberculosis: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0248017.
    PubMed     Abstract available


  30. LANDSMAN D, Abdelbasit A, Wang C, Guerzhoy M, et al
    Cohort profile: St. Michael's Hospital Tuberculosis Database (SMH-TB), a retrospective cohort of electronic health record data and variables extracted using natural language processing.
    PLoS One. 2021;16:e0247872.
    PubMed     Abstract available


  31. TOMAZ APO, Raboni SM, Kussen GMB, da Silva Nogueira K, et al
    The Xpert(R) MTB/RIF diagnostic test for pulmonary and extrapulmonary tuberculosis in immunocompetent and immunocompromised patients: Benefits and experiences over 2 years in different clinical contexts.
    PLoS One. 2021;16:e0247185.
    PubMed     Abstract available


  32. BIERMANN O, Kluppelberg R, Lonnroth K, Viney K, et al
    'A double-edged sword': Perceived benefits and harms of active case-finding for people with presumptive tuberculosis and communities-A qualitative study based on expert interviews.
    PLoS One. 2021;16:e0247568.
    PubMed     Abstract available


  33. BALDWIN SL, Reese VA, Larsen SE, Beebe E, et al
    Prophylactic efficacy against Mycobacterium tuberculosis using ID93 and lipid-based adjuvant formulations in the mouse model.
    PLoS One. 2021;16:e0247990.
    PubMed     Abstract available


  34. HOHLFELD ASJ, Mathebula L, Pienaar ED, Abrams A, et al
    Tuberculosis treatment intervention trials in Africa: A cross-sectional bibliographic study and spatial analysis.
    PLoS One. 2021;16:e0248621.
    PubMed     Abstract available


  35. OHENE SA, Bonsu F, Adusi-Poku Y, Dzata F, et al
    Case finding of tuberculosis among mining communities in Ghana.
    PLoS One. 2021;16:e0248718.
    PubMed     Abstract available


  36. SMITH GC, Budgey R
    Simulating the next steps in badger control for bovine tuberculosis in England.
    PLoS One. 2021;16:e0248426.
    PubMed     Abstract available


  37. ANDARGIE A, Molla A, Tadese F, Zewdie S, et al
    Lost to follow-up and associated factors among patients with drug resistant tuberculosis in Ethiopia: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0248687.
    PubMed     Abstract available


  38. CHARLES M, Richard M, Reichler MR, Koama JB, et al
    Treatment success for patients with tuberculosis receiving care in areas severely affected by Hurricane Matthew - Haiti, 2016.
    PLoS One. 2021;16:e0247750.
    PubMed     Abstract available


  39. AMEKE S, Asare P, Aboagye SY, Otchere ID, et al
    Molecular epidemiology of Mycobacterium tuberculosis complex in the Volta Region of Ghana.
    PLoS One. 2021;16:e0238898.
    PubMed     Abstract available


  40. ROSENFELD G, Gabrielian A, Wang Q, Gu J, et al
    Radiologist observations of computed tomography (CT) images predict treatment outcome in TB Portals, a real-world database of tuberculosis (TB) cases.
    PLoS One. 2021;16:e0247906.
    PubMed     Abstract available


  41. ABDU M, Ali Y, Anteneh S, Yesuf M, et al
    Determinant factors for the occurrence of tuberculosis after initiation of antiretroviral treatment among adult patients living with HIV at Dessie Referral Hospital, South Wollo, Northeast Ethiopia, 2020. A case-control study.
    PLoS One. 2021;16:e0248490.
    PubMed     Abstract available


  42. HUDDART S, Singh M, Jha N, Benedetti A, et al
    Case fatality and recurrent tuberculosis among patients managed in the private sector: A cohort study in Patna, India.
    PLoS One. 2021;16:e0249225.
    PubMed     Abstract available


  43. HAN WM, Mahikul W, Pouplin T, Lawpoolsri S, et al
    Assessing the impacts of short-course multidrug-resistant tuberculosis treatment in the Southeast Asia Region using a mathematical modeling approach.
    PLoS One. 2021;16:e0248846.
    PubMed     Abstract available


  44. HERMAN B, Sirichokchatchawan W, Pongpanich S, Nantasenamat C, et al
    Development and performance of CUHAS-ROBUST application for pulmonary rifampicin-resistance tuberculosis screening in Indonesia.
    PLoS One. 2021;16:e0249243.
    PubMed     Abstract available


  45. HEFFERNAN C, Paulsen C, Asadi L, Egedahl ML, et al
    Individual and public health consequences associated with a missed diagnosis of pulmonary tuberculosis in the emergency department: A retrospective cohort study.
    PLoS One. 2021;16:e0248493.
    PubMed     Abstract available


  46. WOLDESEMAYAT EM, Azeze Z
    Treatment outcome of tuberculosis at Dilla Referral Hospital, Gedeo Zone, southern Ethiopia: A retrospective study.
    PLoS One. 2021;16:e0249369.
    PubMed     Abstract available


  47. MIRZAZADEH A, Kahn JG, Haddad MB, Hill AN, et al
    State-level prevalence estimates of latent tuberculosis infection in the United States by medical risk factors, demographic characteristics and nativity.
    PLoS One. 2021;16:e0249012.
    PubMed     Abstract available


  48. STEFANESCU S, Cocos R, Turcu-Stiolica A, Mahler B, et al
    Evaluation of prognostic significance of hematological profiles after the intensive phase treatment in pulmonary tuberculosis patients from Romania.
    PLoS One. 2021;16:e0249301.
    PubMed     Abstract available


  49. XU F, Tian L, Li Y, Zhang X, et al
    High prevalence of extrapulmonary tuberculosis in dairy farms: Evidence for possible gastrointestinal transmission.
    PLoS One. 2021;16:e0249341.
    PubMed     Abstract available


  50. DE MENDONCA EB, Schmaltz CA, Sant'Anna FM, Vizzoni AG, et al
    Correction: Anemia in tuberculosis cases: A biomarker of severity?
    PLoS One. 2021;16:e0249545.
    PubMed     Abstract available


  51. THIEL BA, Worodria W, Nalukwago S, Nsereko M, et al
    Immune cells in bronchoalveolar lavage fluid of Ugandan adults who resist versus those who develop latent Mycobacterium tuberculosis infection.
    PLoS One. 2021;16:e0249477.
    PubMed     Abstract available


  52. SANTOS FLD, Souza LLL, Bruce ATI, Crispim JA, et al
    Patients' perceptions regarding multidrug-resistant tuberculosis and barriers to seeking care in a priority city in Brazil during COVID-19 pandemic: A qualitative study.
    PLoS One. 2021;16:e0249822.
    PubMed     Abstract available


  53. HEWAGE S, Somasundaram N, Ratnasamy V, Ranathunga I, et al
    Active screening of patients with diabetes mellitus for pulmonary tuberculosis in a tertiary care hospital in Sri Lanka.
    PLoS One. 2021;16:e0249787.
    PubMed     Abstract available


  54. MEKKAOUI L, Hallin M, Mouchet F, Payen MC, et al
    Performance of Xpert MTB/RIF Ultra for diagnosis of pulmonary and extra-pulmonary tuberculosis, one year of use in a multi-centric hospital laboratory in Brussels, Belgium.
    PLoS One. 2021;16:e0249734.
    PubMed     Abstract available


  55. GWITIRA I, Karumazondo N, Shekede MD, Sandy C, et al
    Spatial patterns of pulmonary tuberculosis (TB) cases in Zimbabwe from 2015 to 2018.
    PLoS One. 2021;16:e0249523.
    PubMed     Abstract available


  56. JAKHAR S, Sakamuri R, Vu D, Dighe P, et al
    Interaction of amphiphilic lipoarabinomannan with host carrier lipoproteins in tuberculosis patients: Implications for blood-based diagnostics.
    PLoS One. 2021;16:e0243337.
    PubMed     Abstract available


  57. SPEKKER O, Kis L, Deak A, Makai E, et al
    An unusual case of childhood osteoarticular tuberculosis from the Arpadian Age cemetery of Gyorszentivan-Revhegyi tag (Gyor-Moson-Sopron county, Hungary).
    PLoS One. 2021;16:e0249939.
    PubMed     Abstract available


  58. CHAVES-TORRES NM, Fadul S, Patino J, Netto E, et al
    Factors associated with unfavorable treatment outcomes in patients with rifampicin-resistant tuberculosis in Colombia 2013-2015: A retrospective cohort study.
    PLoS One. 2021;16:e0249565.
    PubMed     Abstract available


  59. MCCALLAN L, Brooks C, Barry C, Couzens C, et al
    Serological test performance for bovine tuberculosis in cattle from herds with evidence of on-going infection in Northern Ireland.
    PLoS One. 2021;16:e0245655.
    PubMed     Abstract available


  60. RAISANEN PE, Haanpera M, Soini H, Ruutu P, et al
    Transmission of tuberculosis between foreign-born and Finnish-born populations in Finland, 2014-2017.
    PLoS One. 2021;16:e0250674.
    PubMed     Abstract available


  61. CARTER BB, Zhang Y, Zou H, Zhang C, et al
    Survival analysis of patients with tuberculosis and risk factors for multidrug-resistant tuberculosis in Monrovia, Liberia.
    PLoS One. 2021;16:e0249474.
    PubMed     Abstract available


  62. SAKTIAWATI AMI, Triyana K, Wahyuningtias SD, Dwihardiani B, et al
    eNose-TB: A trial study protocol of electronic nose for tuberculosis screening in Indonesia.
    PLoS One. 2021;16:e0249689.
    PubMed     Abstract available


  63. OLIVEIRA O, Gaio R, Correia-Neves M, Rito T, et al
    Evaluation of drug-resistant tuberculosis treatment outcome in Portugal, 2000-2016.
    PLoS One. 2021;16:e0250028.
    PubMed     Abstract available


  64. COLY S, Garrido M, Abrial D, Yao AF, et al
    Bayesian hierarchical models for disease mapping applied to contagious pathologies.
    PLoS One. 2021;16:e0222898.
    PubMed     Abstract available


  65. MINJA LT, Hella J, Mbwambo J, Nyandindi C, et al
    High burden of tuberculosis infection and disease among people receiving medication-assisted treatment for substance use disorder in Tanzania.
    PLoS One. 2021;16:e0250038.
    PubMed     Abstract available


  66. HO LJ, Yang HY, Chung CH, Chang WC, et al
    Increased risk of secondary lung cancer in patients with tuberculosis: A nationwide, population-based cohort study.
    PLoS One. 2021;16:e0250531.
    PubMed     Abstract available


  67. NGUYEN LH, Tran PTM, Dam TA, Forse RJ, et al
    Assessing private provider perceptions and the acceptability of video observed treatment technology for tuberculosis treatment adherence in three cities across Viet Nam.
    PLoS One. 2021;16:e0250644.
    PubMed     Abstract available


  68. BIGIO J, Kohli M, Klinton JS, MacLean E, et al
    Diagnostic accuracy of point-of-care ultrasound for pulmonary tuberculosis: A systematic review.
    PLoS One. 2021;16:e0251236.
    PubMed     Abstract available


  69. WOLDEYOHANNES D, Tekalegn Y, Sahiledengle B, Assefa T, et al
    Predictors of mortality and loss to follow-up among drug resistant tuberculosis patients in Oromia Hospitals, Ethiopia: A retrospective follow-up study.
    PLoS One. 2021;16:e0250804.
    PubMed     Abstract available


  70. SCHRAMM B, Nganaboy RC, Uwiragiye P, Mukeba D, et al
    Potential value of urine lateral-flow lipoarabinomannan (LAM) test for diagnosing tuberculosis among severely acute malnourished children.
    PLoS One. 2021;16:e0250933.
    PubMed     Abstract available


  71. JARSBERG LG, Kedia K, Wendler J, Wright AT, et al
    Nutritional markers and proteome in patients undergoing treatment for pulmonary tuberculosis differ by geographic region.
    PLoS One. 2021;16:e0250586.
    PubMed     Abstract available


  72. NERLICH AG, Kirchhoff SM, Panzer S, Lehn C, et al
    Chronic active non-lethal human-type tuberculosis in a high royal Bavarian officer of Napoleonic times-a mummy study.
    PLoS One. 2021;16:e0249955.
    PubMed     Abstract available


  73. LEE HN, Kim JI, Kim YH
    Clinical and CT characteristics of Xpert MTB/RIF-negative pulmonary tuberculosis.
    PLoS One. 2021;16:e0250616.
    PubMed     Abstract available


  74. JADHAV R, Gallardo-Macias R, Kumar G, Daher SS, et al
    Assessment of carbapenems in a mouse model of Mycobacterium tuberculosis infection.
    PLoS One. 2021;16:e0249841.
    PubMed     Abstract available


  75. KABUGO J, Namutebi J, Mujuni D, Nsawotebba A, et al
    Implementation of GeneXpert MTB/Rif proficiency testing program: A Case of the Uganda national tuberculosis reference laboratory/supranational reference laboratory.
    PLoS One. 2021;16:e0251691.
    PubMed     Abstract available


  76. ROBSKY KO, Isooba D, Nakasolya O, Mukiibi J, et al
    Characterization of geographic mobility among participants in facility- and community-based tuberculosis case finding in urban Uganda.
    PLoS One. 2021;16:e0251806.
    PubMed     Abstract available


  77. FOSTER N, Cunnama L, McCarthy K, Ramma L, et al
    Strengthening health systems to improve the value of tuberculosis diagnostics in South Africa: A cost and cost-effectiveness analysis.
    PLoS One. 2021;16:e0251547.
    PubMed     Abstract available


  78. ARAYA BT, Ali KE, Geleta DA, Tekele SG, et al
    Performance of the Abbott RealTime MTB and RIF/INH resistance assays for the detection of Mycobacterium Tuberculosis and resistance markers in sputum specimens.
    PLoS One. 2021;16:e0251602.
    PubMed     Abstract available


  79. KABIR S, Parash MTH, Emran NA, Hossain ABMT, et al
    Diagnostic challenges and Gene-Xpert utility in detecting Mycobacterium tuberculosis among suspected cases of Pulmonary tuberculosis.
    PLoS One. 2021;16:e0251858.
    PubMed     Abstract available


  80. HIRSCH-MOVERMAN Y, Howard AA, Mantell JE, Lebelo L, et al
    Improving child tuberculosis contact identification and screening in Lesotho: Results from a mixed-methods cluster-randomized implementation science study.
    PLoS One. 2021;16:e0248516.
    PubMed     Abstract available


  81. WOOD RC, Andama A, Hermansky G, Burkot S, et al
    Characterization of oral swab samples for diagnosis of pulmonary tuberculosis.
    PLoS One. 2021;16:e0251422.
    PubMed     Abstract available


  82. BERRA TZ, Gomes D, Ramos ACV, Alves YM, et al
    Effectiveness and trend forecasting of tuberculosis diagnosis after the introduction of GeneXpert in a city in south-eastern Brazil.
    PLoS One. 2021;16:e0252375.
    PubMed     Abstract available


  83. VASANTHA M, Muniyandi M, Ponnuraja C, Srinivasan R, et al
    Bayesian structural equation modeling for post treatment health related quality of life among tuberculosis patients.
    PLoS One. 2021;16:e0252205.
    PubMed     Abstract available


  84. SHIFERAW MB, Sinishaw MA, Amare D, Alem G, et al
    Prevalence of active tuberculosis disease among healthcare workers and support staff in healthcare settings of the Amhara region, Ethiopia.
    PLoS One. 2021;16:e0253177.
    PubMed     Abstract available


  85. YANG H, Yang Y, Hu ZD, Xia L, et al
    High rate of completion for weekly rifapentine plus isoniazid treatment in Chinese children with latent tuberculosis infection-A single center study.
    PLoS One. 2021;16:e0253159.
    PubMed     Abstract available


  86. SINGPANOMCHAI N, Akeda Y, Tomono K, Tamaru A, et al
    Rapid detection of multidrug-resistant tuberculosis based on allele-specific recombinase polymerase amplification and colorimetric detection.
    PLoS One. 2021;16:e0253235.
    PubMed     Abstract available


  87. SYLVERKEN AA, Kwarteng A, Twumasi-Ankrah S, Owusu M, et al
    The burden of drug resistance tuberculosis in Ghana; results of the First National Survey.
    PLoS One. 2021;16:e0252819.
    PubMed     Abstract available


  88. ARCENCIO RA, Berra TZ, Terena NFM, Rocha MP, et al
    Spatial clustering and temporal trend analysis of international migrants diagnosed with tuberculosis in Brazil.
    PLoS One. 2021;16:e0252712.
    PubMed     Abstract available


  89. JEREMIAH K, Lyimo E, Ritz C, PrayGod G, et al
    Prevalence of Mycobacterium tuberculosis infection as measured by the QuantiFERON-TB Gold assay and ESAT-6 free IGRA among adolescents in Mwanza, Tanzania.
    PLoS One. 2021;16:e0252808.
    PubMed     Abstract available



  90. Retraction: The Clinical Outcomes of Surgical Treatment of Noncontiguous Spinal Tuberculosis: A Retrospective Study in 23 Cases.
    PLoS One. 2021;16:e0253035.
    PubMed    


  91. THOMAS BE, Thiruvengadam K, Vedhachalam C, A S, et al
    Prevalence of pulmonary tuberculosis among the tribal populations in India.
    PLoS One. 2021;16:e0251519.
    PubMed     Abstract available


  92. QADER GQ, Seddiq MK, Rashidi KM, Manzoor L, et al
    Prevalence of latent tuberculosis infection among health workers in Afghanistan: A cross-sectional study.
    PLoS One. 2021;16:e0252307.
    PubMed     Abstract available


  93. MUSAKWA NO, Bor J, Nattey C, Lonnermark E, et al
    Perceived barriers to the uptake of health services among first-year university students in Johannesburg, South Africa.
    PLoS One. 2021;16:e0245427.
    PubMed     Abstract available


  94. WOLDU HG, Zalwango S, Martinez L, Castellanos ME, et al
    Defining an intermediate category of tuberculin skin test: A mixture model analysis of two high-risk populations from Kampala, Uganda.
    PLoS One. 2021;16:e0245328.
    PubMed     Abstract available


  95. LIANG T, Chen J, Xu G, Zhang Z, et al
    Immune status changing helps diagnose osteoarticular tuberculosis.
    PLoS One. 2021;16:e0252875.
    PubMed     Abstract available


  96. OSMAN M, Meehan SA, von Delft A, Du Preez K, et al
    Early mortality in tuberculosis patients initially lost to follow up following diagnosis in provincial hospitals and primary health care facilities in Western Cape, South Africa.
    PLoS One. 2021;16:e0252084.
    PubMed     Abstract available


  97. PAN SW, Su WJ, Chan YJ, Chuang FY, et al
    Mycobacterium tuberculosis-derived circulating cell-free DNA in patients with pulmonary tuberculosis and persons with latent tuberculosis infection.
    PLoS One. 2021;16:e0253879.
    PubMed     Abstract available


  98. AGGARWAL AN, Agarwal R, Dhooria S, Prasad KT, et al
    Comparative accuracy of pleural fluid unstimulated interferon-gamma and adenosine deaminase for diagnosing pleural tuberculosis: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0253525.
    PubMed     Abstract available


  99. YU G, Shen Y, Ye B, Shi Y, et al
    Diagnostic accuracy of Mycobacterium tuberculosis cell-free DNA for tuberculosis: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0253658.
    PubMed     Abstract available


  100. INOUE K, Kashima S
    Association of the past epidemic of Mycobacterium tuberculosis with mortality and incidence of COVID-19.
    PLoS One. 2021;16:e0253169.
    PubMed     Abstract available


  101. CHAI J, Wang Q, Qin B, Wang S, et al
    Association of NOS2A gene polymorphisms with susceptibility to bovine tuberculosis in Chinese Holstein cattle.
    PLoS One. 2021;16:e0253339.
    PubMed     Abstract available


  102. MOHIDEM NA, Osman M, Hashim Z, Muharam FM, et al
    Association of sociodemographic and environmental factors with spatial distribution of tuberculosis cases in Gombak, Selangor, Malaysia.
    PLoS One. 2021;16:e0252146.
    PubMed     Abstract available


  103. LAZZARI TK, Cavalheiro E, Coutinho SE, da Silva LF, et al
    Leptin and advanced glycation end products receptor (RAGE) in tuberculosis patients.
    PLoS One. 2021;16:e0254198.
    PubMed     Abstract available


  104. OUDGHIRI A, Momen G, Aainouss A, Laglaoui A, et al
    Genotypic diversity of multi- and pre-extremely drug-resistant Mycobacterium tuberculosis isolates from Morocco.
    PLoS One. 2021;16:e0253826.
    PubMed     Abstract available


  105. ALMAW G, Conlan AJK, Ameni G, Gumi B, et al
    The variable prevalence of bovine tuberculosis among dairy herds in Central Ethiopia provides opportunities for targeted intervention.
    PLoS One. 2021;16:e0254091.
    PubMed     Abstract available


  106. OBSA MS, Daga WB, Wosene NG, Gebremedhin TD, et al
    Treatment seeking delay and associated factors among tuberculosis patients attending health facility in Ethiopia from 2000 to 2020: A systematic review and meta analysis.
    PLoS One. 2021;16:e0253746.
    PubMed     Abstract available


  107. DAWIT Z, Abebe S, Dessu S, Mesele M, et al
    Incidence and predictors of mortality among children co-infected with tuberculosis and human immunodeficiency virus at public hospitals in Southern Ethiopia.
    PLoS One. 2021;16:e0253449.
    PubMed     Abstract available


  108. ALEMU A, Bitew ZW, Worku T, Gamtesa DF, et al
    Predictors of mortality in patients with drug-resistant tuberculosis: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0253848.
    PubMed     Abstract available


  109. CRECELIUS EM, Lustik MB, Horseman TS, Jones MU, et al
    The prevalence of M. tuberculosis among acid fast bacilli cultures from military health system and veterans affairs beneficiaries in Hawaii and the Pacific Islands from 2002 to 2019.
    PLoS One. 2021;16:e0254312.
    PubMed     Abstract available


  110. CUONG NK, Ngoc NB, Hoa NB, Dat VQ, et al
    GeneXpert on patients with human immunodeficiency virus and smear-negative pulmonary tuberculosis.
    PLoS One. 2021;16:e0253961.
    PubMed     Abstract available


  111. TADOKERA R, Huo S, Theron G, Timire C, et al
    Health care seeking patterns of rifampicin-resistant tuberculosis patients in Harare, Zimbabwe: A prospective cohort study.
    PLoS One. 2021;16:e0254204.
    PubMed     Abstract available


  112. TANG J, Huang Y, Cai Z, Ma Y, et al
    Mycobacterial heparin-binding hemagglutinin (HBHA)-induced interferon-gamma release assay (IGRA) for discrimination of latent and active tuberculosis: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0254571.
    PubMed     Abstract available


  113. MAOKOLA WM, Ngowi BJ, Mahande MJ, Todd J, et al
    Impact of Isoniazid Preventive Therapy on Tuberculosis incidence among people living with HIV: A secondary data analysis using Inverse Probability Weighting of individuals attending HIV care and treatment clinics in Tanzania.
    PLoS One. 2021;16:e0254082.
    PubMed     Abstract available


  114. SHAYO FK, Shayo SC
    Readiness of healthcare facilities with tuberculosis services to manage diabetes mellitus in Tanzania: A nationwide analysis for evidence-informed policy-making in high burden settings.
    PLoS One. 2021;16:e0254349.
    PubMed     Abstract available


  115. BOAH M, Kpordoxah MR, Adokiya MN
    Self-reported gender differentials in the knowledge of tuberculosis transmission and curative possibility using national representative data in Ghana.
    PLoS One. 2021;16:e0254499.
    PubMed     Abstract available


  116. SAMUELS THA, Wyss R, Ongarello S, Moore DAJ, et al
    Evaluation of the diagnostic performance of laboratory-based c-reactive protein as a triage test for active pulmonary tuberculosis.
    PLoS One. 2021;16:e0254002.
    PubMed     Abstract available


  117. TAYE H, Alemu K, Mihret A, Ayalew S, et al
    Epidemiology of Mycobacterium tuberculosis lineages and strain clustering within urban and peri-urban settings in Ethiopia.
    PLoS One. 2021;16:e0253480.
    PubMed     Abstract available


  118. SALCEDO J, Rosales M, Kim JS, Nuno D, et al
    Cost-effectiveness of artificial intelligence monitoring for active tuberculosis treatment: A modeling study.
    PLoS One. 2021;16:e0254950.
    PubMed     Abstract available


    January 2020
  119. RUIZ-GROSSO P, Cachay R, de la Flor A, Schwalb A, et al
    Association between tuberculosis and depression on negative outcomes of tuberculosis treatment: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0227472.
    PubMed     Abstract available


  120. YAMAUCHI M, Kinjo T, Parrott G, Miyagi K, et al
    Diagnostic performance of serum interferon gamma, matrix metalloproteinases, and periostin measurements for pulmonary tuberculosis in Japanese patients with pneumonia.
    PLoS One. 2020;15:e0227636.
    PubMed     Abstract available


  121. MORASKI GC, Deboosere N, Marshall KL, Weaver HA, et al
    Intracellular and in vivo evaluation of imidazo[2,1-b]thiazole-5-carboxamide anti-tuberculosis compounds.
    PLoS One. 2020;15:e0227224.
    PubMed     Abstract available


  122. ALENE KA, Viney K, Gray DJ, McBryde ES, et al
    Development of a risk score for prediction of poor treatment outcomes among patients with multidrug-resistant tuberculosis.
    PLoS One. 2020;15:e0227100.
    PubMed     Abstract available


  123. ERESO BM, Yimer SA, Gradmann C, Sagbakken M, et al
    Barriers for tuberculosis case finding in Southwest Ethiopia: A qualitative study.
    PLoS One. 2020;15:e0226307.
    PubMed     Abstract available


  124. BRUGUERAS S, Molina VI, Casas X, Gonzalez YD, et al
    Tuberculosis recurrences and predictive factors in a vulnerable population in Catalonia.
    PLoS One. 2020;15:e0227291.
    PubMed     Abstract available


  125. MARAHATTA SB, Yadav RK, Giri D, Lama S, et al
    Barriers in the access, diagnosis and treatment completion for tuberculosis patients in central and western Nepal: A qualitative study among patients, community members and health care workers.
    PLoS One. 2020;15:e0227293.
    PubMed     Abstract available


  126. KUMAR SK, Arya S, Aggarwal A, Kapoor P, et al
    Immune responses to Mycobacterium tuberculosis membrane-associated antigens including alpha crystallin can potentially discriminate between latent infection and active tuberculosis disease.
    PLoS One. 2020;15:e0228359.
    PubMed     Abstract available


  127. YAKHELEF N, Audibert M, Ferlazzo G, Sitienei J, et al
    Cost-effectiveness of diagnostic algorithms including lateral-flow urine lipoarabinomannan for HIV-positive patients with symptoms of tuberculosis.
    PLoS One. 2020;15:e0227138.
    PubMed     Abstract available


  128. MARQUEZ C, Atukunda M, Balzer LB, Chamie G, et al
    The age-specific burden and household and school-based predictors of child and adolescent tuberculosis infection in rural Uganda.
    PLoS One. 2020;15:e0228102.
    PubMed     Abstract available


  129. SAMPAIO VS, Rodrigues MGA, Silva LCFD, Castro DB, et al
    Social, demographic, health care and co-morbidity predictors of tuberculosis mortality in Amazonas, Brazil: a multiple cause of death approach.
    PLoS One. 2020;15:e0218359.
    PubMed     Abstract available


  130. ENGLE E, Gabrielian A, Long A, Hurt DE, et al
    Performance of Qure.ai automatic classifiers against a large annotated database of patients with diverse forms of tuberculosis.
    PLoS One. 2020;15:e0224445.
    PubMed     Abstract available


  131. NYANGOMA M, Bajunirwe F, Atwine D
    Non-disclosure of tuberculosis diagnosis by patients to their household members in south western Uganda.
    PLoS One. 2020;15:e0216689.
    PubMed     Abstract available


  132. SAFAR HA, Mustafa AS, Amoudy HA, El-Hashim A, et al
    The effect of adjuvants and delivery systems on Th1, Th2, Th17 and Treg cytokine responses in mice immunized with Mycobacterium tuberculosis-specific proteins.
    PLoS One. 2020;15:e0228381.
    PubMed     Abstract available


  133. SARKAR A, Ghosh S, Shaw R, Patra MM, et al
    Mycobacterium tuberculosis thymidylate synthase (ThyX) is a target for plumbagin, a natural product with antimycobacterial activity.
    PLoS One. 2020;15:e0228657.
    PubMed     Abstract available


  134. SINGH H, Ramamohan V
    A model-based investigation into urban-rural disparities in tuberculosis treatment outcomes under the Revised National Tuberculosis Control Programme in India.
    PLoS One. 2020;15:e0228712.
    PubMed     Abstract available


  135. SHIBABAW A, Gelaw B, Gebreyes W, Robinson R, et al
    The burden of pre-extensively and extensively drug-resistant tuberculosis among MDR-TB patients in the Amhara region, Ethiopia.
    PLoS One. 2020;15:e0229040.
    PubMed     Abstract available


  136. GOMEZ AC, Rodriguez-Fernandez P, Villar-Hernandez R, Gibert I, et al
    E-cigarettes: Effects in phagocytosis and cytokines response against Mycobacterium tuberculosis.
    PLoS One. 2020;15:e0228919.
    PubMed     Abstract available


  137. TOLA HH, Holakouie-Naieni K, Mansournia MA, Yaseri M, et al
    Low enrollment and high treatment success in children with drug-resistant tuberculosis in Ethiopia: A ten years national retrospective cohort study.
    PLoS One. 2020;15:e0229284.
    PubMed     Abstract available


  138. SAMPAIO VS, Rodrigues MGA, Silva LCFD, Castro DB, et al
    Correction: Social, demographic, health care and co-morbidity predictors of tuberculosis mortality in Amazonas, Brazil: a multiple cause of death approach.
    PLoS One. 2020;15:e0229749.
    PubMed     Abstract available


  139. ARPAGAUS A, Franzeck FC, Sikalengo G, Ndege R, et al
    Extrapulmonary tuberculosis in HIV-infected patients in rural Tanzania: The prospective Kilombero and Ulanga antiretroviral cohort.
    PLoS One. 2020;15:e0229875.
    PubMed     Abstract available


  140. TUCCI P, Portela M, Chetto CR, Gonzalez-Sapienza G, et al
    Integrative proteomic and glycoproteomic profiling of Mycobacterium tuberculosis culture filtrate.
    PLoS One. 2020;15:e0221837.
    PubMed     Abstract available


  141. EDWARDS BD, Edwards J, Cooper R, Kunimoto D, et al
    Incidence, treatment, and outcomes of isoniazid mono-resistant Mycobacterium tuberculosis infections in Alberta, Canada from 2007-2017.
    PLoS One. 2020;15:e0229691.
    PubMed     Abstract available


  142. OU X, Li Q, Su D, Xia H, et al
    A pilot study: VereMTB detection kit for rapid detection of multidrug-resistant mycobcterium tuberculosis in clinical sputum samples.
    PLoS One. 2020;15:e0228312.
    PubMed     Abstract available


  143. NACARAPA E, Muchiri E, Moon TD, Charalambous S, et al
    Effect of Xpert MTB/RIF testing introduction and favorable outcome predictors for tuberculosis treatment among HIV infected adults in rural southern Mozambique. A retrospective cohort study.
    PLoS One. 2020;15:e0229995.
    PubMed     Abstract available


  144. DER JB, Grint D, Narh CT, Bonsu F, et al
    Where are patients missed in the tuberculosis diagnostic cascade? A prospective cohort study in Ghana.
    PLoS One. 2020;15:e0230604.
    PubMed     Abstract available


  145. SHIFERAW MB, Sisay Misganaw A
    Evaluation of continuous quality improvement of tuberculosis and HIV diagnostic services in Amhara Public Health Institute, Ethiopia.
    PLoS One. 2020;15:e0230532.
    PubMed     Abstract available


  146. MACPHERSON P, Lebina L, Motsomi K, Bosch Z, et al
    Prevalence and risk factors for latent tuberculosis infection among household contacts of index cases in two South African provinces: Analysis of baseline data from a cluster-randomised trial.
    PLoS One. 2020;15:e0230376.
    PubMed     Abstract available


  147. SRIVASTAVA S, Chapagain M, Gumbo T
    Effect of specimen processing, growth supplement, and different metabolic population on Mycobacterium tuberculosis laboratory diagnosis.
    PLoS One. 2020;15:e0230927.
    PubMed     Abstract available


  148. SUN HY, Wang JY, Chen YC, Hsueh PR, et al
    Impact of introducing fluorescent microscopy on hospital tuberculosis control: A before-after study at a high caseload medical center in Taiwan.
    PLoS One. 2020;15:e0230067.
    PubMed     Abstract available


  149. ARINAMINPATHY N, Gomez GB, Sachdeva KS, Rao R, et al
    The potential deployment of a pan-tuberculosis drug regimen in India: A modelling analysis.
    PLoS One. 2020;15:e0230808.
    PubMed     Abstract available


  150. LOBIE TA, Woldeamanuel Y, Asrat D, Beyene D, et al
    Genetic diversity and drug resistance pattern of Mycobacterium tuberculosis strains isolated from pulmonary tuberculosis patients in the Benishangul Gumuz region and its surroundings, Northwest Ethiopia.
    PLoS One. 2020;15:e0231320.
    PubMed     Abstract available


  151. MOORE BK, Erasmus L, Ershova J, Smith SE, et al
    Pre-treatment loss to follow-up among children with multidrug-resistant tuberculosis in South Africa, 2008-2010.
    PLoS One. 2020;15:e0230504.
    PubMed     Abstract available


  152. HUSSAIN T, Tripathy SS, Das S, Satapathy P, et al
    Prevalence, risk factors and health seeking behaviour of pulmonary tuberculosis in four tribal dominated districts of Odisha: Comparison with studies in other regions of India.
    PLoS One. 2020;15:e0227083.
    PubMed     Abstract available


  153. BEUTLER M, Plesnik S, Mihalic M, Olbrich L, et al
    A pre-clinical validation plan to evaluate analytical sensitivities of molecular diagnostics such as BD MAX MDR-TB, Xpert MTB/Rif Ultra and FluoroType MTB.
    PLoS One. 2020;15:e0227215.
    PubMed     Abstract available


  154. HONG JH, Yoon SH, Goo JM, Yim JJ, et al
    Clustered micronodules as predominant manifestation on CT: A sign of active but indolently evolving pulmonary tuberculosis.
    PLoS One. 2020;15:e0231537.
    PubMed     Abstract available


  155. VARELA-CASTRO L, Alvarez V, Sevilla IA, Barral M, et al
    Risk factors associated to a high Mycobacterium tuberculosis complex seroprevalence in wild boar (Sus scrofa) from a low bovine tuberculosis prevalence area.
    PLoS One. 2020;15:e0231559.
    PubMed     Abstract available


  156. HU J, Jin K, He ZG, Zhang H, et al
    Citrate lyase CitE in Mycobacterium tuberculosis contributes to mycobacterial survival under hypoxic conditions.
    PLoS One. 2020;15:e0230786.
    PubMed     Abstract available


  157. KAEWSEEKHAO B, Roytrakul S, Yingchutrakul Y, Salao K, et al
    Proteomic analysis of infected primary human leucocytes revealed PSTK as potential treatment-monitoring marker for active and latent tuberculosis.
    PLoS One. 2020;15:e0231834.
    PubMed     Abstract available


  158. RAJAVEL S, Raghav P, Gupta MK, Muralidhar V, et al
    Silico-tuberculosis, silicosis and other respiratory morbidities among sandstone mine workers in Rajasthan- a cross-sectional study.
    PLoS One. 2020;15:e0230574.
    PubMed     Abstract available


  159. JO Y, Mirzoeva F, Chry M, Qin ZZ, et al
    Standardized framework for evaluating costs of active case-finding programs: An analysis of two programs in Cambodia and Tajikistan.
    PLoS One. 2020;15:e0228216.
    PubMed     Abstract available


  160. NIETO RAMIREZ LM, Ferro BE, Diaz G, Anthony RM, et al
    Genetic profiling of Mycobacterium tuberculosis revealed "modern" Beijing strains linked to MDR-TB from Southwestern Colombia.
    PLoS One. 2020;15:e0224908.
    PubMed     Abstract available


  161. NGUYEN HV, Tiemersma EW, Nguyen HB, Cobelens FGJ, et al
    The second national tuberculosis prevalence survey in Vietnam.
    PLoS One. 2020;15:e0232142.
    PubMed     Abstract available


  162. MIGAMBI P, Gasana M, Uwizeye CB, Kamanzi E, et al
    Prevalence of tuberculosis in Rwanda: Results of the first nationwide survey in 2012 yielded important lessons for TB control.
    PLoS One. 2020;15:e0231372.
    PubMed     Abstract available


  163. TOK PSK, Liew SM, Wong LP, Razali A, et al
    Determinants of unsuccessful treatment outcomes and mortality among tuberculosis patients in Malaysia: A registry-based cohort study.
    PLoS One. 2020;15:e0231986.
    PubMed     Abstract available


  164. CHIRENDA J, Gwitira I, Warren RM, Sampson SL, et al
    Spatial distribution of Mycobacterium Tuberculosis in metropolitan Harare, Zimbabwe.
    PLoS One. 2020;15:e0231637.
    PubMed     Abstract available


  165. DESAI AN, Seshasayee SM, Majumder MS, Lassmann B, et al
    Tuberculosis and foreign-born populations in the United States: A mixed methods pilot study of media reporting and political identification.
    PLoS One. 2020;15:e0230967.
    PubMed     Abstract available


  166. HUIBERS MHW, Bates I, McKew S, Allain TJ, et al
    Severe anaemia complicating HIV in Malawi; Multiple co-existing aetiologies are associated with high mortality.
    PLoS One. 2020;15:e0218695.
    PubMed     Abstract available


  167. MATAMBO R, Takarinda KC, Thekkur P, Sandy C, et al
    Treatment outcomes of multi drug resistant and rifampicin resistant Tuberculosis in Zimbabwe: A cohort analysis of patients initiated on treatment during 2010 to 2015.
    PLoS One. 2020;15:e0230848.
    PubMed     Abstract available


  168. TESEMA T, Seyoum D, Ejeta E, Tsegaye R, et al
    Determinants of tuberculosis treatment outcome under directly observed treatment short courses in Adama City, Ethiopia.
    PLoS One. 2020;15:e0232468.
    PubMed     Abstract available


  169. WANG N, Shewade HD, Thekkur P, Huang F, et al
    Electronic medication monitor for people with tuberculosis: Implementation experience from thirty counties in China.
    PLoS One. 2020;15:e0232337.
    PubMed     Abstract available


  170. TAHSEEN S, Khanzada FM, Baloch AQ, Abbas Q, et al
    Extrapulmonary tuberculosis in Pakistan- A nation-wide multicenter retrospective study.
    PLoS One. 2020;15:e0232134.
    PubMed     Abstract available


  171. MWAURA M, Kao K, Wambugu J, Trollip A, et al
    Situating trade-offs: Stakeholder perspectives on overtreatment versus missed diagnosis in transition to Xpert MTB/RIF Ultra in Kenya and Swaziland.
    PLoS One. 2020;15:e0228669.
    PubMed     Abstract available


  172. ROWNEKI M, Aronson N, Du P, Sachs P, et al
    Detection of drug resistant Mycobacterium tuberculosis by high-throughput sequencing of DNA isolated from acid fast bacilli smears.
    PLoS One. 2020;15:e0232343.
    PubMed     Abstract available


  173. ALEMU A, Yesuf A, Gebrehanna E, Zerihun B, et al
    Incidence and predictors of extrapulmonary tuberculosis among people living with Human Immunodeficiency Virus in Addis Ababa, Ethiopia: A retrospective cohort study.
    PLoS One. 2020;15:e0232426.
    PubMed     Abstract available


  174. BISOGNIN F, Lombardi G, Finelli C, Re MC, et al
    Simultaneous detection of Mycobacterium tuberculosis complex and resistance to Rifampicin and Isoniazid by MDR/MTB ELITe MGB(R) Kit for the diagnosis of tuberculosis.
    PLoS One. 2020;15:e0232632.
    PubMed     Abstract available


  175. NALUYANGE R, Mboowa G, Komakech K, Semugenze D, et al
    High prevalence of phenotypic pyrazinamide resistance and its association with pncA gene mutations in Mycobacterium tuberculosis isolates from Uganda.
    PLoS One. 2020;15:e0232543.
    PubMed     Abstract available


  176. LISBOA M, Fronteira I, Mason PH, Martins MDRO, et al
    National TB program shortages as potential factor for poor-quality TB care cascade: Healthcare workers' perspective from Beira, Mozambique.
    PLoS One. 2020;15:e0228927.
    PubMed     Abstract available


  177. CHEKESA B, Gumi B, Chanyalew M, Zewude A, et al
    Prevalence of latent tuberculosis infection and associated risk factors in prison in East Wollega Zone of western Ethiopia.
    PLoS One. 2020;15:e0233314.
    PubMed     Abstract available


  178. MARTINEZ-GUIJOSA J, Romero B, Infantes-Lorenzo JA, Diez E, et al
    Environmental DNA: A promising factor for tuberculosis risk assessment in multi-host settings.
    PLoS One. 2020;15:e0233837.
    PubMed     Abstract available


  179. DEMEMEW ZG, Jerene D, Datiko DG, Hiruy N, et al
    The yield of community-based tuberculosis and HIV among key populations in hotspot settings of Ethiopia: A cross-sectional implementation study.
    PLoS One. 2020;15:e0233730.
    PubMed     Abstract available


  180. YU EA, Finkelstein JL, Brannon PM, Bonam W, et al
    Nutritional assessment among adult patients with suspected or confirmed active tuberculosis disease in rural India.
    PLoS One. 2020;15:e0233306.
    PubMed     Abstract available


  181. TESFAYE L, Lemu YK, Tareke KG, Chaka M, et al
    Exploration of barriers and facilitators to household contact tracing of index tuberculosis cases in Anlemo district, Hadiya zone, Southern Ethiopia: Qualitative study.
    PLoS One. 2020;15:e0233358.
    PubMed     Abstract available


  182. WOLDAY D, Kebede Y, Legesse D, Siraj DS, et al
    Role of CD4/CD8 ratio on the incidence of tuberculosis in HIV-infected patients on antiretroviral therapy followed up for more than a decade.
    PLoS One. 2020;15:e0233049.
    PubMed     Abstract available


  183. HOLDEN IK, Lillebaek T, Andersen PH, Wejse C, et al
    Characteristics and predictors for tuberculosis related mortality in Denmark from 2009 through 2014: A retrospective cohort study.
    PLoS One. 2020;15:e0231821.
    PubMed     Abstract available


  184. JAGANATH D, Rajan J, Yoon C, Ravindran R, et al
    Evaluation of multi-antigen serological screening for active tuberculosis among people living with HIV.
    PLoS One. 2020;15:e0234130.
    PubMed     Abstract available


  185. GEHLEN M, Costa ERD, Rossetti MLR, Silva DR, et al
    Macrophage migration inhibitory factor -173 G>C single nucleotide polymorphism and its association with active pulmonary tuberculosis.
    PLoS One. 2020;15:e0234565.
    PubMed     Abstract available


  186. KAKINDA M, Matovu JKB
    A yield and cost comparison of tuberculosis contact investigation and intensified case finding in Uganda.
    PLoS One. 2020;15:e0234418.
    PubMed     Abstract available


  187. LEE GO, Comina G, Hernandez-Cordova G, Naik N, et al
    Cough dynamics in adults receiving tuberculosis treatment.
    PLoS One. 2020;15:e0231167.
    PubMed     Abstract available


  188. KIM OH, Jo KW, Park S, Jo YH, et al
    Comparison of the change in QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube results after preventive therapy for latent tuberculosis infection.
    PLoS One. 2020;15:e0234700.
    PubMed     Abstract available


  189. CHAVAN VV, Dalal A, Nagaraja S, Thekkur P, et al
    Ambulatory management of pre- and extensively drug resistant tuberculosis patients with imipenem delivered through port-a-cath: A mixed methods study on treatment outcomes and challenges.
    PLoS One. 2020;15:e0234651.
    PubMed     Abstract available


  190. RUFAI SB, Umay K, Singh PK, Singh S, et al
    Performance of Genotype MTBDRsl V2.0 over the Genotype MTBDRsl V1 for detection of second line drug resistance: An Indian perspective.
    PLoS One. 2020;15:e0229419.
    PubMed     Abstract available


  191. SAFE IP, Lacerda MVG, Printes VS, Praia Marins AF, et al
    Safety and efficacy of N-acetylcysteine in hospitalized patients with HIV-associated tuberculosis: An open-label, randomized, phase II trial (RIPENACTB Study).
    PLoS One. 2020;15:e0235381.
    PubMed     Abstract available


  192. KIM SB, Lee WY, Lee JH, Lee SJ, et al
    A variety of bacterial aetiologies in the lower respiratory tract at patients with endobronchial tuberculosis.
    PLoS One. 2020;15:e0234558.
    PubMed     Abstract available


  193. OSEI E, Oppong S, Der J
    Trends of tuberculosis case detection, mortality and co-infection with HIV in Ghana: A retrospective cohort study.
    PLoS One. 2020;15:e0234878.
    PubMed     Abstract available


  194. GENET C, Andualem T, Melese A, Mulu W, et al
    Quality of care for tuberculosis patients in public health facilities of Debre Tabor town, Northwest Ethiopia.
    PLoS One. 2020;15:e0234988.
    PubMed     Abstract available


  195. KYAW KWY, Kyaw NTT, Kyi MS, Aye S, et al
    HIV testing uptake and HIV positivity among presumptive tuberculosis patients in Mandalay, Myanmar, 2014-2017.
    PLoS One. 2020;15:e0234429.
    PubMed     Abstract available


  196. SPEKKER O, Hunt DR, Paja L, Molnar E, et al
    Tracking down the White Plague: The skeletal evidence of tuberculous meningitis in the Robert J. Terry Anatomical Skeletal Collection.
    PLoS One. 2020;15:e0230418.
    PubMed     Abstract available


  197. OTIENDE VA, Achia TN, Mwambi HG
    Bayesian hierarchical modeling of joint spatiotemporal risk patterns for Human Immunodeficiency Virus (HIV) and Tuberculosis (TB) in Kenya.
    PLoS One. 2020;15:e0234456.
    PubMed     Abstract available


  198. BUNYASI EW, Mulenga H, Luabeya AKK, Shenje J, et al
    Regional changes in tuberculosis disease burden among adolescents in South Africa (2005-2015).
    PLoS One. 2020;15:e0235206.
    PubMed     Abstract available


  199. AREFAINE ZG, Abebe S, Bekele E, Adem A, et al
    Incidence and predictors of HIV related opportunistic infections after initiation of highly active antiretroviral therapy at Ayder Referral Hospital, Mekelle, Ethiopia: A retrospective single centered cohort study.
    PLoS One. 2020;15:e0229757.
    PubMed     Abstract available


  200. BASHAM CA, Smith SJ, Romanowski K, Johnston JC, et al
    Cardiovascular morbidity and mortality among persons diagnosed with tuberculosis: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0235821.
    PubMed     Abstract available


  201. BAHRAINWALA L, Knoblauch AM, Andriamiadanarivo A, Diab MM, et al
    Drones and digital adherence monitoring for community-based tuberculosis control in remote Madagascar: A cost-effectiveness analysis.
    PLoS One. 2020;15:e0235572.
    PubMed     Abstract available


  202. KIM S, de Los Reyes V AA, Jung E
    Country-specific intervention strategies for top three TB burden countries using mathematical model.
    PLoS One. 2020;15:e0230964.
    PubMed     Abstract available


  203. NGUYEN HV, Tiemersma EW, Nguyen HB, Cobelens FGJ, et al
    Correction: The second national tuberculosis prevalence survey in Vietnam.
    PLoS One. 2020;15:e0236532.
    PubMed     Abstract available


  204. LEAL DFDVB, Santana da Silva MN, Fernandes DCRO, Rodrigues JCG, et al
    Amerindian genetic ancestry as a risk factor for tuberculosis in an amazonian population.
    PLoS One. 2020;15:e0236033.
    PubMed     Abstract available


  205. TANEJA V, Kalra P, Goel M, Khilnani GC, et al
    Impact and prognosis of the expression of IFN-alpha among tuberculosis patients.
    PLoS One. 2020;15:e0235488.
    PubMed     Abstract available


  206. SEMA BALTAZAR C, DeLima YV, Ricardo H, Botao C, et al
    HIV prevalence and TB in migrant miners communities of origin in Gaza Province, Mozambique: The need for increasing awareness and knowledge.
    PLoS One. 2020;15:e0231303.
    PubMed     Abstract available


  207. KUDDUS MA, Meehan MT, White LJ, McBryde ES, et al
    Modeling drug-resistant tuberculosis amplification rates and intervention strategies in Bangladesh.
    PLoS One. 2020;15:e0236112.
    PubMed     Abstract available


  208. TOONKOMDANG S, Phinyo P, Phetsuksiri B, Patumanond J, et al
    Pragmatic accuracy of an in-house loop-mediated isothermal amplification (LAMP) for diagnosis of pulmonary tuberculosis in a Thai community hospital.
    PLoS One. 2020;15:e0236496.
    PubMed     Abstract available


  209. KWON BS, Kim Y, Lee SH, Lim SY, et al
    The high incidence of severe adverse events due to pyrazinamide in elderly patients with tuberculosis.
    PLoS One. 2020;15:e0236109.
    PubMed     Abstract available


  210. ESTEVEZ O, Anibarro L, Garet E, Pallares A, et al
    Identification of candidate host serum and saliva biomarkers for a better diagnosis of active and latent tuberculosis infection.
    PLoS One. 2020;15:e0235859.
    PubMed     Abstract available


  211. CASAS I, Esteve M, Guerola R, Latorre I, et al
    Serial testing of health care workers for tuberculosis infection: A prospective cohort study.
    PLoS One. 2020;15:e0235986.
    PubMed     Abstract available


  212. SUPO-ESCALANTE RR, Medico A, Gushiken E, Olivos-Ramirez GE, et al
    Prediction of Mycobacterium tuberculosis pyrazinamidase function based on structural stability, physicochemical and geometrical descriptors.
    PLoS One. 2020;15:e0235643.
    PubMed     Abstract available


  213. SOBOKA M, Tolessa O, Tesfaye M, Adorjan K, et al
    Magnitude and predictors of khat use among patients with tuberculosis in Southwest Ethiopia: A longitudinal study.
    PLoS One. 2020;15:e0236154.
    PubMed     Abstract available


  214. PARADKAR M, Padmapriyadarsini C, Jain D, Shivakumar SVBY, et al
    Tuberculosis preventive treatment should be considered for all household contacts of pulmonary tuberculosis patients in India.
    PLoS One. 2020;15:e0236743.
    PubMed     Abstract available


  215. TENZIN C, Chansatitporn N, Dendup T, Dorji T, et al
    Factors associated with multidrug-resistant tuberculosis (MDR-TB) in Bhutan: A nationwide case-control study.
    PLoS One. 2020;15:e0236250.
    PubMed     Abstract available


  216. ALEMAYEHU S, Yigezu A, Hailemariam D, Hailu A, et al
    Cost-effectiveness of treating multidrug-resistant tuberculosis in treatment initiative centers and treatment follow-up centers in Ethiopia.
    PLoS One. 2020;15:e0235820.
    PubMed     Abstract available


  217. ZHU QQ, Wu Q, Wang AM, Bao FJ, et al
    Epidemiological characteristics of pulmonary tuberculosis in Anhui Province, Eastern China from 2013 to 2018.
    PLoS One. 2020;15:e0237311.
    PubMed     Abstract available


  218. NIKI M, Yoshiyama T, Nagai H, Miyamoto Y, et al
    Nutritional status positively impacts humoral immunity against its Mycobacterium tuberculosis, disease progression, and vaccine development.
    PLoS One. 2020;15:e0237062.
    PubMed     Abstract available


  219. SHINU P, Singh VA, Nair A, Venugopala KN, et al
    Papain-cetylpyridinium chloride and pepsin-cetylpyridinium chloride; two novel, highly sensitive, concentration, digestion and decontamination techniques for culturing mycobacteria from clinically suspected pulmonary tuberculosis cases.
    PLoS One. 2020;15:e0236700.
    PubMed     Abstract available


  220. KASHONGWE IM, Mawete F, Mbulula L, Nsuela DJ, et al
    Outcomes and adverse events of pre- and extensively drug-resistant tuberculosis patients in Kinshasa, Democratique Republic of the Congo: A retrospective cohort study.
    PLoS One. 2020;15:e0236264.
    PubMed     Abstract available


  221. TILAHUN M, Shimelis E, Wogayehu T, Assefa G, et al
    Molecular detection of multidrug resistance pattern and associated gene mutations in M. tuberculosis isolates from newly diagnosed pulmonary tuberculosis patients in Addis Ababa, Ethiopia.
    PLoS One. 2020;15:e0236054.
    PubMed     Abstract available


  222. GRANDE SW, Adams LV, Maseko TSB, Talbot EA, et al
    The social implications of participant choice on adherence to Isonaizid Preventive Therapy (IPT): A follow-up study to high completion rates in Eswatini.
    PLoS One. 2020;15:e0232841.
    PubMed     Abstract available


  223. UMEKITA K, Hashiba Y, Iwao K, Iwao C, et al
    Human T-cell leukemia virus type 1 may invalidate T-SPOT.TB assay results in rheumatoid arthritis patients: A retrospective case-control observational study.
    PLoS One. 2020;15:e0233159.
    PubMed     Abstract available


  224. HASSANE-HAROUNA S, Cherif GF, Ortuno-Gutierrez N, Cisse D, et al
    Better programmatic outcome with the shorter regimen for the treatment of multidrug-resistant tuberculosis (MDR-TB) in Guinea: A retrospective cohort study.
    PLoS One. 2020;15:e0237355.
    PubMed     Abstract available


  225. PANDEY P, Bhatnagar AK, Mohan A, Sachdeva KS, et al
    Mycobacterium tuberculosis polyclonal infections through treatment and recurrence.
    PLoS One. 2020;15:e0237345.
    PubMed     Abstract available


  226. EDESSA D, Sisay M, Dessie Y
    Unfavorable outcomes to second-line tuberculosis therapy among HIV-infected versus HIV-uninfected patients in sub-Saharan Africa: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0237534.
    PubMed     Abstract available


  227. WELEKIDAN LN, Skjerve E, Dejene TA, Gebremichael MW, et al
    Characteristics of pulmonary multidrug-resistant tuberculosis patients in Tigray Region, Ethiopia: A cross-sectional study.
    PLoS One. 2020;15:e0236362.
    PubMed     Abstract available


  228. DABHI PA, Thangakunam B, Gupta R, James P, et al
    Screening for prevalence of current TB disease and latent TB infection in type 2 diabetes mellitus patients attending a diabetic clinic in an Indian tertiary care hospital.
    PLoS One. 2020;15:e0233385.
    PubMed     Abstract available


  229. VAN DEUN A, Decroo T, Kya Jai Maug A, Hossain MA, et al
    The perceived impact of isoniazid resistance on outcome of first-line rifampicin-throughout regimens is largely due to missed rifampicin resistance.
    PLoS One. 2020;15:e0233500.
    PubMed     Abstract available


  230. O'CONNELL J, de Barra E, McConkey S
    Hospital inpatient care utilization among patients with tuberculosis, Republic of Ireland, 2015-2018.
    PLoS One. 2020;15:e0238142.
    PubMed     Abstract available


  231. SHARMA P, Anthwal D, Kumari P, Gupta RK, et al
    Utility of circulating cell-free Mycobacterium tuberculosis DNA for the improved diagnosis of abdominal tuberculosis.
    PLoS One. 2020;15:e0238119.
    PubMed     Abstract available


  232. MESIC A, Khan WH, Lenglet A, Lynen L, et al
    Translating drug resistant tuberculosis treatment guidelines to reality in war-torn Kandahar, Afghanistan: A retrospective cohort study.
    PLoS One. 2020;15:e0237787.
    PubMed     Abstract available


  233. TEDLA K, Medhin G, Berhe G, Mulugeta A, et al
    Factors associated with treatment initiation delay among new adult pulmonary tuberculosis patients in Tigray, Northern Ethiopia.
    PLoS One. 2020;15:e0235411.
    PubMed     Abstract available


  234. KANG W, Yu J, Du J, Yang S, et al
    The epidemiology of extrapulmonary tuberculosis in China: A large-scale multi-center observational study.
    PLoS One. 2020;15:e0237753.
    PubMed     Abstract available


  235. MULENGA H, Zauchenberger CZ, Bunyasi EW, Mbandi SK, et al
    Performance of diagnostic and predictive host blood transcriptomic signatures for Tuberculosis disease: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0237574.
    PubMed     Abstract available


  236. AGIZEW T, Boyd R, Mathebula U, Mathoma A, et al
    Outcomes of HIV-positive patients with non-tuberculous mycobacteria positive culture who received anti-tuberculous treatment in Botswana: Implications of using diagnostic algorithms without non-tuberculous mycobacteria.
    PLoS One. 2020;15:e0234646.
    PubMed     Abstract available


  237. ALBERT H, Purcell R, Wang YY, Kao K, et al
    Designing an optimized diagnostic network to improve access to TB diagnosis and treatment in Lesotho.
    PLoS One. 2020;15:e0233620.
    PubMed     Abstract available


  238. OSPINA JE, Orcau A, Millet JP, Ros M, et al
    Correction: Epidemiology of Tuberculosis in Immigrants in a Large City with Large-Scale Immigration (1991-2013).
    PLoS One. 2020;15:e0238963.
    PubMed     Abstract available


  239. PATTERSON B, Dinkele R, Gessner S, Morrow C, et al
    Sensitivity optimisation of tuberculosis bioaerosol sampling.
    PLoS One. 2020;15:e0238193.
    PubMed     Abstract available


  240. TIAMIYU AB, Iliyasu G, Dayyab FM, Habib ZG, et al
    A descriptive study of smear negative pulmonary tuberculosis in a high HIV burden patient's population in North Central Nigeria.
    PLoS One. 2020;15:e0238007.
    PubMed     Abstract available


  241. DECROO T, Maug AKJ, Hossain MA, Uwizeye C, et al
    Injectables' key role in rifampicin-resistant tuberculosis shorter treatment regimen outcomes.
    PLoS One. 2020;15:e0238016.
    PubMed     Abstract available


  242. HUANG Y, Huang J, Su X, Chen L, et al
    Analysis of the economic burden of diagnosis and treatment on patients with tuberculosis in Bao'an district of Shenzhen City, China.
    PLoS One. 2020;15:e0237865.
    PubMed     Abstract available


  243. FERNANDO R, McDowell AC, Bhavaraju R, Fraimow H, et al
    A model for bringing TB expertise to HIV providers: Medical consultations to the CDC-funded Regional Tuberculosis Training and Medical Consultation Centers, 2013-2017.
    PLoS One. 2020;15:e0236933.
    PubMed     Abstract available


  244. PARK JH, Kim N, Park H, Kim TS, et al
    The use of a borderline zone for the interpretation of interferon-gamma release assay results for serial screening of healthcare workers.
    PLoS One. 2020;15:e0235254.
    PubMed     Abstract available


  245. ODAFE S, Onotu D, Fagbamigbe JO, Ene U, et al
    Increasing pediatric HIV testing positivity rates through focused testing in high-yield points of service in health facilities-Nigeria, 2016-2017.
    PLoS One. 2020;15:e0234717.
    PubMed     Abstract available


  246. KATHAMUTHU GR, Moideen K, Kumar NP, Sridhar R, et al
    Altered systemic levels of acute phase proteins in tuberculous lymphadenitis and modulation after treatment.
    PLoS One. 2020;15:e0233426.
    PubMed     Abstract available


  247. BURUSIE A, Enquesilassie F, Addissie A, Dessalegn B, et al
    Effect of smoking on tuberculosis treatment outcomes: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0239333.
    PubMed     Abstract available


  248. CATALA M, Prats C, Lopez D, Cardona PJ, et al
    A reaction-diffusion model to understand granulomas formation inside secondary lobule during tuberculosis infection.
    PLoS One. 2020;15:e0239289.
    PubMed     Abstract available


  249. BITEW ZW, Alebel A, Worku T, Alemu A, et al
    Recovery rate and its predictors among children with severe acute malnutrition in Addis Ababa, Ethiopia: A retrospective cohort study.
    PLoS One. 2020;15:e0235259.
    PubMed     Abstract available


  250. MUYINDIKE WR, Fatch R, Cheng DM, Emenyonu NI, et al
    Tuberculin skin test positivity among HIV-infected alcohol drinkers on antiretrovirals in south-western Uganda.
    PLoS One. 2020;15:e0235261.
    PubMed     Abstract available


  251. KONDRATIEVA T, Shleeva M, Kapina M, Rubakova E, et al
    Prolonged infection triggered by dormant Mycobacterium tuberculosis: Immune and inflammatory responses in lungs of genetically susceptible and resistant mice.
    PLoS One. 2020;15:e0239668.
    PubMed     Abstract available


  252. WALT MV, Masuku S, Botha S, Nkwenika T, et al
    Retrospective record review of pregnant women treated for rifampicin-resistant tuberculosis in South Africa.
    PLoS One. 2020;15:e0239018.
    PubMed     Abstract available


  253. TAHSEEN S, Khanzada FM, Rizvi AH, Qadir M, et al
    Isoniazid resistance profile and associated levofloxacin and pyrazinamide resistance in rifampicin resistant and sensitive isolates/from pulmonary and extrapulmonary tuberculosis patients in Pakistan: A laboratory based surveillance study 2015-19.
    PLoS One. 2020;15:e0239328.
    PubMed     Abstract available


  254. TADESSE AW, Alagaw A, Kassa M, Bekele M, et al
    Tuberculosis infection control practices and associated factors among healthcare workers in hospitals of Gamo Gofa Zone, Southern Ethiopia, institution-based cross-sectional study.
    PLoS One. 2020;15:e0239159.
    PubMed     Abstract available


  255. JOSE B, Manhica I, Jones J, Mutaquiha C, et al
    Using community health workers for facility and community based TB case finding: An evaluation in central Mozambique.
    PLoS One. 2020;15:e0236262.
    PubMed     Abstract available


  256. SALIFU RS, Hlongwana KW
    Barriers and facilitators to bidirectional screening of TB-DM in Ghana: Healthcare workers' perspectives.
    PLoS One. 2020;15:e0235914.
    PubMed     Abstract available


  257. MAIR L, Corbett EL, Feasey HRA, Kamchedzera W, et al
    Provider-initiated HIV testing and TB screening in the era of universal coverage: Are the right people being reached? A cohort study in Blantyre, Malawi.
    PLoS One. 2020;15:e0236407.
    PubMed     Abstract available


  258. KALRA A, Parija D, Raizada N, Sachdeva KS, et al
    Upfront Xpert MTB/RIF for diagnosis of pediatric TB-Does it work? Experience from India.
    PLoS One. 2020;15:e0236057.
    PubMed     Abstract available


  259. NACHER M, Adenis A, Guarmit B, Lucarelli A, et al
    What is AIDS in the Amazon and the Guianas in the 90-90-90 era?
    PLoS One. 2020;15:e0236368.
    PubMed     Abstract available


  260. ANKU PJ, Amo-Adjei J, Doku D, Kumi-Kyereme A, et al
    Challenges of scaling-up of TB-HIV integrated service delivery in Ghana.
    PLoS One. 2020;15:e0235843.
    PubMed     Abstract available


  261. SAYEDI SM, Seddiq MK, Rashidi MK, Qader G, et al
    Active household contact screening for tuberculosis and provision of isoniazid preventive therapy to under-five children in Afghanistan.
    PLoS One. 2020;15:e0240031.
    PubMed     Abstract available


  262. VIANA PVS, Paiva NS, Villela DAM, Bastos LS, et al
    Factors associated with death in patients with tuberculosis in Brazil: Competing risks analysis.
    PLoS One. 2020;15:e0240090.
    PubMed     Abstract available


  263. LINCE-DEROCHE N, Leuner R, Kgowedi S, Moolla A, et al
    Voices from the front lines: A qualitative study of integration of HIV, tuberculosis, and primary healthcare services in Johannesburg, South Africa.
    PLoS One. 2020;15:e0230849.
    PubMed     Abstract available


  264. KRISHNAKUMARIAMMA K, Ellappan K, Muthuraj M, Tamilarasu K, et al
    Molecular diagnosis, genetic diversity and drug sensitivity patterns of Mycobacterium tuberculosis strains isolated from tuberculous meningitis patients at a tertiary care hospital in South India.
    PLoS One. 2020;15:e0240257.
    PubMed     Abstract available


  265. SHIN HS, Choi DS, Na JB, Choi HY, et al
    Low pectoralis muscle index, cavitary nodule or mass and segmental to lobar consolidation as predictors of primary multidrug-resistant tuberculosis: A comparison with primary drug sensitive tuberculosis.
    PLoS One. 2020;15:e0239431.
    PubMed     Abstract available


  266. SALA C, Benjak A, Goletti D, Banu S, et al
    Multicenter analysis of sputum microbiota in tuberculosis patients.
    PLoS One. 2020;15:e0240250.
    PubMed     Abstract available


  267. TING NCH, El-Turk N, Chou MSH, Dobler CC, et al
    Patient-perceived treatment burden of tuberculosis treatment.
    PLoS One. 2020;15:e0241124.
    PubMed     Abstract available


  268. TAN C, Kallon II, Colvin CJ, Grant AD, et al
    Barriers and facilitators of tuberculosis infection prevention and control in low- and middle-income countries from the perspective of healthcare workers: A systematic review.
    PLoS One. 2020;15:e0241039.
    PubMed     Abstract available


  269. NGUIPDOP-DJOMO P, Rodrigues LC, Abubakar I, Mangtani P, et al
    Small-area level socio-economic deprivation and tuberculosis rates in England: An ecological analysis of tuberculosis notifications between 2008 and 2012.
    PLoS One. 2020;15:e0240879.
    PubMed     Abstract available


  270. BROOKS MB, Mitnick CD, Manjourides J
    Comparison of censoring assumptions to reduce bias in tuberculosis treatment cohort analyses.
    PLoS One. 2020;15:e0240297.
    PubMed     Abstract available


  271. MBUTHIA GW, Nyamogoba HDN, Chiang SS, McGarvey ST, et al
    Burden of stigma among tuberculosis patients in a pastoralist community in Kenya: A mixed methods study.
    PLoS One. 2020;15:e0240457.
    PubMed     Abstract available


  272. VELAYUTHAM B, Jayabal L, Watson B, Jagadeesan S, et al
    Tuberculosis screening in household contacts of pulmonary tuberculosis patients in an urban setting.
    PLoS One. 2020;15:e0240594.
    PubMed     Abstract available


  273. MERID MW, Muluneh AG, Yenit MK, Kassa GM, et al
    Treatment interruption and associated factors among patients registered on drug-resistant tuberculosis treatment in Amhara regional state, Ethiopia: 2010-2017.
    PLoS One. 2020;15:e0240564.
    PubMed     Abstract available


  274. KAGUJJE M, Chilukutu L, Somwe P, Mutale J, et al
    Active TB case finding in a high burden setting; comparison of community and facility-based strategies in Lusaka, Zambia.
    PLoS One. 2020;15:e0237931.
    PubMed     Abstract available


  275. ALAO MA, Maroushek SR, Chan YH, Asinobi AO, et al
    Treatment outcomes of Nigerian patients with tuberculosis: A retrospective 25-year review in a regional medical center.
    PLoS One. 2020;15:e0239225.
    PubMed     Abstract available


  276. RAMOS-SONO D, Laureano R, Rueda D, Gilman RH, et al
    An electrochemical biosensor for the detection of Mycobacterium tuberculosis DNA from sputum and urine samples.
    PLoS One. 2020;15:e0241067.
    PubMed     Abstract available


  277. BIERMANN O, Tran PB, Viney K, Caws M, et al
    Active case-finding policy development, implementation and scale-up in high-burden countries: A mixed-methods survey with National Tuberculosis Programme managers and document review.
    PLoS One. 2020;15:e0240696.
    PubMed     Abstract available


  278. SZIGETI R, Kellermayer D, Trakimas G, Kellermayer R, et al
    BCG epidemiology supports its protection against COVID-19? A word of caution.
    PLoS One. 2020;15:e0240203.
    PubMed     Abstract available


  279. SPEKKER O, Schultz M, Paja L, Varadi OA, et al
    Tracking down the White Plague. Chapter two: The role of endocranial abnormal blood vessel impressions and periosteal appositions in the paleopathological diagnosis of tuberculous meningitis.
    PLoS One. 2020;15:e0238444.
    PubMed     Abstract available


  280. FLORENTINI EA, Angulo N, Gilman RH, Alcantara R, et al
    Immunological detection of pyrazine-2-carboxylic acid for the detection of pyrazinamide resistance in Mycobacterium tuberculosis.
    PLoS One. 2020;15:e0241600.
    PubMed     Abstract available


  281. WAHEDI K, Biddle L, Bozorgmehr K
    Cost-effectiveness of targeted screening for active pulmonary tuberculosis among asylum-seekers: A modelling study with screening data from a German federal state (2002-2015).
    PLoS One. 2020;15:e0241852.
    PubMed     Abstract available


  282. WASIHUN AG, Dejene TA, Hailu GG
    Frequency of MTB and rifampicin resistance MTB using Xpert-MTB/RIF assay among adult presumptive tuberculosis patients in Tigray, Northern Ethiopia: A cross sectional study.
    PLoS One. 2020;15:e0240361.
    PubMed     Abstract available


  283. GOTHAM D, McKenna L, Frick M, Lessem E, et al
    Public investments in the clinical development of bedaquiline.
    PLoS One. 2020;15:e0239118.
    PubMed     Abstract available


  284. BALOGUN OS, Gao XZ, Jolayemi ET, Olaleye SA, et al
    Generalized cure rate model for infectious diseases with possible co-infections.
    PLoS One. 2020;15:e0239003.
    PubMed     Abstract available


  285. CHITTAMANY P, Yamanaka T, Suthepmany S, Sorsavanh T, et al
    First national tuberculosis patient cost survey in Lao People's Democratic Republic: Assessment of the financial burden faced by TB-affected households and the comparisons by drug-resistance and HIV status.
    PLoS One. 2020;15:e0241862.
    PubMed     Abstract available


  286. BASTOS HN, Osorio NS, Castro AG, Ramos A, et al
    Correction: A Prediction Rule to Stratify Mortality Risk of Patients with Pulmonary Tuberculosis.
    PLoS One. 2020;15:e0242455.
    PubMed     Abstract available


  287. ISLAM SKS, Rumi TB, Kabir SML, van der Zanden AGM, et al
    Bovine tuberculosis prevalence and risk factors in selected districts of Bangladesh.
    PLoS One. 2020;15:e0241717.
    PubMed     Abstract available


  288. GEZAHEGN LK, Argaw E, Assefa B, Geberesilassie A, et al
    Magnitude, outcome, and associated factors of anti-tuberculosis drug-induced hepatitis among tuberculosis patients in a tertiary hospital in North Ethiopia: A cross-sectional study.
    PLoS One. 2020;15:e0241346.
    PubMed     Abstract available


  289. BONNEWELL JP, Farrow L, Dicks KV, Cox GM, et al
    Geographic analysis of latent tuberculosis screening: A health system approach.
    PLoS One. 2020;15:e0242055.
    PubMed     Abstract available


  290. WANG N, Shewade HD, Thekkur P, Zhang H, et al
    Do electronic medication monitors improve tuberculosis treatment outcomes? Programmatic experience from China.
    PLoS One. 2020;15:e0242112.
    PubMed     Abstract available


  291. WIARDA JE, Boggiatto PM, Bayles DO, Waters WR, et al
    Severity of bovine tuberculosis is associated with innate immune-biased transcriptional signatures of whole blood in early weeks after experimental Mycobacterium bovis infection.
    PLoS One. 2020;15:e0239938.
    PubMed     Abstract available


  292. MAYITO J, Meya DB, Rhein J, Sekaggya-Wiltshire C, et al
    Utility of the monocyte to lymphocyte ratio in diagnosing latent tuberculosis among HIV-infected individuals with a negative tuberculosis symptom screen.
    PLoS One. 2020;15:e0241786.
    PubMed     Abstract available


  293. BADE AB, Mega TA
    Survival status and its predictors among multi-drug resistance tuberculosis treated patients in Ethiopia: Multicenter observational study.
    PLoS One. 2020;15:e0241684.
    PubMed     Abstract available


  294. SANOGO B, Ouermi AS, Barro M, Millogo A, et al
    Performance of a lymphocyte t interferon gamma test (Quantiferon-TB gold in tube) in the diagnosis of active tuberculosis in HIV-infected children.
    PLoS One. 2020;15:e0241789.
    PubMed     Abstract available


  295. DORJI T, Tshering T, Wangdi K
    Assessment of knowledge, attitude and practice on tuberculosis among teacher trainees of Samtse College of Education, Bhutan.
    PLoS One. 2020;15:e0241923.
    PubMed     Abstract available


  296. KUNDU J, Bakshi S, Joshi H, Bhadada SK, et al
    Proteomic profiling of peripheral blood mononuclear cells isolated from patients with tuberculosis and diabetes copathogenesis - A pilot study.
    PLoS One. 2020;15:e0233326.
    PubMed     Abstract available


  297. DARMA S, Ambara A, Aman AT, Annisa L, et al
    High frequency of azole resistant Candida spp. colonization among presumptive multidrug resistant tuberculosis (MDR-TB) patients.
    PLoS One. 2020;15:e0242542.
    PubMed     Abstract available


  298. KETEMA L, Dememew ZG, Assefa D, Gudina T, et al
    Evaluating the integration of tuberculosis screening and contact investigation in tuberculosis clinics in Ethiopia: A mixed method study.
    PLoS One. 2020;15:e0241977.
    PubMed     Abstract available


  299. FLINT L, Korkegian A, Parish T
    InhA inhibitors have activity against non-replicating Mycobacterium tuberculosis.
    PLoS One. 2020;15:e0239354.
    PubMed     Abstract available


  300. WELDEMHRET L, Hailu A, Gebremedhn G, Bekuretsion H, et al
    Blinded rechecking of sputum smear microscopy performance in public health facilities in Tigray region, Northern Ethiopia: Retrospective cross sectional study.
    PLoS One. 2020;15:e0239342.
    PubMed     Abstract available


  301. HORTER S, Achar J, Gray N, Parpieva N, et al
    Patient and health-care worker perspectives on the short-course regimen for treatment of drug-resistant tuberculosis in Karakalpakstan, Uzbekistan.
    PLoS One. 2020;15:e0242359.
    PubMed     Abstract available


  302. BANU S, Haque F, Ahmed S, Sultana S, et al
    Social Enterprise Model (SEM) for private sector tuberculosis screening and care in Bangladesh.
    PLoS One. 2020;15:e0241437.
    PubMed     Abstract available


  303. AJUDUA FI, Mash RJ
    Implementing active surveillance for TB-The views of managers in a resource limited setting, South Africa.
    PLoS One. 2020;15:e0239430.
    PubMed     Abstract available


  304. HAUK C, Schafermann S, Martus P, Muzafarova N, et al
    Quality assurance in anti-tuberculosis drug procurement by the Stop TB Partnership-Global Drug Facility: Procedures, costs, time requirements, and comparison of assay and dissolution results by manufacturers and by external analysis.
    PLoS One. 2020;15:e0243428.
    PubMed     Abstract available


  305. STOCKBRIDGE EL, Loethen AD, Annan E, Miller TL, et al
    Interferon gamma release assay tests are associated with persistence and completion of latent tuberculosis infection treatment in the United States: Evidence from commercial insurance data.
    PLoS One. 2020;15:e0243102.
    PubMed     Abstract available


  306. LI Y, Pang Y, Zhang T, Xian X, et al
    Genotypes of Mycobacterium tuberculosis isolates circulating in Shaanxi Province, China.
    PLoS One. 2020;15:e0242971.
    PubMed     Abstract available


  307. WANG D, Tong X, Wang L, Zhang S, et al
    The association between osteopontin and tuberculosis: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0242702.
    PubMed     Abstract available


  308. YU G, Zhao W, Shen Y, Zhu P, et al
    Metagenomic next generation sequencing for the diagnosis of tuberculosis meningitis: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0243161.
    PubMed     Abstract available


  309. BADA FO, Blok N, Okpokoro E, Dutt S, et al
    Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in Nigeria.
    PLoS One. 2020;15:e0241065.
    PubMed     Abstract available


  310. LIMSRIVILAI J, Lee CK, Prueksapanich P, Harinwan K, et al
    Validation of models using basic parameters to differentiate intestinal tuberculosis from Crohn's disease: A multicenter study from Asia.
    PLoS One. 2020;15:e0242879.
    PubMed     Abstract available


  311. KITONSA PJ, Nalutaaya A, Mukiibi J, Nakasolya O, et al
    Evaluation of underweight status may improve identification of the highest-risk patients during outpatient evaluation for pulmonary tuberculosis.
    PLoS One. 2020;15:e0243542.
    PubMed     Abstract available


  312. MOHAMMEDHUSSEIN M, Hajure M, Shifa JE, Hassen TA, et al
    Perceived stigma among patient with pulmonary tuberculosis at public health facilities in southwest Ethiopia: A cross-sectional study.
    PLoS One. 2020;15:e0243433.
    PubMed     Abstract available


  313. DIRIBA G, Kebede A, Tola HH, Yenew B, et al
    Molecular characterization and drug resistance patterns of Mycobacterium tuberculosis complex in extrapulmonary tuberculosis patients in Addis Ababa, Ethiopia.
    PLoS One. 2020;15:e0243493.
    PubMed     Abstract available


  314. KAN CK, Ragan EJ, Sarkar S, Knudsen S, et al
    Alcohol use and tuberculosis clinical presentation at the time of diagnosis in Puducherry and Tamil Nadu, India.
    PLoS One. 2020;15:e0240595.
    PubMed     Abstract available


  315. KOLTE IV, Pereira L, Benites A, de Sousa IMC, et al
    The contribution of stigma to the transmission and treatment of tuberculosis in a hyperendemic indigenous population in Brazil.
    PLoS One. 2020;15:e0243988.
    PubMed     Abstract available


  316. AREGA B, Mersha A, Minda A, Getachew Y, et al
    Epidemiology and the diagnostic challenge of extra-pulmonary tuberculosis in a teaching hospital in Ethiopia.
    PLoS One. 2020;15:e0243945.
    PubMed     Abstract available


  317. KOSGEI RJ, Callens S, Gichangi P, Temmerman M, et al
    Gender difference in mortality among pulmonary tuberculosis HIV co-infected adults aged 15-49 years in Kenya.
    PLoS One. 2020;15:e0243977.
    PubMed     Abstract available


  318. SHEN Y, Fang L, Ye B, Yu G, et al
    Meta-analysis of diagnostic accuracy of nucleic acid amplification tests for abdominal tuberculosis: A protocol.
    PLoS One. 2020;15:e0243765.
    PubMed     Abstract available


  319. GADICHERLA S, Krishnappa L, Madhuri B, Mitra SG, et al
    Envisioning a learning surveillance system for tuberculosis.
    PLoS One. 2020;15:e0243610.
    PubMed     Abstract available


  320. ALI N, Bello GL, Rossetti MLR, Krieger MA, et al
    Demonstration of a fast and easy sample-to-answer protocol for tuberculosis screening in point-of-care settings: A proof of concept study.
    PLoS One. 2020;15:e0242408.
    PubMed     Abstract available


  321. MEJIA-PAILLES G, Berrington A, McGrath N, Hosegood V, et al
    Trends in the prevalence and incidence of orphanhood in children and adolescents <20 years in rural KwaZulu-Natal South Africa, 2000-2014.
    PLoS One. 2020;15:e0238563.
    PubMed     Abstract available


  322. HOPKINS KL, Hlongwane KE, Otwombe K, Dietrich J, et al
    Does peer-navigated linkage to care work? A cross-sectional study of active linkage to care within an integrated non-communicable disease-HIV testing centre for adults in Soweto, South Africa.
    PLoS One. 2020;15:e0241014.
    PubMed     Abstract available


  323. LOVEDAY M, Hlangu S, Furin J
    "Take the treatment and be brave": Care experiences of pregnant women with rifampicin-resistant tuberculosis.
    PLoS One. 2020;15:e0242604.
    PubMed     Abstract available


  324. ZAWEDDE-MUYANJA S, Musaazi J, Manabe YC, Katamba A, et al
    Estimating the effect of pretreatment loss to follow up on TB associated mortality at public health facilities in Uganda.
    PLoS One. 2020;15:e0241611.
    PubMed     Abstract available



  325. Correction: Tuberculosis preventive treatment should be considered for all household contacts of pulmonary tuberculosis patients in India.
    PLoS One. 2020;15:e0244914.
    PubMed     Abstract available


  326. NONGHANPHITHAK D, Kaewprasert O, Chaiyachat P, Reechaipichitkul W, et al
    Whole-genome sequence analysis and comparisons between drug-resistance mutations and minimum inhibitory concentrations of Mycobacterium tuberculosis isolates causing M/XDR-TB.
    PLoS One. 2020;15:e0244829.
    PubMed     Abstract available


  327. PARK JW, Curtis JR, Lee H, Lee JK, et al
    Risk-benefit analysis of isoniazid monotherapy to prevent tuberculosis in patients with rheumatic diseases exposed to prolonged, high-dose glucocorticoids.
    PLoS One. 2020;15:e0244239.
    PubMed     Abstract available


  328. KASOZI S, Kirirabwa NS, Kimuli D, Luwaga H, et al
    Addressing the drug-resistant tuberculosis challenge through implementing a mixed model of care in Uganda.
    PLoS One. 2020;15:e0244451.
    PubMed     Abstract available


  329. DIAN S, Hermawan R, van Laarhoven A, Immaculata S, et al
    Brain MRI findings in relation to clinical characteristics and outcome of tuberculous meningitis.
    PLoS One. 2020;15:e0241974.
    PubMed     Abstract available


  330. ANANTHAKRISHNAN R, Thiagesan R, Auguesteen S, Karunakaran N, et al
    The impact of chest radiography and Xpert MTB/RIF testing among household contacts in Chennai, India.
    PLoS One. 2020;15:e0241203.
    PubMed     Abstract available


  331. BORNMANN L, Haunschild R, Patel VM
    Are papers addressing certain diseases perceived where these diseases are prevalent? The proposal to use Twitter data as social-spatial sensors.
    PLoS One. 2020;15:e0242550.
    PubMed     Abstract available


  332. DE MEDEIROS VLS, Santos FCF, Montenegro LML, Silva MDC, et al
    TST conversions and systemic interferon-gamma increase after methotrexate introduction in psoriasis patients.
    PLoS One. 2020;15:e0242098.
    PubMed     Abstract available


  333. KARANJA M, Kingwara L, Owiti P, Kirui E, et al
    Outcomes of isoniazid preventive therapy among people living with HIV in Kenya: A retrospective study of routine health care data.
    PLoS One. 2020;15:e0234588.
    PubMed     Abstract available


  334. SOMNUKE P, Ramlee R, Ratanapaiboon W, Thommaaksorn P, et al
    Factors influencing preoperative chest radiography request for elective endoscopic procedures among medical personnel.
    PLoS One. 2020;15:e0242140.
    PubMed     Abstract available


  335. KAY AW, Thivalapill N, Skinner D, Dube GS, et al
    Predictors of suboptimal adherence to isoniazid preventive therapy among adolescents and children living with HIV.
    PLoS One. 2020;15:e0243713.
    PubMed     Abstract available


  336. ISLAM MS, Chughtai AA, Nazneen A, Chowdhury KIA, et al
    A tuberculin skin test survey among healthcare workers in two public tertiary care hospitals in Bangladesh.
    PLoS One. 2020;15:e0243951.
    PubMed     Abstract available


  337. GOOVAERTS O, Massinga-Loembe M, Ondoa P, Ceulemans A, et al
    Lack of elevated pre-ART elastase-ANCA levels in patients developing TB-IRIS.
    PLoS One. 2020;15:e0244800.
    PubMed     Abstract available


    January 2019
  338. ZEGEYE A, Dessie G, Wagnew F, Gebrie A, et al
    Prevalence and determinants of anti-tuberculosis treatment non-adherence in Ethiopia: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0210422.
    PubMed     Abstract available


  339. OHENE SA, Bakker MI, Ojo J, Toonstra A, et al
    Extra-pulmonary tuberculosis: A retrospective study of patients in Accra, Ghana.
    PLoS One. 2019;14:e0209650.
    PubMed     Abstract available


  340. OLLINGER J, Kumar A, Roberts DM, Bailey MA, et al
    A high-throughput whole cell screen to identify inhibitors of Mycobacterium tuberculosis.
    PLoS One. 2019;14:e0205479.
    PubMed     Abstract available



  341. Correction: Response to anti-tuberculosis treatment by people over age 60 in Kampala, Uganda.
    PLoS One. 2019;14:e0210769.
    PubMed     Abstract available


  342. CHEN YT, Kuo SC, Chao PW, Chang YY, et al
    Use of lipid-lowering agents is not associated with improved outcomes for tuberculosis patients on standard-course therapy: A population-based cohort study.
    PLoS One. 2019;14:e0210479.
    PubMed     Abstract available


  343. ROMANOWSKI K, Campbell JR, Oxlade O, Fregonese F, et al
    The impact of improved detection and treatment of isoniazid resistant tuberculosis on prevalence of multi-drug resistant tuberculosis: A modelling study.
    PLoS One. 2019;14:e0211355.
    PubMed     Abstract available



  344. Retraction: PknE, a Serine/Threonine Protein Kinase of Mycobacterium tuberculosis Initiates Survival Crosstalk That Also Impacts HIV Coinfection.
    PLoS One. 2019;14:e0211247.
    PubMed    


  345. BHATTACHARYA CHAKRAVARTY A, Rangan S, Dholakia Y, Rai S, et al
    Such a long journey: What health seeking pathways of patients with drug resistant tuberculosis in Mumbai tell us.
    PLoS One. 2019;14:e0209924.
    PubMed     Abstract available


  346. BOGDANOVA EN, Mariandyshev AO, Balantcev GA, Eliseev PI, et al
    Cost minimization analysis of line probe assay for detection of multidrug-resistant tuberculosis in Arkhangelsk region of Russian Federation.
    PLoS One. 2019;14:e0211203.
    PubMed     Abstract available


  347. GUERRA J, Mogollon D, Gonzalez D, Sanchez R, et al
    Active and latent tuberculosis among inmates in La Esperanza prison in Guaduas, Colombia.
    PLoS One. 2019;14:e0209895.
    PubMed     Abstract available



  348. Correction: Kenya tuberculosis prevalence survey 2016: Challenges and opportunities of ending TB in Kenya.
    PLoS One. 2019;14:e0211593.
    PubMed     Abstract available


  349. ALOTAIBI B, Yassin Y, Mushi A, Maashi F, et al
    Tuberculosis knowledge, attitude and practice among healthcare workers during the 2016 Hajj.
    PLoS One. 2019;14:e0210913.
    PubMed     Abstract available


  350. HIPPNER P, Sumner T, Houben RM, Cardenas V, et al
    Application of provincial data in mathematical modelling to inform sub-national tuberculosis program decision-making in South Africa.
    PLoS One. 2019;14:e0209320.
    PubMed     Abstract available


  351. ZHANG F, Xu C, Ning L, Hu F, et al
    Correction: Exploration of Serum Proteomic Profiling and Diagnostic Model That Differentiate Crohn's Disease and Intestinal Tuberculosis.
    PLoS One. 2019;14:e0212300.
    PubMed     Abstract available


  352. WOOD HN, Venken T, Willems H, Jacobs A, et al
    Molecular drug susceptibility testing and strain typing of tuberculosis by DNA hybridization.
    PLoS One. 2019;14:e0212064.
    PubMed     Abstract available


  353. MULONGENI P, Hermans S, Caldwell J, Bekker LG, et al
    HIV prevalence and determinants of loss-to-follow-up in adolescents and young adults with tuberculosis in Cape Town.
    PLoS One. 2019;14:e0210937.
    PubMed     Abstract available


  354. YIRDAW KD, Teklu AM, Mamuye AT, Zewdu S, et al
    Breakthrough tuberculosis disease among people with HIV - Should we be worried? A retrospective longitudinal study.
    PLoS One. 2019;14:e0211688.
    PubMed     Abstract available


  355. DJIMEU EW, Heard AC
    Treatment of HIV among tuberculosis patients: A replication study of timing of antiretroviral therapy for HIV-1-associated tuberculosis.
    PLoS One. 2019;14:e0210327.
    PubMed     Abstract available


  356. AFSHAR B, Carless J, Roche A, Balasegaram S, et al
    Surveillance of tuberculosis (TB) cases attributable to relapse or reinfection in London, 2002-2015.
    PLoS One. 2019;14:e0211972.
    PubMed     Abstract available


  357. RING SC, Purfield DC, Good M, Breslin P, et al
    Variance components for bovine tuberculosis infection and multi-breed genome-wide association analysis using imputed whole genome sequence data.
    PLoS One. 2019;14:e0212067.
    PubMed     Abstract available


  358. ROE WD, Lenting B, Kokosinska A, Hunter S, et al
    Pathology and molecular epidemiology of Mycobacterium pinnipedii tuberculosis in native New Zealand marine mammals.
    PLoS One. 2019;14:e0212363.
    PubMed     Abstract available


  359. DOULLA BE, Squire SB, MacPherson E, Ngadaya ES, et al
    Routine surveillance for the identification of drug resistant Tuberculosis in Tanzania: A cross-sectional study of stakeholders' perceptions.
    PLoS One. 2019;14:e0212421.
    PubMed     Abstract available


  360. REIS-SANTOS B, Shete P, Bertolde A, Sales CM, et al
    Tuberculosis in Brazil and cash transfer programs: A longitudinal database study of the effect of cash transfer on cure rates.
    PLoS One. 2019;14:e0212617.
    PubMed     Abstract available


  361. ADESOKAN HK, Streicher EM, van Helden PD, Warren RM, et al
    Genetic diversity of Mycobacterium tuberculosis complex strains isolated from livestock workers and cattle in Nigeria.
    PLoS One. 2019;14:e0211637.
    PubMed     Abstract available


  362. SOEROTO AY, Lestari BW, Santoso P, Chaidir L, et al
    Evaluation of Xpert MTB-RIF guided diagnosis and treatment of rifampicin-resistant tuberculosis in Indonesia: A retrospective cohort study.
    PLoS One. 2019;14:e0213017.
    PubMed     Abstract available


  363. NGUYEN DT, Agarwal S, Graviss EA
    Trends of tuberculosis meningitis and associated mortality in Texas, 2010-2017, a large population-based analysis.
    PLoS One. 2019;14:e0212729.
    PubMed     Abstract available


  364. IWAMOTO T, Murase Y, Yoshida S, Aono A, et al
    Overcoming the pitfalls of automatic interpretation of whole genome sequencing data by online tools for the prediction of pyrazinamide resistance in Mycobacterium tuberculosis.
    PLoS One. 2019;14:e0212798.
    PubMed     Abstract available


  365. DENEGRE AA, Ndeffo Mbah ML, Myers K, Fefferman NH, et al
    Emergence of antibiotic resistance in immunocompromised host populations: A case study of emerging antibiotic resistant tuberculosis in AIDS patients.
    PLoS One. 2019;14:e0212969.
    PubMed     Abstract available


  366. GUALANO G, Mencarini P, Musso M, Mosti S, et al
    Putting in harm to cure: Drug related adverse events do not affect outcome of patients receiving treatment for multidrug-resistant Tuberculosis. Experience from a tertiary hospital in Italy.
    PLoS One. 2019;14:e0212948.
    PubMed     Abstract available


  367. LOPEZ-GARNIER S, Sheen P, Zimic M
    Automatic diagnostics of tuberculosis using convolutional neural networks analysis of MODS digital images.
    PLoS One. 2019;14:e0212094.
    PubMed     Abstract available


  368. LONG R, Asadi L, Heffernan C, Barrie J, et al
    Is there a fundamental flaw in Canada's post-arrival immigrant surveillance system for tuberculosis?
    PLoS One. 2019;14:e0212706.
    PubMed     Abstract available


  369. BACK YW, Choi S, Choi HG, Shin KW, et al
    Cell wall skeleton of Mycobacterium bovis BCG enhances the vaccine potential of antigen 85B against tuberculosis by inducing Th1 and Th17 responses.
    PLoS One. 2019;14:e0213536.
    PubMed     Abstract available


  370. BADR MT, Hacker G
    Gene expression profiling meta-analysis reveals novel gene signatures and pathways shared between tuberculosis and rheumatoid arthritis.
    PLoS One. 2019;14:e0213470.
    PubMed     Abstract available


  371. NGUYEN DT, Phan H, Trinh T, Nguyen H, et al
    Sensitivity and characteristics associated with positive QuantiFERON-TB Gold-Plus assay in children with confirmed tuberculosis.
    PLoS One. 2019;14:e0213304.
    PubMed     Abstract available


  372. DA SILVA LF, Skupien EC, Lazzari TK, Holler SR, et al
    Advanced glycation end products (AGE) and receptor for AGE (RAGE) in patients with active tuberculosis, and their relationship between food intake and nutritional status.
    PLoS One. 2019;14:e0213991.
    PubMed     Abstract available


  373. SEIJGER C, Hoefsloot W, Bergsma-de Guchteneire I, Te Brake L, et al
    High-dose rifampicin in tuberculosis: Experiences from a Dutch tuberculosis centre.
    PLoS One. 2019;14:e0213718.
    PubMed     Abstract available


  374. NWANA N, Marks SM, Lan E, Chang AH, et al
    Treatment of latent Mycobacterium tuberculosis infection with 12 once weekly directly-observed doses of isoniazid and rifapentine among persons experiencing homelessness.
    PLoS One. 2019;14:e0213524.
    PubMed     Abstract available


  375. ANDRES M, van der Werf MJ, Kodmon C, Albrecht S, et al
    Molecular and genomic typing for tuberculosis surveillance: A survey study in 26 European countries.
    PLoS One. 2019;14:e0210080.
    PubMed     Abstract available


  376. LEE HJ, Ko HJ, Kim SH, Jung YJ, et al
    Pasakbumin A controls the growth of Mycobacterium tuberculosis by enhancing the autophagy and production of antibacterial mediators in mouse macrophages.
    PLoS One. 2019;14:e0199799.
    PubMed     Abstract available


  377. HWANG B, Shroufi A, Gils T, Steele SJ, et al
    Stock-outs of antiretroviral and tuberculosis medicines in South Africa: A national cross-sectional survey.
    PLoS One. 2019;14:e0212405.
    PubMed     Abstract available


  378. SUMI A, Kobayashi N
    Time-series analysis of geographically specific monthly number of newly registered cases of active tuberculosis in Japan.
    PLoS One. 2019;14:e0213856.
    PubMed     Abstract available


  379. ZHANG C, Xia L, Rainey JJ, Li Y, et al
    Findings from a pilot project to assess the feasibility of active tuberculosis case finding among seniors in rural Sichuan Province, China, 2017.
    PLoS One. 2019;14:e0214761.
    PubMed     Abstract available


  380. HOYT KJ, Sarkar S, White L, Joseph NM, et al
    Effect of malnutrition on radiographic findings and mycobacterial burden in pulmonary tuberculosis.
    PLoS One. 2019;14:e0214011.
    PubMed     Abstract available


  381. AL-GHAFLI H, Varghese B, Enani M, Alrajhi A, et al
    Demographic risk factors for extra-pulmonary tuberculosis among adolescents and adults in Saudi Arabia.
    PLoS One. 2019;14:e0213846.
    PubMed     Abstract available


  382. VON STREIT F, Bartels C, Kuczius T, Cassier C, et al
    Prevalence of latent tuberculosis in homeless persons: A single-centre cross-sectional study, Germany.
    PLoS One. 2019;14:e0214556.
    PubMed     Abstract available


  383. WOOD A, Barizuddin S, Darr CM, Mathai CJ, et al
    Ultrasensitive detection of lipoarabinomannan with plasmonic grating biosensors in clinical samples of HIV negative patients with tuberculosis.
    PLoS One. 2019;14:e0214161.
    PubMed     Abstract available


  384. ANAND S, Ganaie AA, Sharma C
    Differential thermal stability, conformational stability and unfolding behavior of Eis proteins from Mycobacterium smegmatis and Mycobacterium tuberculosis.
    PLoS One. 2019;14:e0213933.
    PubMed     Abstract available


  385. BORRELL S, Trauner A, Brites D, Rigouts L, et al
    Reference set of Mycobacterium tuberculosis clinical strains: A tool for research and product development.
    PLoS One. 2019;14:e0214088.
    PubMed     Abstract available


  386. HENRARD S, Corbiere V, Schandene L, Ducarme M, et al
    Proportions of interferon-gamma-producing ascites lymphocytes in response to mycobacterial antigens: A help for early diagnosis of peritoneal tuberculosis in a low TB incidence country.
    PLoS One. 2019;14:e0214333.
    PubMed     Abstract available


  387. GUTHRIE JL, Marchand-Austin A, Cronin K, Lam K, et al
    Universal genotyping reveals province-level differences in the molecular epidemiology of tuberculosis.
    PLoS One. 2019;14:e0214870.
    PubMed     Abstract available


  388. SHIMELES E, Enquselassie F, Aseffa A, Tilahun M, et al
    Risk factors for tuberculosis: A case-control study in Addis Ababa, Ethiopia.
    PLoS One. 2019;14:e0214235.
    PubMed     Abstract available


  389. LEE PH, Chan PC, Peng YT, Chu PW, et al
    Impact of universal drug susceptibility testing and effective management of multidrug-resistant tuberculosis in Taiwan.
    PLoS One. 2019;14:e0214792.
    PubMed     Abstract available


  390. SARIN S, Huddart S, Raizada N, Parija D, et al
    Cost and operational impact of promoting upfront GeneXpert MTB/RIF test referrals for presumptive pediatric tuberculosis patients in India.
    PLoS One. 2019;14:e0214675.
    PubMed     Abstract available


  391. DHIMAN RK, Pujari V, Kincaid JM, Ikeh MA, et al
    Characterization of MenA (isoprenyl diphosphate:1,4-dihydroxy-2-naphthoate isoprenyltransferase) from Mycobacterium tuberculosis.
    PLoS One. 2019;14:e0214958.
    PubMed     Abstract available


  392. RUTAIHWA LK, Sasamalo M, Jaleco A, Hella J, et al
    Insights into the genetic diversity of Mycobacterium tuberculosis in Tanzania.
    PLoS One. 2019;14:e0206334.
    PubMed     Abstract available


  393. JAGANATH D, Wobudeya E, Sekadde MP, Nsangi B, et al
    Seasonality of childhood tuberculosis cases in Kampala, Uganda, 2010-2015.
    PLoS One. 2019;14:e0214555.
    PubMed     Abstract available


  394. GOODELL AJ, Shete PB, Vreman R, McCabe D, et al
    Outlook for tuberculosis elimination in California: An individual-based stochastic model.
    PLoS One. 2019;14:e0214532.
    PubMed     Abstract available


  395. BROGER T, Tsionksy M, Mathew A, Lowary TL, et al
    Sensitive electrochemiluminescence (ECL) immunoassays for detecting lipoarabinomannan (LAM) and ESAT-6 in urine and serum from tuberculosis patients.
    PLoS One. 2019;14:e0215443.
    PubMed     Abstract available


  396. MARTIN-SANCHEZ M, Brugueras S, de Andres A, Simon P, et al
    Tuberculosis incidence among infected contacts detected through contact tracing of smear-positive patients.
    PLoS One. 2019;14:e0215322.
    PubMed     Abstract available


  397. JO EJ, Park S, Lee KM, Kim I, et al
    Time to appropriate treatment in patients with multidrug-resistant tuberculosis in South Korea: Are we still in 2010?
    PLoS One. 2019;14:e0216084.
    PubMed     Abstract available


  398. OGA-OMENKA C, Zarowsky C, Agbaje A, Kuye J, et al
    Rates and timeliness of treatment initiation among drug-resistant tuberculosis patients in Nigeria- A retrospective cohort study.
    PLoS One. 2019;14:e0215542.
    PubMed     Abstract available


  399. CUI Z, Lin D, Chongsuvivatwong V, Zhao J, et al
    Spatiotemporal patterns and ecological factors of tuberculosis notification: A spatial panel data analysis in Guangxi, China.
    PLoS One. 2019;14:e0212051.
    PubMed     Abstract available


  400. GUTHRIE JL, Ronald LA, Cook VJ, Johnston J, et al
    The problem with defining foreign birth as a risk factor in tuberculosis epidemiology studies.
    PLoS One. 2019;14:e0216271.
    PubMed     Abstract available


  401. DATTA S, Alvarado K, Gilman RH, Valencia T, et al
    Optimising fluorescein diacetate sputum smear microscopy for assessing patients with pulmonary tuberculosis.
    PLoS One. 2019;14:e0214131.
    PubMed     Abstract available


  402. MOGASHOA T, Melamu P, Ley SD, Streicher EM, et al
    Genetic diversity of Mycobacterium tuberculosis strains circulating in Botswana.
    PLoS One. 2019;14:e0216306.
    PubMed     Abstract available


  403. COHEN DB, Davies G, Malwafu W, Mangochi H, et al
    Poor outcomes in recurrent tuberculosis: More than just drug resistance?
    PLoS One. 2019;14:e0215855.
    PubMed     Abstract available


  404. YUEN CM, Millones AK, Contreras CC, Lecca L, et al
    Tuberculosis household accompaniment to improve the contact management cascade: A prospective cohort study.
    PLoS One. 2019;14:e0217104.
    PubMed     Abstract available


  405. CROSS GB, Yeo BC, Hutchinson PE, Tan MC, et al
    Impact of selective immune-cell depletion on growth of Mycobacterium tuberculosis (Mtb) in a whole-blood bactericidal activity (WBA) assay.
    PLoS One. 2019;14:e0216616.
    PubMed     Abstract available


  406. CHOI H, Chung H, Muntaner C
    Social selection in historical time: The case of tuberculosis in South Korea after the East Asian financial crisis.
    PLoS One. 2019;14:e0217055.
    PubMed     Abstract available


  407. GABRIELIAN A, Engle E, Harris M, Wollenberg K, et al
    TB DEPOT (Data Exploration Portal): A multi-domain tuberculosis data analysis resource.
    PLoS One. 2019;14:e0217410.
    PubMed     Abstract available


  408. GUPTE AN, Paradkar M, Selvaraju S, Thiruvengadam K, et al
    Assessment of lung function in successfully treated tuberculosis reveals high burden of ventilatory defects and COPD.
    PLoS One. 2019;14:e0217289.
    PubMed     Abstract available


  409. MCKAY B, Castellanos M, Ebell M, Whalen CC, et al
    An attempt to reproduce a previous meta-analysis and a new analysis regarding the impact of directly observed therapy on tuberculosis treatment outcomes.
    PLoS One. 2019;14:e0217219.
    PubMed     Abstract available


  410. THEE S, Kruger R, von Bernuth H, Meisel C, et al
    Screening and treatment for tuberculosis in a cohort of unaccompanied minor refugees in Berlin, Germany.
    PLoS One. 2019;14:e0216234.
    PubMed     Abstract available


  411. RODRIGUEZ-FLORES EM, Mata-Espinosa D, Barrios-Payan J, Marquina-Castillo B, et al
    A significant therapeutic effect of silymarin administered alone, or in combination with chemotherapy, in experimental pulmonary tuberculosis caused by drug-sensitive or drug-resistant strains: In vitro and in vivo studies.
    PLoS One. 2019;14:e0217457.
    PubMed     Abstract available


  412. MEKONNEN B, Mihret A, Getahun M, Hailu T, et al
    Evaluation of the tuberculosis culture color plate test for rapid detection of drug susceptible and drug-resistant Mycobacterium tuberculosis in a resource-limited setting, Addis Ababa, Ethiopia.
    PLoS One. 2019;14:e0215679.
    PubMed     Abstract available


  413. MUTTAMBA W, Ssengooba W, Kirenga B, Sekibira R, et al
    Health seeking behavior among individuals presenting with chronic cough at referral hospitals in Uganda; Missed opportunity for early tuberculosis diagnosis.
    PLoS One. 2019;14:e0217900.
    PubMed     Abstract available


  414. VAN RENSBURG C, Berhanu R, Hirasen K, Evans D, et al
    Cost outcome analysis of decentralized care for drug-resistant tuberculosis in Johannesburg, South Africa.
    PLoS One. 2019;14:e0217820.
    PubMed     Abstract available


  415. SHAMU S, Kuwanda L, Farirai T, Guloba G, et al
    Study on knowledge about associated factors of Tuberculosis (TB) and TB/HIV co-infection among young adults in two districts of South Africa.
    PLoS One. 2019;14:e0217836.
    PubMed     Abstract available


  416. MADRAZO-MOYA CF, Cancino-Munoz I, Cuevas-Cordoba B, Gonzalez-Covarrubias V, et al
    Whole genomic sequencing as a tool for diagnosis of drug and multidrug-resistance tuberculosis in an endemic region in Mexico.
    PLoS One. 2019;14:e0213046.
    PubMed     Abstract available


  417. DEO S, Jindal P, Gupta D, Khaparde S, et al
    What would it cost to scale-up private sector engagement efforts for tuberculosis care? Evidence from three pilot programs in India.
    PLoS One. 2019;14:e0214928.
    PubMed     Abstract available


  418. SPAGGIARI D, Desfontaine V, Cruchon S, Guinchard S, et al
    Development and validation of a multiplex UHPLC-MS/MS method for the determination of the investigational antibiotic against multi-resistant tuberculosis macozinone (PBTZ169) and five active metabolites in human plasma.
    PLoS One. 2019;14:e0217139.
    PubMed     Abstract available


  419. HUANG F, Li W, Xu H, Qin H, et al
    Cordycepin kills Mycobacterium tuberculosis through hijacking the bacterial adenosine kinase.
    PLoS One. 2019;14:e0218449.
    PubMed     Abstract available


  420. SAKTIAWATI AMI, Stienstra Y, Subronto YW, Rintiswati N, et al
    Sensitivity and specificity of an electronic nose in diagnosing pulmonary tuberculosis among patients with suspected tuberculosis.
    PLoS One. 2019;14:e0217963.
    PubMed     Abstract available


  421. MIN J, Chung C, Jung SS, Park HK, et al
    Understanding illness perception in pulmonary tuberculosis patients: One step towards patient-centered care.
    PLoS One. 2019;14:e0218106.
    PubMed     Abstract available


  422. GLASAUER S, Altmann D, Hauer B, Brodhun B, et al
    First-line tuberculosis drug resistance patterns and associated risk factors in Germany, 2008-2017.
    PLoS One. 2019;14:e0217597.
    PubMed     Abstract available


  423. ONWUBIKO U, Wall K, Sales RM, Holland DP, et al
    Using Directly Observed Therapy (DOT) for latent tuberculosis treatment - A hit or a miss? A propensity score analysis of treatment completion among 274 homeless adults in Fulton County, GA.
    PLoS One. 2019;14:e0218373.
    PubMed     Abstract available


  424. WAGSTAFF A, van Doorslaer E, Burger R
    SMS nudges as a tool to reduce tuberculosis treatment delay and pretreatment loss to follow-up. A randomized controlled trial.
    PLoS One. 2019;14:e0218527.
    PubMed     Abstract available


  425. TOLA HH, Holakouie-Naieni K, Lejisa T, Mansournia MA, et al
    Is hypothyroidism rare in multidrug resistance tuberculosis patients on treatment? A systematic review and meta-analysis.
    PLoS One. 2019;14:e0218487.
    PubMed     Abstract available


  426. AUNG YK, Swe PP, Kyaw Z, Thein ST, et al
    Differential loss to follow-up rates among adult tuberculosis patients - Findings from the largest private sector tuberculosis clinic database in Myanmar.
    PLoS One. 2019;14:e0218450.
    PubMed     Abstract available


  427. YOUNIS H, Kerschbaumer I, Moon JY, Kim RS, et al
    Combining urine lipoarabinomannan with antibody detection as a simple non-sputum-based screening method for HIV-associated tuberculosis.
    PLoS One. 2019;14:e0218606.
    PubMed     Abstract available


  428. DAMENA D, Tolosa S, Hailemariam M, Zewude A, et al
    Genetic diversity and drug susceptibility profiles of Mycobacterium tuberculosis obtained from Saint Peter's TB specialized Hospital, Ethiopia.
    PLoS One. 2019;14:e0218545.
    PubMed     Abstract available


  429. SEGAFREDO G, Kapur A, Robbiati C, Joseph N, et al
    Integrating TB and non-communicable diseases services: Pilot experience of screening for diabetes and hypertension in patients with Tuberculosis in Luanda, Angola.
    PLoS One. 2019;14:e0218052.
    PubMed     Abstract available


  430. LEE DJ, Kumarasamy N, Resch SC, Sivaramakrishnan GN, et al
    Rapid, point-of-care diagnosis of tuberculosis with novel Truenat assay: Cost-effectiveness analysis for India's public sector.
    PLoS One. 2019;14:e0218890.
    PubMed     Abstract available


  431. TUOT S, Teo AKJ, Cazabon D, Sok S, et al
    Acceptability of active case finding with a seed-and-recruit model to improve tuberculosis case detection and linkage to treatment in Cambodia: A qualitative study.
    PLoS One. 2019;14:e0210919.
    PubMed     Abstract available


  432. SPRUIJT I, Erkens C, Suurmond J, Huisman E, et al
    Implementation of latent tuberculosis infection screening and treatment among newly arriving immigrants in the Netherlands: A mixed methods pilot evaluation.
    PLoS One. 2019;14:e0219252.
    PubMed     Abstract available


  433. BARCELLINI L, Borroni E, Cimaglia C, Girardi E, et al
    App-based symptoms screening with Xpert MTB/RIF Ultra assay used for active tuberculosis detection in migrants at point of arrivals in Italy: The E-DETECT TB intervention analysis.
    PLoS One. 2019;14:e0218039.
    PubMed     Abstract available


  434. COUVIN D, Reynaud Y, Rastogi N
    Two tales: Worldwide distribution of Central Asian (CAS) versus ancestral East-African Indian (EAI) lineages of Mycobacterium tuberculosis underlines a remarkable cleavage for phylogeographical, epidemiological and demographical characteristics.
    PLoS One. 2019;14:e0219706.
    PubMed     Abstract available


  435. BAIK Y, Fane O, Wang Q, Modongo C, et al
    Undetected tuberculosis at enrollment and after hospitalization in medical and oncology wards in Botswana.
    PLoS One. 2019;14:e0219678.
    PubMed     Abstract available


  436. ABDULLAHI OA, Ngari MM, Sanga D, Katana G, et al
    Mortality during treatment for tuberculosis; a review of surveillance data in a rural county in Kenya.
    PLoS One. 2019;14:e0219191.
    PubMed     Abstract available


  437. SARKAR S, Rivas-Santiago CE, Ibironke OA, Carranza C, et al
    Season and size of urban particulate matter differentially affect cytotoxicity and human immune responses to Mycobacterium tuberculosis.
    PLoS One. 2019;14:e0219122.
    PubMed     Abstract available


  438. DE SCHACHT C, Mutaquiha C, Faria F, Castro G, et al
    Barriers to access and adherence to tuberculosis services, as perceived by patients: A qualitative study in Mozambique.
    PLoS One. 2019;14:e0219470.
    PubMed     Abstract available


  439. KINIKAR A, Chandanwale A, Kadam D, Joshi S, et al
    High risk for latent tuberculosis infection among medical residents and nursing students in India.
    PLoS One. 2019;14:e0219131.
    PubMed     Abstract available


  440. MAVE V, Chandrasekaran P, Chavan A, Shivakumar SVBY, et al
    Infection free "resisters" among household contacts of adult pulmonary tuberculosis.
    PLoS One. 2019;14:e0218034.
    PubMed     Abstract available


  441. DIAZ-HUERTA JL, Tellez-Anguiano ADC, Fraga-Aguilar M, Gutierrez-Gnecchi JA, et al
    Image processing for AFB segmentation in bacilloscopies of pulmonary tuberculosis diagnosis.
    PLoS One. 2019;14:e0218861.
    PubMed     Abstract available


  442. GOTO A, Komiya K, Kan T, Honjo K, et al
    Factors associated with atypical radiological findings of pulmonary tuberculosis.
    PLoS One. 2019;14:e0220346.
    PubMed     Abstract available


  443. OGBUABOR DC, Okoronkwo IL
    The influence of quality of work life on motivation and retention of local government tuberculosis control programme supervisors in South-eastern Nigeria.
    PLoS One. 2019;14:e0220292.
    PubMed     Abstract available


  444. BEN AYED H, Koubaa M, Gargouri L, Ben Jemaa M, et al
    Epidemiology and disease burden of tuberculosis in south of Tunisia over a 22-year period: Current trends and future projections.
    PLoS One. 2019;14:e0212853.
    PubMed     Abstract available


  445. DRABAREK D, Anh NT, Nhung NV, Hoa NB, et al
    Implementation of Medication Event Reminder Monitors among patients diagnosed with drug susceptible tuberculosis in rural Viet Nam: A qualitative study.
    PLoS One. 2019;14:e0219891.
    PubMed     Abstract available


  446. YEWARE A, Gample S, Agrawal S, Sarkar D, et al
    Using diphenyleneiodonium to induce a viable but non-culturable phenotype in Mycobacterium tuberculosis and its metabolomics analysis.
    PLoS One. 2019;14:e0220628.
    PubMed     Abstract available


  447. THOMAS BE, Thiruvengadam K, S R, Kadam D, et al
    Smoking, alcohol use disorder and tuberculosis treatment outcomes: A dual co-morbidity burden that cannot be ignored.
    PLoS One. 2019;14:e0220507.
    PubMed     Abstract available



  448. Retraction: Surgical Management for Thoracic Spinal Tuberculosis Posterior Only versus Anterior Video-Assisted Thoracoscopic Surgery.
    PLoS One. 2019;14:e0220752.
    PubMed    


  449. TANUE EA, Nsagha DS, Njamen TN, Assob NJC, et al
    Tuberculosis treatment outcome and its associated factors among people living with HIV and AIDS in Fako Division of Cameroon.
    PLoS One. 2019;14:e0218800.
    PubMed     Abstract available


  450. BHATNAGAR T, Ralte M, Ralte L, Chawnglungmuana, et al
    Intensified tuberculosis and HIV surveillance in a prison in Northeast India: Implementation research.
    PLoS One. 2019;14:e0219988.
    PubMed     Abstract available


  451. ALELIGN A, Petros B, Ameni G
    Smear positive tuberculosis and genetic diversity of M. tuberculosis isolates in individuals visiting health facilities in South Gondar Zone, northwest Ethiopia.
    PLoS One. 2019;14:e0216437.
    PubMed     Abstract available


  452. BENNASRALLAH C, Kacem M, Dhouib W, Zemni I, et al
    BCG vaccination and tuberculosis prevention: A forty years cohort study, Monastir, Tunisia.
    PLoS One. 2019;14:e0219991.
    PubMed     Abstract available


  453. SABRI A, Quistrebert J, Naji Amrani H, Abid A, et al
    Prevalence and risk factors for latent tuberculosis infection among healthcare workers in Morocco.
    PLoS One. 2019;14:e0221081.
    PubMed     Abstract available


  454. FLORES-TREVINO S, Rodriguez-Noriega E, Garza-Gonzalez E, Gonzalez-Diaz E, et al
    Clinical predictors of drug-resistant tuberculosis in Mexico.
    PLoS One. 2019;14:e0220946.
    PubMed     Abstract available


  455. ANTHWAL D, Lavania S, Gupta RK, Verma A, et al
    Development and evaluation of novel bio-safe filter paper-based kits for sputum microscopy and transport to directly detect Mycobacterium tuberculosis and associated drug resistance.
    PLoS One. 2019;14:e0220967.
    PubMed     Abstract available


  456. ALENE KA, Clements ACA
    Spatial clustering of notified tuberculosis in Ethiopia: A nationwide study.
    PLoS One. 2019;14:e0221027.
    PubMed     Abstract available


  457. SHEN Y, Yu G, Zhong F, Kong X, et al
    Diagnostic accuracy of the Xpert MTB/RIF assay for bone and joint tuberculosis: A meta-analysis.
    PLoS One. 2019;14:e0221427.
    PubMed     Abstract available


  458. PUGA MAM, Bandeira LM, Pompilio MA, Rezende GR, et al
    Screening for HBV, HCV, HIV and syphilis infections among bacteriologically confirmed tuberculosis prisoners: An urgent action required.
    PLoS One. 2019;14:e0221265.
    PubMed     Abstract available


  459. SIDDIQUI S, Brooks MB, Malik AA, Fuad J, et al
    Evaluation of GenoType MTBDRplus for the detection of drug-resistant Mycobacterium tuberculosis on isolates from Karachi, Pakistan.
    PLoS One. 2019;14:e0221485.
    PubMed     Abstract available


  460. CHU KA, Hsu CH, Lin MC, Chu YH, et al
    Association of iron deficiency anemia with tuberculosis in Taiwan: A nationwide population-based study.
    PLoS One. 2019;14:e0221908.
    PubMed     Abstract available


  461. SANCHEZ-MONTALVA A, Barios M, Salvador F, Villar A, et al
    Usefulness of FDG PET/CT in the management of tuberculosis.
    PLoS One. 2019;14:e0221516.
    PubMed     Abstract available


  462. CHARYEVA Z, Curtis S, Mullen S, Senik T, et al
    What works best for ensuring treatment adherence. Lessons from a social support program for people treated for tuberculosis in Ukraine.
    PLoS One. 2019;14:e0221688.
    PubMed     Abstract available


  463. ZHANG J, Zhao Z, Bai H, Wang M, et al
    Genetic polymorphisms in PXR and NF-kappaB1 influence susceptibility to anti-tuberculosis drug-induced liver injury.
    PLoS One. 2019;14:e0222033.
    PubMed     Abstract available


  464. VAN HOOFT P, Getz WM, Greyling BJ, Bastos ADS, et al
    A natural gene drive system influences bovine tuberculosis susceptibility in African buffalo: Possible implications for disease management.
    PLoS One. 2019;14:e0221168.
    PubMed     Abstract available


  465. OLIWA JN, Gathara D, Ogero M, van Hensbroek MB, et al
    Diagnostic practices and estimated burden of tuberculosis among children admitted to 13 government hospitals in Kenya: An analysis of two years' routine clinical data.
    PLoS One. 2019;14:e0221145.
    PubMed     Abstract available


  466. HARRIS M, Qi A, Jeagal L, Torabi N, et al
    A systematic review of the diagnostic accuracy of artificial intelligence-based computer programs to analyze chest x-rays for pulmonary tuberculosis.
    PLoS One. 2019;14:e0221339.
    PubMed     Abstract available


  467. FANTAHUN M, Kebede A, Yenew B, Gemechu T, et al
    Diagnostic accuracy of Xpert MTB/RIF assay and non-molecular methods for the diagnosis of tuberculosis lymphadenitis.
    PLoS One. 2019;14:e0222402.
    PubMed     Abstract available


  468. WAMPANDE EM, Naniima P, Mupere E, Kateete DP, et al
    Genetic variability and consequence of Mycobacterium tuberculosis lineage 3 in Kampala-Uganda.
    PLoS One. 2019;14:e0221644.
    PubMed     Abstract available



  469. Retraction: Analysis of Mycobacterium tuberculosis-Specific CD8 T-Cells in Patients with Active Tuberculosis and in Individuals with Latent Infection.
    PLoS One. 2019;14:e0223028.
    PubMed    


  470. HAN SS, Lee SJ, Yim JJ, Song JH, et al
    Evaluation and treatment of latent tuberculosis infection among healthcare workers in Korea: A multicentre cohort analysis.
    PLoS One. 2019;14:e0222810.
    PubMed     Abstract available



  471. Correction: Low Dose Aerosol Fitness at the Innate Phase of Murine Infection Better Predicts Virulence amongst Clinical Strains of Mycobacterium tuberculosis.
    PLoS One. 2019;14:e0222794.
    PubMed     Abstract available


  472. NARANG A, Garima K, Porwal S, Bhandekar A, et al
    Potential impact of efflux pump genes in mediating rifampicin resistance in clinical isolates of Mycobacterium tuberculosis from India.
    PLoS One. 2019;14:e0223163.
    PubMed     Abstract available


  473. HAMID M, Brooks MB, Madhani F, Ali H, et al
    Risk factors for unsuccessful tuberculosis treatment outcomes in children.
    PLoS One. 2019;14:e0222776.
    PubMed     Abstract available


  474. KU CC, Dodd PJ
    Forecasting the impact of population ageing on tuberculosis incidence.
    PLoS One. 2019;14:e0222937.
    PubMed     Abstract available


  475. RICHOMME C, Courcoul A, Moyen JL, Reveillaud E, et al
    Tuberculosis in the wild boar: Frequentist and Bayesian estimations of diagnostic test parameters when Mycobacterium bovis is present in wild boars but at low prevalence.
    PLoS One. 2019;14:e0222661.
    PubMed     Abstract available


  476. ROSSETTO M, Brand EM, Rodrigues RM, Serrant L, et al
    Factors associated with hospitalization and death among TB/HIV co-infected persons in Porto Alegre, Brazil.
    PLoS One. 2019;14:e0209174.
    PubMed     Abstract available


  477. LI Y, Huang H, Dong W, Lan T, et al
    Penetration of linezolid into bone tissue 24 h after administration in patients with multidrug-resistant spinal tuberculosis.
    PLoS One. 2019;14:e0223391.
    PubMed     Abstract available


  478. NYATHI S, Dlodlo RA, Satyanarayana S, Takarinda KC, et al
    Isoniazid preventive therapy: Uptake, incidence of tuberculosis and survival among people living with HIV in Bulawayo, Zimbabwe.
    PLoS One. 2019;14:e0223076.
    PubMed     Abstract available


  479. YEKTAKOOSHALI MH, Movahedzadeh F, Foumani AA, Sabati H, et al
    Is latent tuberculosis infection challenging in Iranian health care workers? A systematic review and meta-analysis.
    PLoS One. 2019;14:e0223335.
    PubMed     Abstract available


  480. BRAND EM, Rossetto M, Calvo KDS, Winkler GB, et al
    Factors associated with directly observed treatment in tuberculosis/HIV coinfection cases in Porto Alegre, 2009-2013: A retrospective cohort.
    PLoS One. 2019;14:e0222786.
    PubMed     Abstract available


  481. MILLER AP, Malekinejad M, Horvath H, Blodgett JC, et al
    Healthcare facility-based strategies to improve tuberculosis testing and linkage to care in non-U.S.-born population in the United States: A systematic review.
    PLoS One. 2019;14:e0223077.
    PubMed     Abstract available



  482. Correction: BCG vaccination and tuberculosis prevention: A forty years cohort study, Monastir, Tunisia.
    PLoS One. 2019;14:e0223903.
    PubMed     Abstract available


  483. EARLY JV, Mullen S, Parish T
    A rapid, low pH, nutrient stress, assay to determine the bactericidal activity of compounds against non-replicating Mycobacterium tuberculosis.
    PLoS One. 2019;14:e0222970.
    PubMed     Abstract available


  484. BOUTON TC, de Vos M, Ragan EJ, White LF, et al
    Switching to bedaquiline for treatment of rifampicin-resistant tuberculosis in South Africa: A retrospective cohort analysis.
    PLoS One. 2019;14:e0223308.
    PubMed     Abstract available


  485. TAGHIPOUR A, Mosadegh M, Kheirollahzadeh F, Olfatifar M, et al
    Are intestinal helminths playing a positive role in tuberculosis risk? A systematic review and meta-analysis.
    PLoS One. 2019;14:e0223722.
    PubMed     Abstract available


  486. MCINTOSH AI, Jenkins HE, Horsburgh CR, Jones-Lopez EC, et al
    Partitioning the risk of tuberculosis transmission in household contact studies.
    PLoS One. 2019;14:e0223966.
    PubMed     Abstract available


  487. MAGHRADZE N, Jugheli L, Borrell S, Tukvadze N, et al
    Classifying recurrent Mycobacterium tuberculosis cases in Georgia using MIRU-VNTR typing.
    PLoS One. 2019;14:e0223610.
    PubMed     Abstract available


  488. THOMAS BE, Thiruvengadam K, S R, Kadam D, et al
    Correction: Smoking, alcohol use disorder and tuberculosis treatment outcomes: A dual co-morbidity burden that cannot be ignored.
    PLoS One. 2019;14:e0224914.
    PubMed     Abstract available


  489. SUBBARAMAN R, Thomas BE, Sellappan S, Suresh C, et al
    Correction: Tuberculosis patients in an Indian mega-city: Where do they live and where are they diagnosed?
    PLoS One. 2019;14:e0224808.
    PubMed     Abstract available


  490. WOLDEYOHANNES D, Assefa T, Aman R, Tekalegn Y, et al
    Predictors of time to unfavorable treatment outcomes among patients with multidrug resistant tuberculosis in Oromia region, Ethiopia.
    PLoS One. 2019;14:e0224025.
    PubMed     Abstract available


  491. REID M, Roberts G, Goosby E, Wesson P, et al
    Monitoring Universal Health Coverage (UHC) in high Tuberculosis burden countries: Tuberculosis mortality an important tracer of UHC service coverage.
    PLoS One. 2019;14:e0223559.
    PubMed     Abstract available



  492. Correction: Forecasting the impact of population ageing on tuberculosis incidence.
    PLoS One. 2019;14:e0224673.
    PubMed     Abstract available


  493. ZHENG Z, Lin J, Lu Z, Su J, et al
    Mortality risk in the population of HIV-positive individuals in Southern China: A cohort study.
    PLoS One. 2019;14:e0210856.
    PubMed     Abstract available


  494. BIRUNGI FM, Graham SM, Uwimana J, Musabimana A, et al
    Adherence to isoniazid preventive therapy among child contacts in Rwanda: A mixed-methods study.
    PLoS One. 2019;14:e0211934.
    PubMed     Abstract available


  495. ASANTE-POKU A, Asare P, Baddoo NA, Forson A, et al
    TB-diabetes co-morbidity in Ghana: The importance of Mycobacterium africanum infection.
    PLoS One. 2019;14:e0211822.
    PubMed     Abstract available


  496. XU J, Wang G, Zhang Y, Zhang G, et al
    An outbreak of tuberculosis in a middle school in Henan, China: Epidemiology and risk factors.
    PLoS One. 2019;14:e0225042.
    PubMed     Abstract available


  497. LOUREIRO RB, Maciel ELN, Caetano R, Peres RL, et al
    Cost-effectiveness of QuantiFERON-TB Gold In-Tube versus tuberculin skin test for diagnosis and treatment of Latent Tuberculosis Infection in primary health care workers in Brazil.
    PLoS One. 2019;14:e0225197.
    PubMed     Abstract available


  498. MUSSIE KM, Yimer SA, Manyazewal T, Gradmann C, et al
    Exploring local realities: Perceptions and experiences of healthcare workers on the management and control of drug-resistant tuberculosis in Addis Ababa, Ethiopia.
    PLoS One. 2019;14:e0224277.
    PubMed     Abstract available


  499. CHADHA VK, Anjinappa SM, Dave P, Rade K, et al
    Sub-national TB prevalence surveys in India, 2006-2012: Results of uniformly conducted data analysis.
    PLoS One. 2019;14:e0212264.
    PubMed     Abstract available


  500. YOSHITAKE N, Omori M, Sugawara M, Akishinonomiya K, et al
    Do health beliefs, personality traits, and interpersonal concerns predict TB prevention behavior among Japanese adults?
    PLoS One. 2019;14:e0211728.
    PubMed     Abstract available


  501. GARCIA PK, Annamalai T, Wang W, Bell RS, et al
    Mechanism and resistance for antimycobacterial activity of a fluoroquinophenoxazine compound.
    PLoS One. 2019;14:e0207733.
    PubMed     Abstract available


  502. VAN GINDERDEUREN E, Bassett J, Hanrahan C, Mutunga L, et al
    Health system barriers to implementation of TB preventive strategies in South African primary care facilities.
    PLoS One. 2019;14:e0212035.
    PubMed     Abstract available


  503. LU Z, Jiang W, Zhang J, Lynn HS, et al
    Drug resistance and epidemiology characteristics of multidrug-resistant tuberculosis patients in 17 provinces of China.
    PLoS One. 2019;14:e0225361.
    PubMed     Abstract available


  504. BAJEHSON M, Musa BM, Gidado M, Nsa B, et al
    Determinants of mortality among patients with drug-resistant tuberculosis in northern Nigeria.
    PLoS One. 2019;14:e0225165.
    PubMed     Abstract available


  505. MA X, Mirutse G, Bayray A, Fang M, et al
    Tuberculosis treatment outcome: The case of women in Ethiopia and China, ten-years retrospective cohort study.
    PLoS One. 2019;14:e0219230.
    PubMed     Abstract available


  506. OTCHERE ID, van Tonder AJ, Asante-Poku A, Sanchez-Buso L, et al
    Molecular epidemiology and whole genome sequencing analysis of clinical Mycobacterium bovis from Ghana.
    PLoS One. 2019;14:e0209395.
    PubMed     Abstract available


  507. TENLAND E, Pochert A, Krishnan N, Umashankar Rao K, et al
    Effective delivery of the anti-mycobacterial peptide NZX in mesoporous silica nanoparticles.
    PLoS One. 2019;14:e0212858.
    PubMed     Abstract available


  508. GUERRA-MAUPOME M, Vang DX, McGill JL
    Aerosol vaccination with Bacille Calmette-Guerin induces a trained innate immune phenotype in calves.
    PLoS One. 2019;14:e0212751.
    PubMed     Abstract available


  509. VARKILA MRJ, Vos AG, Barth RE, Tempelman HA, et al
    The association between HIV infection and pulmonary function in a rural African population.
    PLoS One. 2019;14:e0210573.
    PubMed     Abstract available


  510. GUPTE AN, Paradkar M, Selvaraju S, Thiruvengadam K, et al
    Correction: Assessment of lung function in successfully treated tuberculosis reveals high burden of ventilatory defects and COPD.
    PLoS One. 2019;14:e0226389.
    PubMed     Abstract available


  511. ALENE KA, Viney K, Moore HC, Wagaw M, et al
    Spatial patterns of tuberculosis and HIV co-infection in Ethiopia.
    PLoS One. 2019;14:e0226127.
    PubMed     Abstract available


  512. SARTORI NS, Picon P, Papke A, Neyeloff JL, et al
    A population-based study of tuberculosis incidence among rheumatic disease patients under anti-TNF treatment.
    PLoS One. 2019;14:e0224963.
    PubMed     Abstract available


  513. TSEGAYE SAHLE E, Blumenthal J, Jain S, Sun S, et al
    Bacteriologically-confirmed pulmonary tuberculosis in an Ethiopian prison: Prevalence from screening of entrant and resident prisoners.
    PLoS One. 2019;14:e0226160.
    PubMed     Abstract available


  514. GEBREMICAEL G, Kassa D, Alemayehu Y, Gebreegziaxier A, et al
    Gene expression profiles classifying clinical stages of tuberculosis and monitoring treatment responses in Ethiopian HIV-negative and HIV-positive cohorts.
    PLoS One. 2019;14:e0226137.
    PubMed     Abstract available


  515. RAJAMANICKAM A, Munisankar S, Dolla CK, Babu S, et al
    Undernutrition is associated with perturbations in T cell-, B cell-, monocyte- and dendritic cell- subsets in latent Mycobacterium tuberculosis infection.
    PLoS One. 2019;14:e0225611.
    PubMed     Abstract available


  516. WU B, Yu Y, Du C, Liu Y, et al
    Epidemiology of drug-resistant tuberculosis in Chongqing, China: A retrospective observational study from 2010 to 2017.
    PLoS One. 2019;14:e0216018.
    PubMed     Abstract available


  517. FATIMA R, Yaqoob A, Qadeer E, Hinderaker SG, et al
    Measuring and addressing the childhood tuberculosis reporting gaps in Pakistan: The first ever national inventory study among children.
    PLoS One. 2019;14:e0227186.
    PubMed     Abstract available


  518. FELLAG M, Loukil A, Saad J, Lepidi H, et al
    Translocation of Mycobacterium tuberculosis after experimental ingestion.
    PLoS One. 2019;14:e0227005.
    PubMed     Abstract available


  519. ABONG J, Dalay V, Langley I, Tomeny E, et al
    Use of GeneXpert and the role of an expert panel in improving clinical diagnosis of smear-negative tuberculosis cases.
    PLoS One. 2019;14:e0227093.
    PubMed     Abstract available


  520. ORINA F, Mwangi M, Meme H, Kitole B, et al
    Intrinsic and extrinsic factors associated with sputum characteristics of presumed tuberculosis patients.
    PLoS One. 2019;14:e0227107.
    PubMed     Abstract available


  521. CHAVES TORRES NM, Quijano Rodriguez JJ, Porras Andrade PS, Arriaga MB, et al
    Factors predictive of the success of tuberculosis treatment: A systematic review with meta-analysis.
    PLoS One. 2019;14:e0226507.
    PubMed     Abstract available


  522. ARRIAGA MB, Torres NMC, Araujo NCN, Caldas SCC, et al
    Impact of the change in the antitubercular regimen from three to four drugs on cure and frequency of adverse reactions in tuberculosis patients from Brazil: A retrospective cohort study.
    PLoS One. 2019;14:e0227101.
    PubMed     Abstract available


  523. IZUDI J, Tamwesigire IK, Bajunirwe F
    Does completion of sputum smear monitoring have an effect on treatment success and cure rate among adult tuberculosis patients in rural Eastern Uganda? A propensity score-matched analysis.
    PLoS One. 2019;14:e0226919.
    PubMed     Abstract available


  524. YANG J, Lee S, Oh S, Han S, et al
    The risk of active tuberculosis among individuals living in tuberculosis-affected households in the Republic of Korea, 2015.
    PLoS One. 2019;14:e0225744.
    PubMed     Abstract available


  525. BLANKLEY S, Gashu T, Ahmad B, Belaye AK, et al
    Lessons learned: Retrospective assessment of outcomes and management of patients with advanced HIV disease in a semi-urban polyclinic in Epworth, Zimbabwe.
    PLoS One. 2019;14:e0214739.
    PubMed     Abstract available


  526. XU C, Li R, Shewade HD, Jeyashree K, et al
    Attrition and delays before treatment initiation among patients with MDR-TB in China (2006-13): Magnitude and risk factors.
    PLoS One. 2019;14:e0214943.
    PubMed     Abstract available


  527. DUNCAN K, Sinanovic E
    A cost comparison analysis of paediatric intermediate care in a tertiary hospital and an intermediate care facility in Cape Town, South Africa.
    PLoS One. 2019;14:e0214492.
    PubMed     Abstract available


  528. AGGARWAL AN, Agarwal R, Sehgal IS, Dhooria S, et al
    Adenosine deaminase for diagnosis of tuberculous pleural effusion: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0213728.
    PubMed     Abstract available


  529. SHEWADE HD, Gupta V, Satyanarayana S, Pandey P, et al
    Patient characteristics, health seeking and delays among new sputum smear positive TB patients identified through active case finding when compared to passive case finding in India.
    PLoS One. 2019;14:e0213345.
    PubMed     Abstract available


  530. KANVATIRTH P, Jeeves RE, Bacon J, Besra GS, et al
    Utilisation of the Prestwick Chemical Library to identify drugs that inhibit the growth of mycobacteria.
    PLoS One. 2019;14:e0213713.
    PubMed     Abstract available


  531. GOOVAERTS O, Massinga-Loembe M, Ondoa P, Ceulemans A, et al
    Increased KLRG1 and PD-1 expression on CD8 T lymphocytes in TB-IRIS.
    PLoS One. 2019;14:e0215991.
    PubMed     Abstract available


  532. WILLIAMS GA, Koenen ME, Havenaar R, Wheeler P, et al
    Survival of Mycobacterium bovis BCG oral vaccine during transit through a dynamic in vitro model simulating the upper gastrointestinal tract of badgers.
    PLoS One. 2019;14:e0214859.
    PubMed     Abstract available


  533. JIN KW, Lee JY, Rhiu S, Choi DG, et al
    Longitudinal evaluation of visual function and structure for detection of subclinical Ethambutol-induced optic neuropathy.
    PLoS One. 2019;14:e0215297.
    PubMed     Abstract available


  534. MOAYEDI-NIA S, Barss L, Oxlade O, Valiquette C, et al
    The mTST - An mHealth approach for training and quality assurance of tuberculin skin test administration and reading.
    PLoS One. 2019;14:e0215240.
    PubMed     Abstract available


  535. WHITE LV, Lee N, Marin FP, Saludar NR, et al
    Performance of alternative measures to body mass index in the assessment of moderate and severe under-nutrition among acutely unwell patients hospitalized in a TB ward in the Philippines: A cross-sectional study.
    PLoS One. 2019;14:e0215968.
    PubMed     Abstract available


  536. CLEMENS DL, Lee BY, Silva A, Dillon BJ, et al
    Artificial intelligence enabled parabolic response surface platform identifies ultra-rapid near-universal TB drug treatment regimens comprising approved drugs.
    PLoS One. 2019;14:e0215607.
    PubMed     Abstract available


  537. MEKONNEN D, Derbie A, Abeje A, Shumet A, et al
    Epidemiology of tuberculous lymphadenitis in Africa: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0215647.
    PubMed     Abstract available


  538. NAJJINGO I, Muttamba W, Kirenga BJ, Nalunjogi J, et al
    Comparison of GeneXpert cycle threshold values with smear microscopy and culture as a measure of mycobacterial burden in five regional referral hospitals of Uganda- A cross-sectional study.
    PLoS One. 2019;14:e0216901.
    PubMed     Abstract available


  539. KARMAKAR M, Rodrigues CHM, Holt KE, Dunstan SJ, et al
    Empirical ways to identify novel Bedaquiline resistance mutations in AtpE.
    PLoS One. 2019;14:e0217169.
    PubMed     Abstract available


  540. ROBERTSON A, Judge J, Wilson GJ, Vernon IJ, et al
    Predicting badger visits to farm yards and making predictions available to farmers.
    PLoS One. 2019;14:e0216953.
    PubMed     Abstract available


  541. MASONOU T, Hokey DA, Lahey T, Halliday A, et al
    CD4+ T cell cytokine responses to the DAR-901 booster vaccine in BCG-primed adults: A randomized, placebo-controlled trial.
    PLoS One. 2019;14:e0217091.
    PubMed     Abstract available


  542. DEMITTO FO, Schmaltz CAS, Sant'Anna FM, Arriaga MB, et al
    Predictors of early mortality and effectiveness of antiretroviral therapy in TB-HIV patients from Brazil.
    PLoS One. 2019;14:e0217014.
    PubMed     Abstract available


  543. LEE N, White LV, Marin FP, Saludar NR, et al
    Mid-upper arm circumference predicts death in adult patients admitted to a TB ward in the Philippines: A prospective cohort study.
    PLoS One. 2019;14:e0218193.
    PubMed     Abstract available


  544. CARRISOZA-URBINA J, Morales-Salinas E, Bedolla-Alva MA, Hernandez-Pando R, et al
    Atypical granuloma formation in Mycobacterium bovis-infected calves.
    PLoS One. 2019;14:e0218547.
    PubMed     Abstract available


  545. QURESHI S, Ahmad K, Fatima P, Hassan RM, et al
    Outcome of inadvertent high dose BCG administration in newborns at a tertiary care hospital, Karachi- Case series.
    PLoS One. 2019;14:e0219324.
    PubMed     Abstract available


  546. JENSEN K, Stevens JM, Glass EJ
    Interleukin 10 knock-down in bovine monocyte-derived macrophages has distinct effects during infection with two divergent strains of Mycobacterium bovis.
    PLoS One. 2019;14:e0222437.
    PubMed     Abstract available


  547. HUANG HL, Liu CJ, Lee MR, Cheng MH, et al
    Surgical resection is sufficient for incidentally discovered solitary pulmonary nodule caused by nontuberculous mycobacteria in asymptomatic patients.
    PLoS One. 2019;14:e0222425.
    PubMed     Abstract available


  548. MATHIASEN VD, Eiset AH, Andersen PH, Wejse C, et al
    Epidemiology of tuberculous lymphadenitis in Denmark: A nationwide register-based study.
    PLoS One. 2019;14:e0221232.
    PubMed     Abstract available


  549. BENZEKRI NA, Sambou JF, Tamba IT, Diatta JP, et al
    Nutrition support for HIV-TB co-infected adults in Senegal, West Africa: A randomized pilot implementation study.
    PLoS One. 2019;14:e0219118.
    PubMed     Abstract available


  550. DATIKO DG, Habte D, Jerene D, Suarez P, et al
    Knowledge, attitudes, and practices related to TB among the general population of Ethiopia: Findings from a national cross-sectional survey.
    PLoS One. 2019;14:e0224196.
    PubMed     Abstract available


  551. HOMOLKA S, Zallet J, Albert H, Witt AK, et al
    Introduction of quality management in a National Reference Laboratory in Germany.
    PLoS One. 2019;14:e0222925.
    PubMed     Abstract available


  552. KIM TY, Chang HE, Lee SW, Seo SH, et al
    A novel strategy for interpreting the T-SPOT.TB test results read by an ELISPOT plate imager.
    PLoS One. 2019;14:e0222920.
    PubMed     Abstract available


  553. BENJAMIN A, Cavalcante SC, Jamal LF, Arakaki-Sanchez D, et al
    Accuracy of Determine TB-LAM Ag to detect TB in HIV infected patients associated with diagnostic methods used in Brazilian public health units.
    PLoS One. 2019;14:e0221038.
    PubMed     Abstract available


  554. MARAIS F, Kallon II, Dudley LD
    Continuity of care for TB patients at a South African hospital: A qualitative participatory study of the experiences of hospital staff.
    PLoS One. 2019;14:e0222421.
    PubMed     Abstract available


  555. DUFFY FJ, Thompson EG, Scriba TJ, Zak DE, et al
    Multinomial modelling of TB/HIV co-infection yields a robust predictive signature and generates hypotheses about the HIV+TB+ disease state.
    PLoS One. 2019;14:e0219322.
    PubMed     Abstract available


  556. GAFFAR SMA, Chisti MJ, Mahfuz M, Ahmed T, et al
    Impact of negative tuberculin skin test on growth among disadvantaged Bangladeshi children.
    PLoS One. 2019;14:e0224752.
    PubMed     Abstract available


  557. LOUKIL A, Bouzid F, Osman DA, Drancourt M, et al
    Decrypting the environmental sources of Mycobacterium canettii by high-throughput biochemical profiling.
    PLoS One. 2019;14:e0222078.
    PubMed     Abstract available


  558. WU CY, Chiu HY, Tsai TF
    The seroconversion rate of QuantiFERON-TB Gold In-Tube test in psoriatic patients receiving secukinumab and ixekizumab, the anti-interleukin-17A monoclonal antibodies.
    PLoS One. 2019;14:e0225112.
    PubMed     Abstract available


  559. BHERING M, Duarte R, Kritski A
    Predictive factors for unfavourable treatment in MDR-TB and XDR-TB patients in Rio de Janeiro State, Brazil, 2000-2016.
    PLoS One. 2019;14:e0218299.
    PubMed     Abstract available


  560. KEBEDE A, Beyene D, Yenew B, Diriba G, et al
    Monitoring quality indicators for the Xpert MTB/RIF molecular assay in Ethiopia.
    PLoS One. 2019;14:e0225205.
    PubMed     Abstract available


  561. SINGH B, Saqib M, Chakraborty A, Bhaskar S, et al
    Lipoarabinomannan from Mycobacterium indicus pranii shows immunostimulatory activity and induces autophagy in macrophages.
    PLoS One. 2019;14:e0224239.
    PubMed     Abstract available


  562. KENDALL EA, Kamoga C, Kitonsa PJ, Nalutaaya A, et al
    Empiric treatment of pulmonary TB in the Xpert era: Correspondence of sputum culture, Xpert MTB/RIF, and clinical diagnoses.
    PLoS One. 2019;14:e0220251.
    PubMed     Abstract available


  563. HOWELL AK, McCann CM, Wickstead F, Williams DJL, et al
    Co-infection of cattle with Fasciola hepatica or F. gigantica and Mycobacterium bovis: A systematic review.
    PLoS One. 2019;14:e0226300.
    PubMed     Abstract available


    January 2018
  564. MACIEL EMGS, Amancio JS, Castro DB, Braga JU, et al
    Social determinants of pulmonary tuberculosis treatment non-adherence in Rio de Janeiro, Brazil.
    PLoS One. 2018;13:e0190578.
    PubMed     Abstract available


  565. FELEKE BE, Alene GD, Feleke TE, Motebaynore Y, et al
    Clinical response of tuberculosis patients, a prospective cohort study.
    PLoS One. 2018;13:e0190207.
    PubMed     Abstract available


  566. LI J, Yip BHK, Leung C, Chung W, et al
    Screening for latent and active tuberculosis infection in the elderly at admission to residential care homes: A cost-effectiveness analysis in an intermediate disease burden area.
    PLoS One. 2018;13:e0189531.
    PubMed     Abstract available


  567. PARLATO S, Chiacchio T, Salerno D, Petrone L, et al
    Impaired IFN-alpha-mediated signal in dendritic cells differentiates active from latent tuberculosis.
    PLoS One. 2018;13:e0189477.
    PubMed     Abstract available


  568. HARRINGTON-KANDT R, Stylianou E, Eddowes LA, Lim PJ, et al
    Hepcidin deficiency and iron deficiency do not alter tuberculosis susceptibility in a murine M.tb infection model.
    PLoS One. 2018;13:e0191038.
    PubMed     Abstract available


  569. ABEBE F, Belay M, Legesse M, K L M C F, et al
    IgA and IgG against Mycobacterium tuberculosis Rv2031 discriminate between pulmonary tuberculosis patients, Mycobacterium tuberculosis-infected and non-infected individuals.
    PLoS One. 2018;13:e0190989.
    PubMed     Abstract available


  570. MCCARTHY K, Fielding K, Churchyard GJ, Grant AD, et al
    Empiric tuberculosis treatment in South African primary health care facilities - for whom, where, when and why: Implications for the development of tuberculosis diagnostic tests.
    PLoS One. 2018;13:e0191608.
    PubMed     Abstract available


  571. MUPFUMI L, Moyo S, Molebatsi K, Thami PK, et al
    Immunological non-response and low hemoglobin levels are predictors of incident tuberculosis among HIV-infected individuals on Truvada-based therapy in Botswana.
    PLoS One. 2018;13:e0192030.
    PubMed     Abstract available


  572. ZHU Z, Hao D, Wang B, Gao W, et al
    Selection of surgical treatment approaches for cervicothoracic spinal tuberculosis: A 10-year case review.
    PLoS One. 2018;13:e0192581.
    PubMed     Abstract available


  573. VEESA KS, John KR, Moonan PK, Kaliappan SP, et al
    Diagnostic pathways and direct medical costs incurred by new adult pulmonary tuberculosis patients prior to anti-tuberculosis treatment - Tamil Nadu, India.
    PLoS One. 2018;13:e0191591.
    PubMed     Abstract available


  574. STOCKDALE L, Nash S, Nalwoga A, Painter H, et al
    Human cytomegalovirus epidemiology and relationship to tuberculosis and cardiovascular disease risk factors in a rural Ugandan cohort.
    PLoS One. 2018;13:e0192086.
    PubMed     Abstract available


  575. UFIMTSEVA E, Eremeeva N, Petrunina E, Umpeleva T, et al
    Ex vivo expansion of alveolar macrophages with Mycobacterium tuberculosis from the resected lungs of patients with pulmonary tuberculosis.
    PLoS One. 2018;13:e0191918.
    PubMed     Abstract available


  576. TILAHUN M, Ameni G, Desta K, Zewude A, et al
    Molecular epidemiology and drug sensitivity pattern of Mycobacterium tuberculosis strains isolated from pulmonary tuberculosis patients in and around Ambo Town, Central Ethiopia.
    PLoS One. 2018;13:e0193083.
    PubMed     Abstract available


  577. KORTHALS ALTES H, Kloet S, Cobelens F, Bootsma M, et al
    Latent tuberculosis infection in foreign-born communities: Import vs. transmission in The Netherlands derived through mathematical modelling.
    PLoS One. 2018;13:e0192282.
    PubMed     Abstract available


  578. GAUTAM SS, Mac Aogain M, Cooley LA, Haug G, et al
    Molecular epidemiology of tuberculosis in Tasmania and genomic characterisation of its first known multi-drug resistant case.
    PLoS One. 2018;13:e0192351.
    PubMed     Abstract available


  579. TIWARI V, Kedia S, Garg SK, Rampal R, et al
    CD4+ CD25+ FOXP3+ T cell frequency in the peripheral blood is a biomarker that distinguishes intestinal tuberculosis from Crohn's disease.
    PLoS One. 2018;13:e0193433.
    PubMed     Abstract available


  580. BISALLAH CI, Rampal L, Lye MS, Mohd Sidik S, et al
    Effectiveness of health education intervention in improving knowledge, attitude, and practices regarding Tuberculosis among HIV patients in General Hospital Minna, Nigeria - A randomized control trial.
    PLoS One. 2018;13:e0192276.
    PubMed     Abstract available


  581. DUDLEY L, Mukinda F, Dyers R, Marais F, et al
    Mind the gap! Risk factors for poor continuity of care of TB patients discharged from a hospital in the Western Cape, South Africa.
    PLoS One. 2018;13:e0190258.
    PubMed     Abstract available


  582. BOJOVIC O, Medenica M, Zivkovic D, Rakocevic B, et al
    Factors associated with patient and health system delays in diagnosis and treatment of tuberculosis in Montenegro, 2015-2016.
    PLoS One. 2018;13:e0193997.
    PubMed     Abstract available


  583. PEREIRA GR, Barbosa MS, Dias NJD, Almeida CPB, et al
    Impact of introduction of Xpert MTB/RIF test on tuberculosis (TB) diagnosis in a city with high TB incidence in Brazil.
    PLoS One. 2018;13:e0193988.
    PubMed     Abstract available


  584. BASTARD M, Sanchez-Padilla E, du Cros P, Khamraev AK, et al
    Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study.
    PLoS One. 2018;13:e0193491.
    PubMed     Abstract available


  585. RIVIERE J, Le Strat Y, Hendrikx P, Dufour B, et al
    Perceptions and acceptability of some stakeholders about the bovine tuberculosis surveillance system for wildlife (Sylvatub) in France.
    PLoS One. 2018;13:e0194447.
    PubMed     Abstract available


  586. MUNRO-ROJAS D, Fernandez-Morales E, Zarrabal-Meza J, Martinez-Cazares MT, et al
    Genetic diversity of drug and multidrug-resistant Mycobacterium tuberculosis circulating in Veracruz, Mexico.
    PLoS One. 2018;13:e0193626.
    PubMed     Abstract available


  587. LA MANNA MP, Orlando V, Li Donni P, Sireci G, et al
    Identification of plasma biomarkers for discrimination between tuberculosis infection/disease and pulmonary non tuberculosis disease.
    PLoS One. 2018;13:e0192664.
    PubMed     Abstract available


  588. BLANCO-GUILLOT F, Castaneda-Cediel ML, Cruz-Hervert P, Ferreyra-Reyes L, et al
    Genotyping and spatial analysis of pulmonary tuberculosis and diabetes cases in the state of Veracruz, Mexico.
    PLoS One. 2018;13:e0193911.
    PubMed     Abstract available


  589. DANGISSO MH, Woldesemayat EM, Datiko DG, Lindtjorn B, et al
    Long-term outcome of smear-positive tuberculosis patients after initiation and completion of treatment: A ten-year retrospective cohort study.
    PLoS One. 2018;13:e0193396.
    PubMed     Abstract available


  590. SEIPONE ID, Singh R, Patel VB, Singh A, et al
    Tuberculous meningitis is associated with higher cerebrospinal HIV-1 viral loads compared to other HIV-1-associated meningitides.
    PLoS One. 2018;13:e0192060.
    PubMed     Abstract available


  591. WANGARI IM, Stone L
    Backward bifurcation and hysteresis in models of recurrent tuberculosis.
    PLoS One. 2018;13:e0194256.
    PubMed     Abstract available


  592. ESHETIE S, Gizachew M, Alebel A, van Soolingen D, et al
    Tuberculosis treatment outcomes in Ethiopia from 2003 to 2016, and impact of HIV co-infection and prior drug exposure: A systematic review and meta-analysis.
    PLoS One. 2018;13:e0194675.
    PubMed     Abstract available


  593. ASHHURST AS, Parumasivam T, Chan JGY, Lin LCW, et al
    PLGA particulate subunit tuberculosis vaccines promote humoral and Th17 responses but do not enhance control of Mycobacterium tuberculosis infection.
    PLoS One. 2018;13:e0194620.
    PubMed     Abstract available


  594. STOCKBRIDGE EL, Miller TL, Carlson EK, Ho C, et al
    Private sector tuberculosis prevention in the US: Characteristics associated with interferon-gamma release assay or tuberculin skin testing.
    PLoS One. 2018;13:e0193432.
    PubMed     Abstract available


  595. TAKAKI K, Ramakrishnan L, Basu S
    A zebrafish model for ocular tuberculosis.
    PLoS One. 2018;13:e0194982.
    PubMed     Abstract available


  596. DENNIS EM, Hao Y, Tamambang M, Roshan TN, et al
    Tuberculosis during pregnancy in the United States: Racial/ethnic disparities in pregnancy complications and in-hospital death.
    PLoS One. 2018;13:e0194836.
    PubMed     Abstract available


  597. NOGUEIRA BMF, Rolla VC, Akrami KM, Kiene SM, et al
    Factors associated with tuberculosis treatment delay in patients co-infected with HIV in a high prevalence area in Brazil.
    PLoS One. 2018;13:e0195409.
    PubMed     Abstract available


  598. KONIG WALLES J, Tesfaye F, Jansson M, Tolera Balcha T, et al
    Performance of QuantiFERON-TB Gold Plus for detection of latent tuberculosis infection in pregnant women living in a tuberculosis- and HIV-endemic setting.
    PLoS One. 2018;13:e0193589.
    PubMed     Abstract available


  599. JAJOU R, Neeling A, Hunen RV, Vries G, et al
    Epidemiological links between tuberculosis cases identified twice as efficiently by whole genome sequencing than conventional molecular typing: A population-based study.
    PLoS One. 2018;13:e0195413.
    PubMed     Abstract available


  600. QUAGLIO G, Pizzol D, Bortolani A, Manenti F, et al
    Breast tuberculosis in men: A systematic review.
    PLoS One. 2018;13:e0194766.
    PubMed     Abstract available


  601. PARMAR MM, Sachdeva KS, Dewan PK, Rade K, et al
    Unacceptable treatment outcomes and associated factors among India's initial cohorts of multidrug-resistant tuberculosis (MDR-TB) patients under the revised national TB control programme (2007-2011): Evidence leading to policy enhancement.
    PLoS One. 2018;13:e0193903.
    PubMed     Abstract available


  602. HUDSON M, Rutherford GW, Weiser S, Fair E, et al
    Linking private, for-profit providers to public sector services for HIV and tuberculosis co-infected patients: A systematic review.
    PLoS One. 2018;13:e0194960.
    PubMed     Abstract available


  603. CHAMIE G, Kato-Maeda M, Emperador DM, Wandera B, et al
    Spatial overlap links seemingly unconnected genotype-matched TB cases in rural Uganda.
    PLoS One. 2018;13:e0192666.
    PubMed     Abstract available


  604. SHEWADE HD, Kokane AM, Singh AR, Parmar M, et al
    Provider reported barriers and solutions to improve testing among tuberculosis patients 'eligible for drug susceptibility test': A qualitative study from programmatic setting in India.
    PLoS One. 2018;13:e0196162.
    PubMed     Abstract available


  605. HELLA J, Cercamondi CI, Mhimbira F, Sasamalo M, et al
    Anemia in tuberculosis cases and household controls from Tanzania: Contribution of disease, coinfections, and the role of hepcidin.
    PLoS One. 2018;13:e0195985.
    PubMed     Abstract available


  606. DANGISSO MH, Woldesemayat EM, Datiko DG, Lindtjorn B, et al
    Correction: Long-term outcome of smear-positive tuberculosis patients after initiation and completion of treatment: A ten-year retrospective cohort study.
    PLoS One. 2018;13:e0196432.
    PubMed     Abstract available


  607. KIM SJ, Ye S, Ha E, Chun EM, et al
    Association of body mass index with incident tuberculosis in Korea.
    PLoS One. 2018;13:e0195104.
    PubMed     Abstract available


  608. WU W, Yang M, Xu M, Ding C, et al
    Diagnostic delay and mortality of active tuberculosis in patients after kidney transplantation in a tertiary care hospital in China.
    PLoS One. 2018;13:e0195695.
    PubMed     Abstract available


  609. LEUNG-THEUNG-LONG S, Coupet CA, Gouanvic M, Schmitt D, et al
    A multi-antigenic MVA vaccine increases efficacy of combination chemotherapy against Mycobacterium tuberculosis.
    PLoS One. 2018;13:e0196815.
    PubMed     Abstract available


  610. RENIER W, Bourdin A, Rubbo PA, Peries M, et al
    B cells response directed against Cut4 and CFP21 lipolytic enzymes in active and latent tuberculosis infections.
    PLoS One. 2018;13:e0196470.
    PubMed     Abstract available


  611. MANANA PN, Kuonza L, Musekiwa A, Koornhof H, et al
    Feasibility of using postal and web-based surveys to estimate the prevalence of tuberculosis among health care workers in South Africa.
    PLoS One. 2018;13:e0197022.
    PubMed     Abstract available


  612. PIENAAR E, Linderman JJ, Kirschner DE
    Emergence and selection of isoniazid and rifampin resistance in tuberculosis granulomas.
    PLoS One. 2018;13:e0196322.
    PubMed     Abstract available


  613. ARRIETA-VILLEGAS C, Peralvarez T, Vidal E, Puighibet Z, et al
    Efficacy of parenteral vaccination against tuberculosis with heat-inactivated Mycobacterium bovis in experimentally challenged goats.
    PLoS One. 2018;13:e0196948.
    PubMed     Abstract available


  614. JORSTAD MD, Marijani M, Dyrhol-Riise AM, Sviland L, et al
    MPT64 antigen detection test improves routine diagnosis of extrapulmonary tuberculosis in a low-resource setting: A study from the tertiary care hospital in Zanzibar.
    PLoS One. 2018;13:e0196723.
    PubMed     Abstract available


  615. PADMASAWITRI TIA, Frederix GW, Alisjahbana B, Klungel O, et al
    Disparities in model-based cost-effectiveness analyses of tuberculosis diagnosis: A systematic review.
    PLoS One. 2018;13:e0193293.
    PubMed     Abstract available


  616. TSENG YL, Chang CC, Chen YY, Liu YS, et al
    From one incision to one port: The surgical technique and the evolution of segmentectomy in patients with pulmonary tuberculosis.
    PLoS One. 2018;13:e0197283.
    PubMed     Abstract available


  617. JAJOU R, de Neeling A, van Hunen R, de Vries G, et al
    Correction: Epidemiological links between tuberculosis cases identified twice as efficiently by whole genome sequencing than conventional molecular typing: A population-based study.
    PLoS One. 2018;13:e0197556.
    PubMed     Abstract available


  618. ORDONEZ AA, Pokkali S, Kim S, Carr B, et al
    Adjunct antibody administration with standard treatment reduces relapse rates in a murine tuberculosis model of necrotic granulomas.
    PLoS One. 2018;13:e0197474.
    PubMed     Abstract available


  619. ALENE KA, Viney K, Yi H, McBryde ES, et al
    Comparison of the validity of smear and culture conversion as a prognostic marker of treatment outcome in patients with multidrug-resistant tuberculosis.
    PLoS One. 2018;13:e0197880.
    PubMed     Abstract available


  620. ATALELL KA, Birhan Tebeje N, Ekubagewargies DT
    Survival and predictors of mortality among children co-infected with tuberculosis and human immunodeficiency virus at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia. A retrospective follow-up study.
    PLoS One. 2018;13:e0197145.
    PubMed     Abstract available


  621. NAHID P, Jarlsberg LG, Kato-Maeda M, Segal MR, et al
    Interplay of strain and race/ethnicity in the innate immune response to M. tuberculosis.
    PLoS One. 2018;13:e0195392.
    PubMed     Abstract available


  622. RAIZADA N, Khaparde SD, Salhotra VS, Rao R, et al
    Accelerating access to quality TB care for pediatric TB cases through better diagnostic strategy in four major cities of India.
    PLoS One. 2018;13:e0193194.
    PubMed     Abstract available


  623. DELLA BELLA C, Spinicci M, Grassi A, Bartalesi F, et al
    Novel M. tuberculosis specific IL-2 ELISpot assay discriminates adult patients with active or latent tuberculosis.
    PLoS One. 2018;13:e0197825.
    PubMed     Abstract available


  624. MUPFUMI L, Moyo S, Molebatsi K, Thami PK, et al
    Correction: Immunological non-response and low hemoglobin levels are predictors of incident tuberculosis among HIV-infected individuals on Truvada-based therapy in Botswana.
    PLoS One. 2018;13:e0198711.
    PubMed     Abstract available


  625. LI Y, Jia W, Lei G, Zhao D, et al
    Diagnostic efficiency of Xpert MTB/RIF assay for osteoarticular tuberculosis in patients with inflammatory arthritis in China.
    PLoS One. 2018;13:e0198600.
    PubMed     Abstract available


  626. DEKHIL N, Skhairia MA, Mhenni B, Ben Fradj S, et al
    Automated IS6110-based fingerprinting of Mycobacterium tuberculosis: Reaching unprecedented discriminatory power and versatility.
    PLoS One. 2018;13:e0197913.
    PubMed     Abstract available


  627. LI L, Cheng Y, Emrich S, Schorey J, et al
    Activation of endothelial cells by extracellular vesicles derived from Mycobacterium tuberculosis infected macrophages or mice.
    PLoS One. 2018;13:e0198337.
    PubMed     Abstract available


  628. PAPP AC, Azad AK, Pietrzak M, Williams A, et al
    AmpliSeq transcriptome analysis of human alveolar and monocyte-derived macrophages over time in response to Mycobacterium tuberculosis infection.
    PLoS One. 2018;13:e0198221.
    PubMed     Abstract available


  629. KIGOZI E, Kasule GW, Musisi K, Lukoye D, et al
    Prevalence and patterns of rifampicin and isoniazid resistance conferring mutations in Mycobacterium tuberculosis isolates from Uganda.
    PLoS One. 2018;13:e0198091.
    PubMed     Abstract available


  630. KORTHALS ALTES H, Kloet S, Cobelens F, Bootsma M, et al
    Correction: Latent tuberculosis infection in foreign-born communities: Import vs. transmission in The Netherlands derived through mathematical modelling.
    PLoS One. 2018;13:e0198376.
    PubMed     Abstract available


  631. TADESSE S, Enqueselassie F, Hagos S
    Spatial and space-time clustering of tuberculosis in Gurage Zone, Southern Ethiopia.
    PLoS One. 2018;13:e0198353.
    PubMed     Abstract available


  632. MESFIN EA, Beyene D, Tesfaye A, Admasu A, et al
    Drug-resistance patterns of Mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia.
    PLoS One. 2018;13:e0197737.
    PubMed     Abstract available


  633. ADESOKAN HK, Akinseye VO, Sulaimon MA
    Knowledge and practices about zoonotic tuberculosis prevention and associated determinants amongst livestock workers in Nigeria; 2015.
    PLoS One. 2018;13:e0198810.
    PubMed     Abstract available



  634. Correction: Association of body mass index with incident tuberculosis in Korea.
    PLoS One. 2018;13:e0199065.
    PubMed     Abstract available


  635. MCKINLEY TJ, Lipschutz-Powell D, Mitchell AP, Wood JLN, et al
    Risk factors and variations in detection of new bovine tuberculosis breakdowns via slaughterhouse surveillance in Great Britain.
    PLoS One. 2018;13:e0198760.
    PubMed     Abstract available


  636. BRAHAM CA, White PJ, Arinaminpathy N
    Management of tuberculosis by healthcare practitioners in Pakistan: A systematic review.
    PLoS One. 2018;13:e0199413.
    PubMed     Abstract available


  637. YIHUNIE AKALU T, Muchie KF, Alemu Gelaye K
    Time to sputum culture conversion and its determinants among Multi-drug resistant Tuberculosis patients at public hospitals of the Amhara Regional State: A multicenter retrospective follow up study.
    PLoS One. 2018;13:e0199320.
    PubMed     Abstract available


  638. KAWATSU L, Uchimura K, Ohkado A, Kato S, et al
    A combination of quantitative and qualitative methods in investigating risk factors for lost to follow-up for tuberculosis treatment in Japan - Are physicians and nurses at a particular risk?
    PLoS One. 2018;13:e0198075.
    PubMed     Abstract available


  639. SSENGOOBA W, Nakayita G, Namaganda CC, Joloba ML, et al
    Agreement of Middle brook 7H10 with Lowenstein Jensen and accuracy of the Sensititre MYCOTB plate using either method as a reference standard for Mycobacterium tuberculosis first line drug susceptibility testing.
    PLoS One. 2018;13:e0199638.
    PubMed     Abstract available


  640. MBU ET, Sauter F, Zoufaly A, Bronsvoort BMC, et al
    Tuberculosis in people newly diagnosed with HIV at a large HIV care and treatment center in Northwest Cameroon: Burden, comparative screening and diagnostic yields, and patient outcomes.
    PLoS One. 2018;13:e0199634.
    PubMed     Abstract available


  641. YU G, Shen Y, Zhong F, Ye B, et al
    Diagnostic accuracy of the loop-mediated isothermal amplification assay for extrapulmonary tuberculosis: A meta-analysis.
    PLoS One. 2018;13:e0199290.
    PubMed     Abstract available


  642. SHIBABAW A, Gelaw B, Wang SH, Tessema B, et al
    Time to sputum smear and culture conversions in multidrug resistant tuberculosis at University of Gondar Hospital, Northwest Ethiopia.
    PLoS One. 2018;13:e0198080.
    PubMed     Abstract available


  643. DESTA KT, Masango TE, Nkosi ZZ
    Performance of the National Tuberculosis Control Program in the post conflict Liberia.
    PLoS One. 2018;13:e0199474.
    PubMed     Abstract available


  644. NAFADE V, Nash M, Huddart S, Pande T, et al
    A bibliometric analysis of tuberculosis research, 2007-2016.
    PLoS One. 2018;13:e0199706.
    PubMed     Abstract available


  645. WAI PP, Shewade HD, Kyaw NTT, Thein S, et al
    Community-based MDR-TB care project improves treatment initiation in patients diagnosed with MDR-TB in Myanmar.
    PLoS One. 2018;13:e0194087.
    PubMed     Abstract available


  646. MCDOWELL A, Raizada N, Khaparde SD, Rao R, et al
    "Before Xpert I only had my expertise": A qualitative study on the utilization and effects of Xpert technology among pediatricians in 4 Indian cities.
    PLoS One. 2018;13:e0193656.
    PubMed     Abstract available


  647. BOFFA J, Mayan M, Ndlovu S, Mhlaba T, et al
    The role of agency in the implementation of Isoniazid Preventive Therapy (IPT): Lessons from oMakoti in uMgungundlovu District, South Africa.
    PLoS One. 2018;13:e0193571.
    PubMed     Abstract available


  648. RAIZADA N, Khaparde SD, Swaminathan S, Sarin S, et al
    Catalysing progressive uptake of newer diagnostics by health care providers through outreach and education in four major cities of India.
    PLoS One. 2018;13:e0193341.
    PubMed     Abstract available


  649. NDLOVU Z, Fajardo E, Mbofana E, Maparo T, et al
    Multidisease testing for HIV and TB using the GeneXpert platform: A feasibility study in rural Zimbabwe.
    PLoS One. 2018;13:e0193577.
    PubMed     Abstract available


  650. CERQUEIRA-RODRIGUES B, Mendes A, Correia-Neves M, Nobrega C, et al
    Ag85-focused T-cell immune response controls Mycobacterium avium chronic infection.
    PLoS One. 2018;13:e0193596.
    PubMed     Abstract available


  651. JEONG DH, Kang J, Jung YJ, Yoo B, et al
    Comparison of latent tuberculosis infection screening strategies before tumor necrosis factor inhibitor treatment in inflammatory arthritis: IGRA-alone versus combination of TST and IGRA.
    PLoS One. 2018;13:e0198756.
    PubMed     Abstract available


  652. MARABA N, Hoffmann CJ, Chihota VN, Chang LW, et al
    Using mHealth to improve tuberculosis case identification and treatment initiation in South Africa: Results from a pilot study.
    PLoS One. 2018;13:e0199687.
    PubMed     Abstract available


  653. PAGE-SHIPP L, Lewis JJ, Velen K, Senoge S, et al
    Household point of care CD4 testing and isoniazid preventive therapy initiation in a household TB contact tracing programme in two districts of South Africa.
    PLoS One. 2018;13:e0192089.
    PubMed     Abstract available


  654. VELAYUTHAM B, Chadha VK, Singla N, Narang P, et al
    Recurrence of tuberculosis among newly diagnosed sputum positive pulmonary tuberculosis patients treated under the Revised National Tuberculosis Control Programme, India: A multi-centric prospective study.
    PLoS One. 2018;13:e0200150.
    PubMed     Abstract available


  655. WILLEMSE D, Weber B, Masino L, Warren RM, et al
    Rv1460, a SufR homologue, is a repressor of the suf operon in Mycobacterium tuberculosis.
    PLoS One. 2018;13:e0200145.
    PubMed     Abstract available


  656. SILVA DAAD, Silva MVD, Barros CCO, Alexandre PBD, et al
    TNF-alpha blockade impairs in vitro tuberculous granuloma formation and down modulate Th1, Th17 and Treg cytokines.
    PLoS One. 2018;13:e0194430.
    PubMed     Abstract available


  657. ZHANG R, Xi X, Wang C, Pan Y, et al
    Therapeutic effects of recombinant human interleukin 2 as adjunctive immunotherapy against tuberculosis: A systematic review and meta-analysis.
    PLoS One. 2018;13:e0201025.
    PubMed     Abstract available


  658. BARUA M, Van Driel F, Jansen W
    Tuberculosis and the sexual and reproductive lives of women in Bangladesh.
    PLoS One. 2018;13:e0201134.
    PubMed     Abstract available


  659. MEYVISCH P, Kambili C, Andries K, Lounis N, et al
    Evaluation of six months sputum culture conversion as a surrogate endpoint in a multidrug resistant-tuberculosis trial.
    PLoS One. 2018;13:e0200539.
    PubMed     Abstract available


  660. PARRIOTT A, Malekinejad M, Miller AP, Horvath H, et al
    Yield of testing and treatment for tuberculosis among foreign-born persons during contact investigations in the United States: A semi-systematic review.
    PLoS One. 2018;13:e0200485.
    PubMed     Abstract available


  661. ORLANDO S, Triulzi I, Ciccacci F, Palla I, et al
    Delayed diagnosis and treatment of tuberculosis in HIV+ patients in Mozambique: A cost-effectiveness analysis of screening protocols based on four symptom screening, smear microscopy, urine LAM test and Xpert MTB/RIF.
    PLoS One. 2018;13:e0200523.
    PubMed     Abstract available


  662. PANDE T, Huddart S, Xavier W, Kulavalli S, et al
    Prevalence of diabetes mellitus amongst hospitalized tuberculosis patients at an Indian tertiary care center: A descriptive analysis.
    PLoS One. 2018;13:e0200838.
    PubMed     Abstract available


  663. CHIANG TY, Fan SY, Jou R
    Performance of an Xpert-based diagnostic algorithm for the rapid detection of drug-resistant tuberculosis among high-risk populations in a low-incidence setting.
    PLoS One. 2018;13:e0200755.
    PubMed     Abstract available


  664. MEEHAN SA, Sloot R, Draper HR, Naidoo P, et al
    Factors associated with linkage to HIV care and TB treatment at community-based HIV testing services in Cape Town, South Africa.
    PLoS One. 2018;13:e0195208.
    PubMed     Abstract available


  665. WALKER IF, Khanal S, Hicks JP, Lamichhane B, et al
    Implementation of a psychosocial support package for people receiving treatment for multidrug-resistant tuberculosis in Nepal: A feasibility and acceptability study.
    PLoS One. 2018;13:e0201163.
    PubMed     Abstract available


  666. GARCIA PJ, Hernandez-Cordova G, Pourjavaheri P, Gomez-Paredes HJ, et al
    Knowledge, attitudes and practices related to tuberculosis in pharmacy workers in a cross-sectional survey in El Agustino, Peru.
    PLoS One. 2018;13:e0196648.
    PubMed     Abstract available


  667. KOSTER K, Largen A, Foster JT, Drees KP, et al
    Whole genome SNP analysis suggests unique virulence factor differences of the Beijing and Manila families of Mycobacterium tuberculosis found in Hawaii.
    PLoS One. 2018;13:e0201146.
    PubMed     Abstract available


  668. CHIHOTA VN, Niehaus A, Streicher EM, Wang X, et al
    Geospatial distribution of Mycobacterium tuberculosis genotypes in Africa.
    PLoS One. 2018;13:e0200632.
    PubMed     Abstract available


  669. DUTTA A, Pattanaik S, Choudhury R, Nanda P, et al
    Impact of involvement of non-formal health providers on TB case notification among migrant slum-dwelling populations in Odisha, India.
    PLoS One. 2018;13:e0196067.
    PubMed     Abstract available


  670. PATHMANATHAN I, Pasipamire M, Pals S, Dokubo EK, et al
    High uptake of antiretroviral therapy among HIV-positive TB patients receiving co-located services in Swaziland.
    PLoS One. 2018;13:e0196831.
    PubMed     Abstract available


  671. LOVEDAY M, Wallengren K, Reddy T, Besada D, et al
    MDR-TB patients in KwaZulu-Natal, South Africa: Cost-effectiveness of 5 models of care.
    PLoS One. 2018;13:e0196003.
    PubMed     Abstract available


  672. NGUYEN DT, Jenkins HE, Graviss EA
    Prognostic score to predict mortality during TB treatment in TB/HIV co-infected patients.
    PLoS One. 2018;13:e0196022.
    PubMed     Abstract available


  673. MUTTAMBA W, Ssengooba W, Sekibira R, Kirenga B, et al
    Accuracy of different Xpert MTB/Rif implementation strategies in programmatic settings at the regional referral hospitals in Uganda: Evidence for country wide roll out.
    PLoS One. 2018;13:e0194741.
    PubMed     Abstract available


  674. JOSHI B, Lestari T, Graham SM, Baral SC, et al
    The implementation of Xpert MTB/RIF assay for diagnosis of tuberculosis in Nepal: A mixed-methods analysis.
    PLoS One. 2018;13:e0201731.
    PubMed     Abstract available


  675. PRIEDEMAN SKILES M, Curtis SL, Angeles G, Mullen S, et al
    Evaluating the impact of social support services on tuberculosis treatment default in Ukraine.
    PLoS One. 2018;13:e0199513.
    PubMed     Abstract available


  676. KO Y, Lee HY, Park YB, Hong SJ, et al
    Correlation of microbiological yield with radiographic activity on chest computed tomography in cases of suspected pulmonary tuberculosis.
    PLoS One. 2018;13:e0201748.
    PubMed     Abstract available


  677. NOGUEIRA BMF, Rolla VC, Akrami KM, Kiene SM, et al
    Correction: Factors associated with tuberculosis treatment delay in patients co-infected with HIV in a high prevalence area in Brazil.
    PLoS One. 2018;13:e0202292.
    PubMed     Abstract available


  678. MURADAS TC, Abbadi BL, Villela AD, Macchi FS, et al
    Pre-clinical evaluation of quinoxaline-derived chalcones in tuberculosis.
    PLoS One. 2018;13:e0202568.
    PubMed     Abstract available


  679. BISOGNIN F, Lombardi G, Lombardo D, Re MC, et al
    Improvement of Mycobacterium tuberculosis detection by Xpert MTB/RIF Ultra: A head-to-head comparison on Xpert-negative samples.
    PLoS One. 2018;13:e0201934.
    PubMed     Abstract available


  680. PEREA RAZO CA, Rodriguez Hernandez E, Ponce SIR, Milian Suazo F, et al
    Molecular epidemiology of cattle tuberculosis in Mexico through whole-genome sequencing and spoligotyping.
    PLoS One. 2018;13:e0201981.
    PubMed     Abstract available


  681. ANAND T, Kishore J, Isaakidis P, Gupte HA, et al
    Integrating screening for non-communicable diseases and their risk factors in routine tuberculosis care in Delhi, India: A mixed-methods study.
    PLoS One. 2018;13:e0202256.
    PubMed     Abstract available


  682. CHINGONZOH R, Manesen MR, Madlavu MJ, Sopiseka N, et al
    Risk factors for mortality among adults registered on the routine drug resistant tuberculosis reporting database in the Eastern Cape Province, South Africa, 2011 to 2013.
    PLoS One. 2018;13:e0202469.
    PubMed     Abstract available


  683. AVONG YK, Jatau B, Gurumnaan R, Danat N, et al
    Addressing the under-reporting of adverse drug reactions in public health programs controlling HIV/AIDS, Tuberculosis and Malaria: A prospective cohort study.
    PLoS One. 2018;13:e0200810.
    PubMed     Abstract available


  684. SHARROCK A, Ruthe A, Andrews ESV, Arcus VA, et al
    VapC proteins from Mycobacterium tuberculosis share ribonuclease sequence specificity but differ in regulation and toxicity.
    PLoS One. 2018;13:e0203412.
    PubMed     Abstract available


  685. HIZA H, Fenner L, Hella J, Kuchaka D, et al
    Boosting effect of IL-7 in interferon gamma release assays to diagnose Mycobacterium tuberculosis infection.
    PLoS One. 2018;13:e0202525.
    PubMed     Abstract available


  686. SANTOS AP, Correa RDS, Ribeiro-Alves M, Soares da Silva ACO, et al
    Application of Venn's diagram in the diagnosis of pleural tuberculosis using IFN-gamma, IP-10 and adenosine deaminase.
    PLoS One. 2018;13:e0202481.
    PubMed     Abstract available


  687. KAWATSU L, Uchimura K, Ohkado A
    A situational analysis of latent tuberculosis infection among incarcerated population in Japan.
    PLoS One. 2018;13:e0203815.
    PubMed     Abstract available


  688. CHANG CH, Hu CC, Chang Y, Hsieh PH, et al
    Two-stage revision arthroplasty for Mycobacterium Tuberculosis periprosthetic joint infection: An outcome analysis.
    PLoS One. 2018;13:e0203585.
    PubMed     Abstract available


  689. ALIYU G, El-Kamary SS, Abimiku A, Blattner W, et al
    Demography and the dual epidemics of tuberculosis and HIV: Analysis of cross-sectional data from Sub-Saharan Africa.
    PLoS One. 2018;13:e0191387.
    PubMed     Abstract available


  690. JORSTAD MD, Amus J, Marijani M, Sviland L, et al
    Diagnostic delay in extrapulmonary tuberculosis and impact on patient morbidity: A study from Zanzibar.
    PLoS One. 2018;13:e0203593.
    PubMed     Abstract available


  691. TEMESSZENTANDRASI-AMBRUS C, Toth S, Verma R, Banhegyi P, et al
    Characterization of new, efficient Mycobacterium tuberculosis topoisomerase-I inhibitors and their interaction with human ABC multidrug transporters.
    PLoS One. 2018;13:e0202749.
    PubMed     Abstract available


  692. GUEDES L, Jaeger LH, Liryo A, Rodrigues-Carvalho C, et al
    Tuberculosis in post-contact Native Americans of Brazil: Paleopathological and paleogenetic evidence from the Tenetehara-Guajajara.
    PLoS One. 2018;13:e0202394.
    PubMed     Abstract available


  693. MOHR E, Snyman L, Mbakaz Z, Caldwell J, et al
    "Life continues": Patient, health care and community care workers perspectives on self-administered treatment for rifampicin-resistant tuberculosis in Khayelitsha, South Africa.
    PLoS One. 2018;13:e0203888.
    PubMed     Abstract available


  694. TOGUN TO, MacLean E, Kampmann B, Pai M, et al
    Biomarkers for diagnosis of childhood tuberculosis: A systematic review.
    PLoS One. 2018;13:e0204029.
    PubMed     Abstract available


  695. RAHMAN SMM, Maliha UT, Ahmed S, Kabir S, et al
    Evaluation of Xpert MTB/RIF assay for detection of Mycobacterium tuberculosis in stool samples of adults with pulmonary tuberculosis.
    PLoS One. 2018;13:e0203063.
    PubMed     Abstract available


  696. HUAMAN MA, Henson D, Rondan PL, Ticona E, et al
    Latent tuberculosis infection is associated with increased unstimulated levels of interferon-gamma in Lima, Peru.
    PLoS One. 2018;13:e0202191.
    PubMed     Abstract available


  697. BHAVANAM S, Rayat GR, Keelan M, Kunimoto D, et al
    Characterization of immune responses of human PBMCs infected with Mycobacterium tuberculosis H37Ra: Impact of donor declared BCG vaccination history on immune responses and M. tuberculosis growth.
    PLoS One. 2018;13:e0203822.
    PubMed     Abstract available


  698. MADEIRA DE OLIVEIRA S, Altmayer S, Zanon M, Alves Sidney-Filho L, et al
    Predictors of noncompliance to pulmonary tuberculosis treatment: An insight from South America.
    PLoS One. 2018;13:e0202593.
    PubMed     Abstract available



  699. Retraction: Survival Analysis of Adult Tuberculosis Disease.
    PLoS One. 2018;13:e0204676.
    PubMed    


  700. PARK Y, Kim SY, Kim JW, Park MS, et al
    Serial testing of healthcare workers for latent tuberculosis infection and long-term follow up for development of active tuberculosis.
    PLoS One. 2018;13:e0204035.
    PubMed     Abstract available


  701. YAHYAOUI AZAMI H, Ducrotoy MJ, Bouslikhane M, Hattendorf J, et al
    The prevalence of brucellosis and bovine tuberculosis in ruminants in Sidi Kacem Province, Morocco.
    PLoS One. 2018;13:e0203360.
    PubMed     Abstract available


  702. MEKONNEN A, Merker M, Collins JM, Addise D, et al
    Molecular epidemiology and drug resistance patterns of Mycobacterium tuberculosis complex isolates from university students and the local community in Eastern Ethiopia.
    PLoS One. 2018;13:e0198054.
    PubMed     Abstract available


  703. MONTGOMERY SA, Young EF, Durham PG, Zulauf KE, et al
    Efficacy of pyrazinoic acid dry powder aerosols in resolving necrotic and non-necrotic granulomas in a guinea pig model of tuberculosis.
    PLoS One. 2018;13:e0204495.
    PubMed     Abstract available


  704. BARON S, Peleg Y, Grunwald J, Morgenstern D, et al
    Expression of a recombinant, 4'-Phosphopantetheinylated, active M. tuberculosis fatty acid synthase I in E. coli.
    PLoS One. 2018;13:e0204457.
    PubMed     Abstract available


  705. AGGERBECK H, Ruhwald M, Hoff ST, Borregaard B, et al
    C-Tb skin test to diagnose Mycobacterium tuberculosis infection in children and HIV-infected adults: A phase 3 trial.
    PLoS One. 2018;13:e0204554.
    PubMed     Abstract available


  706. ARYA S, Kumar SK, Nath A, Kapoor P, et al
    Synergy between tuberculin skin test and proliferative T cell responses to PPD or cell-membrane antigens of Mycobacterium tuberculosis for detection of latent TB infection in a high disease-burden setting.
    PLoS One. 2018;13:e0204429.
    PubMed     Abstract available


  707. MADAN C, Chopra KK, Satyanarayana S, Surie D, et al
    Developing a model to predict unfavourable treatment outcomes in patients with tuberculosis and human immunodeficiency virus co-infection in Delhi, India.
    PLoS One. 2018;13:e0204982.
    PubMed     Abstract available


  708. KIMUDA SG, Biraro IA, Bagaya BS, Raynes JG, et al
    Characterising antibody avidity in individuals of varied Mycobacterium tuberculosis infection status using surface plasmon resonance.
    PLoS One. 2018;13:e0205102.
    PubMed     Abstract available


  709. COLLINS JM, Walker DI, Jones DP, Tukvadze N, et al
    High-resolution plasma metabolomics analysis to detect Mycobacterium tuberculosis-associated metabolites that distinguish active pulmonary tuberculosis in humans.
    PLoS One. 2018;13:e0205398.
    PubMed     Abstract available


  710. VAN DE BERG S, Jansen-Aaldring N, de Vries G, van den Hof S, et al
    Patient support for tuberculosis patients in low-incidence countries: A systematic review.
    PLoS One. 2018;13:e0205433.
    PubMed     Abstract available


  711. WU K, Koo J, Jiang X, Chen R, et al
    Correction: Improved Control of Tuberculosis and Activation of Macrophages in Mice Lacking Protein Kinase R.
    PLoS One. 2018;13:e0205424.
    PubMed     Abstract available


  712. VERDECCHIA M, Keus K, Blankley S, Vambe D, et al
    Model of care and risk factors for poor outcomes in patients on multi-drug resistant tuberculosis treatment at two facilities in eSwatini (formerly Swaziland), 2011-2013.
    PLoS One. 2018;13:e0205601.
    PubMed     Abstract available


  713. BONNETT SA, Dennison D, Files M, Bajpai A, et al
    A class of hydrazones are active against non-replicating Mycobacterium tuberculosis.
    PLoS One. 2018;13:e0198059.
    PubMed     Abstract available


  714. KIELMANN K, Vidal N, Riekstina V, Krutikov M, et al
    "Treatment is of primary importance, and social assistance is secondary": A qualitative study on the organisation of tuberculosis (TB) care and patients' experience of starting and staying on TB treatment in Riga, Latvia.
    PLoS One. 2018;13:e0203937.
    PubMed     Abstract available


  715. ROBA AA, Dasa TT, Weldegebreal F, Asfaw A, et al
    Tuberculosis patients are physically challenged and socially isolated: A mixed methods case-control study of Health Related Quality of Life in Eastern Ethiopia.
    PLoS One. 2018;13:e0204697.
    PubMed     Abstract available


  716. MULUYE AB, Kebamo S, Teklie T, Alemkere G, et al
    Poor treatment outcomes and its determinants among tuberculosis patients in selected health facilities in East Wollega, Western Ethiopia.
    PLoS One. 2018;13:e0206227.
    PubMed     Abstract available


  717. OHARA Y, Ozeki Y, Tateishi Y, Mashima T, et al
    Significance of a histone-like protein with its native structure for the diagnosis of asymptomatic tuberculosis.
    PLoS One. 2018;13:e0204160.
    PubMed     Abstract available


  718. FARR K, Ravindran R, Strnad L, Chang E, et al
    Diagnostic performance of blood inflammatory markers for tuberculosis screening in people living with HIV.
    PLoS One. 2018;13:e0206119.
    PubMed     Abstract available


  719. LA DISTIA NORA R, Sitompul R, Bakker M, Versnel MA, et al
    Type 1 interferon-inducible gene expression in QuantiFERON Gold TB-positive uveitis: A tool to stratify a high versus low risk of active tuberculosis?
    PLoS One. 2018;13:e0206073.
    PubMed     Abstract available


  720. LEE MC, Chiang CY, Lee CH, Ho CM, et al
    Metformin use is associated with a low risk of tuberculosis among newly diagnosed diabetes mellitus patients with normal renal function: A nationwide cohort study with validated diagnostic criteria.
    PLoS One. 2018;13:e0205807.
    PubMed     Abstract available


  721. EJETA E, Beyene G, Balay G, Bonsa Z, et al
    Factors associated with unsuccessful treatment outcome in tuberculosis patients among refugees and their surrounding communities in Gambella Regional State, Ethiopia.
    PLoS One. 2018;13:e0205468.
    PubMed     Abstract available


  722. ZHAO X, Yuan Y, Lin Y, Zhang T, et al
    Vitamin D status of tuberculosis patients with diabetes mellitus in different economic areas and associated factors in China.
    PLoS One. 2018;13:e0206372.
    PubMed     Abstract available


  723. PEDERSEN MK, Andersen AB, Folkvardsen DB, Rasmussen EM, et al
    Set-up and validation of mycobacterial interspersed repetitive unit-variable number of tandem repeat (MIRU-VNTR) analysis of Mycobacterium tuberculosis using BioNumerics software.
    PLoS One. 2018;13:e0205336.
    PubMed     Abstract available


  724. HUDDART S, Bossuroy T, Pons V, Baral S, et al
    Knowledge about tuberculosis and infection prevention behavior: A nine city longitudinal study from India.
    PLoS One. 2018;13:e0206245.
    PubMed     Abstract available


  725. ACUNA-VILLAORDUNA C, Schmidt-Castellani LG, Marques-Rodrigues P, White LF, et al
    Cough-aerosol cultures of Mycobacterium tuberculosis in the prediction of outcomes after exposure. A household contact study in Brazil.
    PLoS One. 2018;13:e0206384.
    PubMed     Abstract available


  726. SAGILI KD, Muniyandi M, Nilgiriwala KS, Shringarpure KS, et al
    Cost-effectiveness of GeneXpert and LED-FM for diagnosis of pulmonary tuberculosis: A systematic review.
    PLoS One. 2018;13:e0205233.
    PubMed     Abstract available


  727. CARTER SP, Robertson A, Palphramand KL, Chambers MA, et al
    Bait uptake by wild badgers and its implications for oral vaccination against tuberculosis.
    PLoS One. 2018;13:e0206136.
    PubMed     Abstract available


  728. LI T, Du X, Shewade HD, Soe KT, et al
    What happens to migrant tuberculosis patients who are transferred out using a web-based system in China?
    PLoS One. 2018;13:e0206580.
    PubMed     Abstract available



  729. Correction: Efficacy of pyrazinoic acid dry powder aerosols in resolving necrotic and non-necrotic granulomas in a guinea pig model of tuberculosis.
    PLoS One. 2018;13:e0207257.
    PubMed     Abstract available


  730. MUBIN N, Pahari S, Owais M, Zubair S, et al
    Mycobacterium tuberculosis host cell interaction: Role of latency associated protein Acr-1 in differential modulation of macrophages.
    PLoS One. 2018;13:e0206459.
    PubMed     Abstract available


  731. VAN DE WATER BJ, Silva SG, Prvu Bettger J, Humphreys J, et al
    Provision of guideline-based care for drug-resistant tuberculosis in South Africa: Level of concordance between prescribing practices and guidelines.
    PLoS One. 2018;13:e0203749.
    PubMed     Abstract available


  732. SCOLARICI M, Dekitani K, Chen L, Sokol-Anderson M, et al
    A scoring strategy for progression risk and rates of treatment completion in subjects with latent tuberculosis.
    PLoS One. 2018;13:e0207582.
    PubMed     Abstract available


  733. GRENZEL ML, Grande AJ, Paniago AMM, Pompilio MA, et al
    Tuberculosis among correctional facility workers: A systematic review and meta-analysis.
    PLoS One. 2018;13:e0207400.
    PubMed     Abstract available


  734. KATHAMUTHU GR, Moideen K, Banurekha VV, Nair D, et al
    Altered circulating levels of B cell growth factors and their modulation upon anti-tuberculosis treatment in pulmonary tuberculosis and tuberculous lymphadenitis.
    PLoS One. 2018;13:e0207404.
    PubMed     Abstract available


  735. WANGARI IM, Trauer J, Stone L
    Modelling heterogeneity in host susceptibility to tuberculosis and its effect on public health interventions.
    PLoS One. 2018;13:e0206603.
    PubMed     Abstract available


  736. BUI LV, Mor Z, Chemtob D, Ha ST, et al
    Use of Geographically Weighted Poisson Regression to examine the effect of distance on Tuberculosis incidence: A case study in Nam Dinh, Vietnam.
    PLoS One. 2018;13:e0207068.
    PubMed     Abstract available


  737. SARACENI V, Benzaken AS, Pereira GFM, Andrade KB, et al
    Tuberculosis burden on AIDS in Brazil: A study using linked databases.
    PLoS One. 2018;13:e0207859.
    PubMed     Abstract available


  738. SAUER CM, Sasson D, Paik KE, McCague N, et al
    Feature selection and prediction of treatment failure in tuberculosis.
    PLoS One. 2018;13:e0207491.
    PubMed     Abstract available



  739. Correction: Rv1460, a SufR homologue, is a repressor of the suf operon in Mycobacterium tuberculosis.
    PLoS One. 2018;13:e0208568.
    PubMed     Abstract available


  740. MBUTHIA GW, Olungah CO, Ondicho TG
    Health-seeking pathway and factors leading to delays in tuberculosis diagnosis in West Pokot County, Kenya: A grounded theory study.
    PLoS One. 2018;13:e0207995.
    PubMed     Abstract available


  741. HERMES R, Saragusty J, Moser I, Barth SA, et al
    Differential detection of tuberculous and non-tuberculous mycobacteria by qPCR in lavage fluids of tuberculosis-suspicious white rhinoceros.
    PLoS One. 2018;13:e0207365.
    PubMed     Abstract available


  742. LEE CU, Chong S, Choi HW, Choi JC, et al
    Quantitative image analysis using chest computed tomography in the evaluation of lymph node involvement in pulmonary sarcoidosis and tuberculosis.
    PLoS One. 2018;13:e0207959.
    PubMed     Abstract available


  743. ABRAHAM PR, Devalraju KP, Jha V, Valluri VL, et al
    PPE17 (Rv1168c) protein of Mycobacterium tuberculosis detects individuals with latent TB infection.
    PLoS One. 2018;13:e0207787.
    PubMed     Abstract available


  744. CLOETE R, Kapp E, Joubert J, Christoffels A, et al
    Molecular modelling and simulation studies of the Mycobacterium tuberculosis multidrug efflux pump protein Rv1258c.
    PLoS One. 2018;13:e0207605.
    PubMed     Abstract available


  745. GASHU Z, Jerene D, Datiko DG, Hiruy N, et al
    Seasonal patterns of tuberculosis case notification in the tropics of Africa: A six-year trend analysis in Ethiopia.
    PLoS One. 2018;13:e0207552.
    PubMed     Abstract available


  746. MICHELET L, de Cruz K, Karoui C, Tambosco J, et al
    Second line molecular diagnosis for bovine tuberculosis to improve diagnostic schemes.
    PLoS One. 2018;13:e0207614.
    PubMed     Abstract available


  747. MASIEWICZ P, Brzostek A, Wolanski M, Dziadek J, et al
    Correction: A Novel Role of the PrpR as a Transcription Factor Involved in the Regulation of Methylcitrate Pathway in Mycobacterium tuberculosis.
    PLoS One. 2018;13:e0208565.
    PubMed     Abstract available


  748. CORNEJO GARCIA JG, Alarcon Guizado VA, Mendoza Ticona A, Alarcon E, et al
    Treatment outcomes for isoniazid-monoresistant tuberculosis in Peru, 2012-2014.
    PLoS One. 2018;13:e0206658.
    PubMed     Abstract available


  749. DIARRA B, Kone M, Togo ACG, Sarro YDS, et al
    Mycobacterium africanum (Lineage 6) shows slower sputum smear conversion on tuberculosis treatment than Mycobacterium tuberculosis (Lineage 4) in Bamako, Mali.
    PLoS One. 2018;13:e0208603.
    PubMed     Abstract available



  750. Correction: Molecular modelling and simulation studies of the Mycobacterium tuberculosis multidrug efflux pump protein Rv1258c.
    PLoS One. 2018;13:e0209717.
    PubMed     Abstract available


  751. KIRIRABWA NS, Kimuli D, DeJene S, Nanziri C, et al
    Response to anti-tuberculosis treatment by people over age 60 in Kampala, Uganda.
    PLoS One. 2018;13:e0208390.
    PubMed     Abstract available


  752. VO LNQ, Vu TN, Nguyen HT, Truong TT, et al
    Optimizing community screening for tuberculosis: Spatial analysis of localized case finding from door-to-door screening for TB in an urban district of Ho Chi Minh City, Viet Nam.
    PLoS One. 2018;13:e0209290.
    PubMed     Abstract available


  753. READHEAD A, Chang AH, Ghosh JK, Sorvillo F, et al
    Challenges and solutions to estimating tuberculosis disease incidence by country of birth in Los Angeles County.
    PLoS One. 2018;13:e0209051.
    PubMed     Abstract available


  754. JHILMEET N, Lowe DM, Riou C, Scriba TJ, et al
    The effect of antiretroviral treatment on selected genes in whole blood from HIV-infected adults sensitised by Mycobacterium tuberculosis.
    PLoS One. 2018;13:e0209516.
    PubMed     Abstract available


  755. ENOS M, Sitienei J, Ong'ang'o J, Mungai B, et al
    Kenya tuberculosis prevalence survey 2016: Challenges and opportunities of ending TB in Kenya.
    PLoS One. 2018;13:e0209098.
    PubMed     Abstract available


  756. SLOGOTSKAYA L, Bogorodskaya E, Ivanova D, Sevostyanova T, et al
    Comparative sensitivity of the test with tuberculosis recombinant allergen, containing ESAT6-CFP10 protein, and Mantoux test with 2 TU PPD-L in newly diagnosed tuberculosis children and adolescents in Moscow.
    PLoS One. 2018;13:e0208705.
    PubMed     Abstract available


  757. MEKONEN A, Ayele Y, Berhan Y, Woldeyohannes D, et al
    Factors which contributed for low quality sputum smears for the detection of acid fast bacilli (AFB) at selected health centers in Ethiopia: A quality control perspective.
    PLoS One. 2018;13:e0198947.
    PubMed     Abstract available


  758. ZHOU M, Liu S, Li Q, Wang Q, et al
    Drug resistance characteristics of Mycobacterium tuberculosis isolates between 2014 and 2017 in Sichuan, China: A retrospective study.
    PLoS One. 2018;13:e0209902.
    PubMed     Abstract available


  759. HTUN YM, Khaing TMM, Aung NM, Yin Y, et al
    Delay in treatment initiation and treatment outcomes among adult patients with multidrug-resistant tuberculosis at Yangon Regional Tuberculosis Centre, Myanmar: A retrospective study.
    PLoS One. 2018;13:e0209932.
    PubMed     Abstract available


  760. METCALF T, Soria J, Montano SM, Ticona E, et al
    Evaluation of the GeneXpert MTB/RIF in patients with presumptive tuberculous meningitis.
    PLoS One. 2018;13:e0198695.
    PubMed     Abstract available


  761. THAKORE N, Norville R, Franke M, Calderon R, et al
    Automated TruTip nucleic acid extraction and purification from raw sputum.
    PLoS One. 2018;13:e0199869.
    PubMed     Abstract available


  762. THAKUR A, Andrea A, Mikkelsen H, Woodworth JS, et al
    Targeting the Mincle and TLR3 receptor using the dual agonist cationic adjuvant formulation 9 (CAF09) induces humoral and polyfunctional memory T cell responses in calves.
    PLoS One. 2018;13:e0201253.
    PubMed     Abstract available


  763. CHANDRASEKARAN P, Mave V, Thiruvengadam K, Gupte N, et al
    Tuberculin skin test and QuantiFERON-Gold In Tube assay for diagnosis of latent TB infection among household contacts of pulmonary TB patients in high TB burden setting.
    PLoS One. 2018;13:e0199360.
    PubMed     Abstract available


  764. RAIZADA N, Khaparde SD, Rao R, Kalra A, et al
    Upfront Xpert MTB/RIF testing on various specimen types for presumptive infant TB cases for early and appropriate treatment initiation.
    PLoS One. 2018;13:e0202085.
    PubMed     Abstract available


  765. FAN X, Li N, Wang X, Zhang J, et al
    Protective immune mechanisms of Yifei Tongluo, a Chinese herb formulation, in the treatment of mycobacterial infection.
    PLoS One. 2018;13:e0203678.
    PubMed     Abstract available


  766. MBOERA LEG, Rumisha SF, Lyimo EP, Chiduo MG, et al
    Cause-specific mortality patterns among hospital deaths in Tanzania, 2006-2015.
    PLoS One. 2018;13:e0205833.
    PubMed     Abstract available


  767. HIRASEN K, Berhanu R, Evans D, Rosen S, et al
    High rates of death and loss to follow-up by 12 months of rifampicin resistant TB treatment in South Africa.
    PLoS One. 2018;13:e0205463.
    PubMed     Abstract available


  768. PAVAN TAFFNER BM, Mattos FB, Cunha MCD, Saraiva FP, et al
    The use of optical coherence tomography for the detection of ocular toxicity by ethambutol.
    PLoS One. 2018;13:e0204655.
    PubMed     Abstract available


  769. MUKHTAR F, Butt ZA
    Risk of adverse treatment outcomes among new pulmonary TB patients co-infected with diabetes in Pakistan: A prospective cohort study.
    PLoS One. 2018;13:e0207148.
    PubMed     Abstract available


  770. TESFAYE B, Alebel A, Gebrie A, Zegeye A, et al
    The twin epidemics: Prevalence of TB/HIV co-infection and its associated factors in Ethiopia; A systematic review and meta-analysis.
    PLoS One. 2018;13:e0203986.
    PubMed     Abstract available


    January 2017
  771. TORNACK J, Reece ST, Bauer WM, Vogelzang A, et al
    Human and Mouse Hematopoietic Stem Cells Are a Depot for Dormant Mycobacterium tuberculosis.
    PLoS One. 2017;12:e0169119.
    PubMed     Abstract available


  772. LAI HH, Lai YJ, Yen YF
    Association of Body Mass Index with Timing of Death during Tuberculosis Treatment.
    PLoS One. 2017;12:e0170104.
    PubMed     Abstract available


  773. SARIKO M, Anderson C, Mujaga BS, Gratz J, et al
    Evaluation of the Antibody in Lymphocyte Supernatant Assay to Detect Active Tuberculosis.
    PLoS One. 2017;12:e0169118.
    PubMed     Abstract available


  774. PANDEY P, Pant ND, Rijal KR, Shrestha B, et al
    Diagnostic Accuracy of GeneXpert MTB/RIF Assay in Comparison to Conventional Drug Susceptibility Testing Method for the Diagnosis of Multidrug-Resistant Tuberculosis.
    PLoS One. 2017;12:e0169798.
    PubMed     Abstract available


  775. XIA H, Zheng Y, Zhao B, van den Hof S, et al
    Assessment of a 96-Well Plate Assay of Quantitative Drug Susceptibility Testing for Mycobacterium Tuberculosis Complex in China.
    PLoS One. 2017;12:e0169413.
    PubMed     Abstract available


  776. SERRANO M, Elguezabal N, Sevilla IA, Geijo MV, et al
    Tuberculosis Detection in Paratuberculosis Vaccinated Calves: New Alternatives against Interference.
    PLoS One. 2017;12:e0169735.
    PubMed     Abstract available


  777. MWANSA-KAMBAFWILE J, Maitshotlo B, Black A
    Microbiologically Confirmed Tuberculosis: Factors Associated with Pre-Treatment Loss to Follow-Up, and Time to Treatment Initiation.
    PLoS One. 2017;12:e0168659.
    PubMed     Abstract available


  778. SHARMA SK, Vashishtha R, Chauhan LS, Sreenivas V, et al
    Comparison of TST and IGRA in Diagnosis of Latent Tuberculosis Infection in a High TB-Burden Setting.
    PLoS One. 2017;12:e0169539.
    PubMed     Abstract available


  779. KHARE G, Nangpal P, Tyagi AK
    Differential Roles of Iron Storage Proteins in Maintaining the Iron Homeostasis in Mycobacterium tuberculosis.
    PLoS One. 2017;12:e0169545.
    PubMed     Abstract available


  780. ANDRE E, Lufungulo Bahati Y, Mulume Musafiri E, Bahati Rusumba O, et al
    Prediction of Under-Detection of Paediatric Tuberculosis in the Democratic Republic of Congo: Experience of Six Years in the South-Kivu Province.
    PLoS One. 2017;12:e0169014.
    PubMed     Abstract available


  781. KHANAL S, Elsey H, King R, Baral SC, et al
    Development of a Patient-Centred, Psychosocial Support Intervention for Multi-Drug-Resistant Tuberculosis (MDR-TB) Care in Nepal.
    PLoS One. 2017;12:e0167559.
    PubMed     Abstract available


  782. LOPEZ-VARELA E, L Garcia-Basteiro A, Augusto OJ, Fraile O, et al
    High Rates of Non-Tuberculous Mycobacteria Isolation in Mozambican Children with Presumptive Tuberculosis.
    PLoS One. 2017;12:e0169757.
    PubMed     Abstract available


  783. CHEN MY, Lo YC, Chen WC, Wang KF, et al
    Recurrence after Successful Treatment of Multidrug-Resistant Tuberculosis in Taiwan.
    PLoS One. 2017;12:e0170980.
    PubMed     Abstract available


  784. FU Y, Xu X, Xue J, Duan W, et al
    Deregulated lncRNAs in B Cells from Patients with Active Tuberculosis.
    PLoS One. 2017;12:e0170712.
    PubMed     Abstract available


  785. GORMLEY E, Ni Bhuachalla D, O'Keeffe J, Murphy D, et al
    Oral Vaccination of Free-Living Badgers (Meles meles) with Bacille Calmette Guerin (BCG) Vaccine Confers Protection against Tuberculosis.
    PLoS One. 2017;12:e0168851.
    PubMed     Abstract available


  786. SUN Y, Harley D, Vally H, Sleigh A, et al
    Impact of Multidrug Resistance on Tuberculosis Recurrence and Long-Term Outcome in China.
    PLoS One. 2017;12:e0168865.
    PubMed     Abstract available


  787. HUHNS M, Erbersdobler A, Obliers A, Ropenack P, et al
    Identification of HPV Types and Mycobacterium Tuberculosis Complex in Historical Long-Term Preserved Formalin Fixed Tissues in Different Human Organs.
    PLoS One. 2017;12:e0170353.
    PubMed     Abstract available


  788. XU Z, Xiao T, Li Y, Yang K, et al
    Reasons for Non-Enrollment in Treatment among Multi-Drug Resistant Tuberculosis Patients in Hunan Province, China.
    PLoS One. 2017;12:e0170718.
    PubMed     Abstract available


  789. MORISHITA F, Garfin AM, Lew W, Oh KH, et al
    Bringing state-of-the-art diagnostics to vulnerable populations: The use of a mobile screening unit in active case finding for tuberculosis in Palawan, the Philippines.
    PLoS One. 2017;12:e0171310.
    PubMed     Abstract available


  790. ZHANG Z, Ordonez AA, Smith-Jones P, Wang H, et al
    The biodistribution of 5-[18F]fluoropyrazinamide in Mycobacterium tuberculosis-infected mice determined by positron emission tomography.
    PLoS One. 2017;12:e0170871.
    PubMed     Abstract available


  791. EBERS A, Stroup S, Mpagama S, Kisonga R, et al
    Determination of plasma concentrations of levofloxacin by high performance liquid chromatography for use at a multidrug-resistant tuberculosis hospital in Tanzania.
    PLoS One. 2017;12:e0170663.
    PubMed     Abstract available


  792. MACHOVA I, Hubalek M, Lepsik M, Bednarova L, et al
    The Role of Cysteine Residues in Catalysis of Phosphoenolpyruvate Carboxykinase from Mycobacterium tuberculosis.
    PLoS One. 2017;12:e0170373.
    PubMed     Abstract available


  793. ALENE KA, Viney K, McBryde ES, Clements AC, et al
    Spatial patterns of multidrug resistant tuberculosis and relationships to socio-economic, demographic and household factors in northwest Ethiopia.
    PLoS One. 2017;12:e0171800.
    PubMed     Abstract available


  794. REYNAUD Y, Zheng C, Wu G, Sun Q, et al
    Bayesian population structure analysis reveals presence of phylogeographically specific sublineages within previously ill-defined T group of Mycobacterium tuberculosis.
    PLoS One. 2017;12:e0171584.
    PubMed     Abstract available


  795. HUNDIE GB, Woldemeskel D, Gessesse A
    Correction: Evaluation of Direct Colorimetric MTT Assay for Rapid Detection of Rifampicin and Isoniazid Resistance in Mycobacterium tuberculosis.
    PLoS One. 2017;12:e0171964.
    PubMed     Abstract available


  796. LA MANNA MP, Orlando V, Dieli F, Di Carlo P, et al
    Quantitative and qualitative profiles of circulating monocytes may help identifying tuberculosis infection and disease stages.
    PLoS One. 2017;12:e0171358.
    PubMed     Abstract available


  797. NAIDOO P, Dunbar R, Caldwell J, Lombard C, et al
    Has universal screening with Xpert(R) MTB/RIF increased the proportion of multidrug-resistant tuberculosis cases diagnosed in a routine operational setting?
    PLoS One. 2017;12:e0172143.
    PubMed     Abstract available


  798. VLUGGEN C, Soetaert K, Groenen G, Wanlin M, et al
    Molecular epidemiology of Mycobacterium tuberculosis complex in Brussels, 2010-2013.
    PLoS One. 2017;12:e0172554.
    PubMed     Abstract available


  799. GHIELMETTI G, Scherrer S, Friedel U, Frei D, et al
    Epidemiological tracing of bovine tuberculosis in Switzerland, multilocus variable number of tandem repeat analysis of Mycobacterium bovis and Mycobacterium caprae.
    PLoS One. 2017;12:e0172474.
    PubMed     Abstract available


  800. MARIN D, Marin N, Del Corral H, Lopez L, et al
    PPD-induced monocyte mitochondrial damage is associated with a protective effect to develop tuberculosis in BCG vaccinated individuals: A cohort study.
    PLoS One. 2017;12:e0171930.
    PubMed     Abstract available


  801. NABETA P, Havumaki J, Ha DT, Caceres T, et al
    Feasibility of the TBDx automated digital microscopy system for the diagnosis of pulmonary tuberculosis.
    PLoS One. 2017;12:e0173092.
    PubMed     Abstract available


  802. HERMOSILLA S, You P, Aifah A, Abildayev T, et al
    Identifying risk factors associated with smear positivity of pulmonary tuberculosis in Kazakhstan.
    PLoS One. 2017;12:e0172942.
    PubMed     Abstract available


  803. JIANG TT, Shi LY, Wei LL, Li X, et al
    Serum amyloid A, protein Z, and C4b-binding protein beta chain as new potential biomarkers for pulmonary tuberculosis.
    PLoS One. 2017;12:e0173304.
    PubMed     Abstract available


  804. LEE HJ, Lee DG, Choi SM, Park SH, et al
    The demanding attention of tuberculosis in allogeneic hematopoietic stem cell transplantation recipients: High incidence compared with general population.
    PLoS One. 2017;12:e0173250.
    PubMed     Abstract available


  805. KENDALL EA, Azman AS, Cobelens FG, Dowdy DW, et al
    MDR-TB treatment as prevention: The projected population-level impact of expanded treatment for multidrug-resistant tuberculosis.
    PLoS One. 2017;12:e0172748.
    PubMed     Abstract available


  806. SHARPE SA, White AD, Sibley L, Gleeson F, et al
    An aerosol challenge model of tuberculosis in Mauritian cynomolgus macaques.
    PLoS One. 2017;12:e0171906.
    PubMed     Abstract available


  807. OJO OB, Lougue S, Woldegerima WA
    Bayesian generalized linear mixed modeling of Tuberculosis using informative priors.
    PLoS One. 2017;12:e0172580.
    PubMed     Abstract available


  808. CLAASSENS MM, van Schalkwyk C, Floyd S, Ayles H, et al
    Symptom screening rules to identify active pulmonary tuberculosis: Findings from the Zambian South African Tuberculosis and HIV/AIDS Reduction (ZAMSTAR) trial prevalence surveys.
    PLoS One. 2017;12:e0172881.
    PubMed     Abstract available


  809. ALMEIDA FM, Ventura TL, Amaral EP, Ribeiro SC, et al
    Hypervirulent Mycobacterium tuberculosis strain triggers necrotic lung pathology associated with enhanced recruitment of neutrophils in resistant C57BL/6 mice.
    PLoS One. 2017;12:e0173715.
    PubMed     Abstract available


  810. SHARMA S, Ryndak MB, Aggarwal AN, Yadav R, et al
    Transcriptome analysis of mycobacteria in sputum samples of pulmonary tuberculosis patients.
    PLoS One. 2017;12:e0173508.
    PubMed     Abstract available


  811. PATHMANATHAN I, Dokubo EK, Shiraishi RW, Agolory SG, et al
    Incidence and predictors of tuberculosis among HIV-infected adults after initiation of antiretroviral therapy in Nigeria, 2004-2012.
    PLoS One. 2017;12:e0173309.
    PubMed     Abstract available


  812. DROZNIN M, Johnson A, Johnson AM
    Multidrug resistant tuberculosis in prisons located in former Soviet countries: A systematic review.
    PLoS One. 2017;12:e0174373.
    PubMed     Abstract available


  813. KARAT AS, Tlali M, Fielding KL, Charalambous S, et al
    Measuring mortality due to HIV-associated tuberculosis among adults in South Africa: Comparing verbal autopsy, minimally-invasive autopsy, and research data.
    PLoS One. 2017;12:e0174097.
    PubMed     Abstract available


  814. ZHOU Y, van den Hof S, Wang S, Pang Y, et al
    Association between genotype and drug resistance profiles of Mycobacterium tuberculosis strains circulating in China in a national drug resistance survey.
    PLoS One. 2017;12:e0174197.
    PubMed     Abstract available


  815. FAN L, Shen H, Huang H, Yang R, et al
    Impairment of Wnt/beta-catenin signaling in blood cells of patients with severe cavitary pulmonary tuberculosis.
    PLoS One. 2017;12:e0172549.
    PubMed     Abstract available


  816. MOORES A, Riesco AB, Schwenk S, Arnvig KB, et al
    Expression, maturation and turnover of DrrS, an unusually stable, DosR regulated small RNA in Mycobacterium tuberculosis.
    PLoS One. 2017;12:e0174079.
    PubMed     Abstract available


  817. VIDYARTHI A, Khan N, Agnihotri T, Siddiqui KF, et al
    Antibody response against PhoP efficiently discriminates among healthy individuals, tuberculosis patients and their contacts.
    PLoS One. 2017;12:e0173769.
    PubMed     Abstract available


  818. ADANE K, Spigt M, Johanna L, Noortje D, et al
    Tuberculosis knowledge, attitudes, and practices among northern Ethiopian prisoners: Implications for TB control efforts.
    PLoS One. 2017;12:e0174692.
    PubMed     Abstract available


  819. CUI Z, Lin M, Nie S, Lan R, et al
    Risk factors associated with Tuberculosis (TB) among people living with HIV/AIDS: A pair-matched case-control study in Guangxi, China.
    PLoS One. 2017;12:e0173976.
    PubMed     Abstract available


  820. HONG EP, Go MJ, Kim HL, Park JW, et al
    Risk prediction of pulmonary tuberculosis using genetic and conventional risk factors in adult Korean population.
    PLoS One. 2017;12:e0174642.
    PubMed     Abstract available


  821. KIM C, Park SH, Oh SY, Kim SS, et al
    Comparison of chest CT findings in nontuberculous mycobacterial diseases vs. Mycobacterium tuberculosis lung disease in HIV-negative patients with cavities.
    PLoS One. 2017;12:e0174240.
    PubMed     Abstract available


  822. HAVUMAKI J, Hillemann D, Ismail N, Omar SV, et al
    Comparative accuracy of the REBA MTB MDR and Hain MTBDRplus line probe assays for the detection of multidrug-resistant tuberculosis: A multicenter, non-inferiority study.
    PLoS One. 2017;12:e0173804.
    PubMed     Abstract available


  823. LOPEZ-VARELA E, Garcia-Basteiro AL, Augusto OJ, Fraile O, et al
    Correction: High Rates of Non-Tuberculous Mycobacteria Isolation in Mozambican Children with Presumptive Tuberculosis.
    PLoS One. 2017;12:e0175613.
    PubMed     Abstract available


  824. MIRANDA P, Gil-Santana L, Oliveira MG, Mesquita ED, et al
    Sustained elevated levels of C-reactive protein and ferritin in pulmonary tuberculosis patients remaining culture positive upon treatment initiation.
    PLoS One. 2017;12:e0175278.
    PubMed     Abstract available


  825. ZHANG H, Xin H, Li X, Li H, et al
    A dose-response relationship of smoking with tuberculosis infection: A cross-sectional study among 21008 rural residents in China.
    PLoS One. 2017;12:e0175183.
    PubMed     Abstract available


  826. ALMEIDA FM, Ventura TL, Amaral EP, Ribeiro SC, et al
    Correction: Hypervirulent Mycobacterium tuberculosis strain triggers necrotic lung pathology associated with enhanced recruitment of neutrophils in resistant C57BL/6 mice.
    PLoS One. 2017;12:e0175652.
    PubMed     Abstract available


  827. KE CC, Lin CS, Yeh CC, Chung CL, et al
    Correction: Adverse Outcomes after Non-Chest Surgeries in Patients with Pulmonary Tuberculosis: A Nationwide Study.
    PLoS One. 2017;12:e0175603.
    PubMed     Abstract available


  828. UREN C, Henn BM, Franke A, Wittig M, et al
    A post-GWAS analysis of predicted regulatory variants and tuberculosis susceptibility.
    PLoS One. 2017;12:e0174738.
    PubMed     Abstract available


  829. KHALIQ A, Ravindran R, Hussainy SF, Krishnan VV, et al
    Field evaluation of a blood based test for active tuberculosis in endemic settings.
    PLoS One. 2017;12:e0173359.
    PubMed     Abstract available


  830. GAO Y, Ou Y, Deng Q, He B, et al
    Comparison between titanium mesh and autogenous iliac bone graft to restore vertebral height through posterior approach for the treatment of thoracic and lumbar spinal tuberculosis.
    PLoS One. 2017;12:e0175567.
    PubMed     Abstract available


  831. BALCELLS ME, Garcia P, Tiznado C, Villarroel L, et al
    Association of vitamin D deficiency, season of the year, and latent tuberculosis infection among household contacts.
    PLoS One. 2017;12:e0175400.
    PubMed     Abstract available


  832. PARDESHI P, Rao KK, Balaji PV
    Rv3634c from Mycobacterium tuberculosis H37Rv encodes an enzyme with UDP-Gal/Glc and UDP-GalNAc 4-epimerase activities.
    PLoS One. 2017;12:e0175193.
    PubMed     Abstract available


  833. SHAH J, Weltman H, Narciso P, Murphy C, et al
    Dual color fluorescence in situ hybridization (FISH) assays for detecting Mycobacterium tuberculosis and Mycobacterium avium complexes and related pathogens in cultures.
    PLoS One. 2017;12:e0174989.
    PubMed     Abstract available


  834. WAN X, Koster K, Qian L, Desmond E, et al
    Genomic analyses of the ancestral Manila family of Mycobacterium tuberculosis.
    PLoS One. 2017;12:e0175330.
    PubMed     Abstract available


  835. LEE SW, Liu CW, Hu JY, Chiang LM, et al
    Suppressors of cytokine signaling in tuberculosis.
    PLoS One. 2017;12:e0176377.
    PubMed     Abstract available


  836. LOMBARDI G, Di Gregori V, Girometti N, Tadolini M, et al
    Diagnosis of smear-negative tuberculosis is greatly improved by Xpert MTB/RIF.
    PLoS One. 2017;12:e0176186.
    PubMed     Abstract available


  837. WORKNEH MH, Bjune GA, Yimer SA
    Prevalence and associated factors of tuberculosis and diabetes mellitus comorbidity: A systematic review.
    PLoS One. 2017;12:e0175925.
    PubMed     Abstract available


  838. DEJENE SW, Heitkonig IMA, Prins HHT, Lemma FA, et al
    Correction: Risk Factors for Bovine Tuberculosis (bTB) in Cattle in Ethiopia.
    PLoS One. 2017;12:e0176654.
    PubMed     Abstract available


  839. KASTIEN-HILKA T, Rosenkranz B, Sinanovic E, Bennett B, et al
    Health-related quality of life in South African patients with pulmonary tuberculosis.
    PLoS One. 2017;12:e0174605.
    PubMed     Abstract available


  840. NHAVOTO JA, Gronlund A, Klein GO
    Mobile health treatment support intervention for HIV and tuberculosis in Mozambique: Perspectives of patients and healthcare workers.
    PLoS One. 2017;12:e0176051.
    PubMed     Abstract available


  841. PELISSARI DM, Diaz-Quijano FA
    Household crowding as a potential mediator of socioeconomic determinants of tuberculosis incidence in Brazil.
    PLoS One. 2017;12:e0176116.
    PubMed     Abstract available


  842. SESHADRI C, Sedaghat N, Campo M, Peterson G, et al
    Transcriptional networks are associated with resistance to Mycobacterium tuberculosis infection.
    PLoS One. 2017;12:e0175844.
    PubMed     Abstract available


  843. KUMAR NP, Banurekha VV, Nair D, Babu S, et al
    Diminished plasma levels of common gamma-chain cytokines in pulmonary tuberculosis and reversal following treatment.
    PLoS One. 2017;12:e0176495.
    PubMed     Abstract available


  844. JEONG H, Baek SY, Kim SW, Eun YH, et al
    Comorbidities of rheumatoid arthritis: Results from the Korean National Health and Nutrition Examination Survey.
    PLoS One. 2017;12:e0176260.
    PubMed     Abstract available


  845. PANZER S, Wittig H, Zesch S, Rosendahl W, et al
    Evidence of neurofibromatosis type 1 in a multi-morbid Inca child mummy: A paleoradiological investigation using computed tomography.
    PLoS One. 2017;12:e0175000.
    PubMed     Abstract available


  846. GADOEV J, Asadov D, Harries AD, Parpieva N, et al
    Recurrent tuberculosis and associated factors: A five - year countrywide study in Uzbekistan.
    PLoS One. 2017;12:e0176473.
    PubMed     Abstract available


  847. FERRIAN S, Manca C, Lubbe S, Conradie F, et al
    A combination of baseline plasma immune markers can predict therapeutic response in multidrug resistant tuberculosis.
    PLoS One. 2017;12:e0176660.
    PubMed     Abstract available


  848. VON REYN CF, Lahey T, Arbeit RD, Landry B, et al
    Safety and immunogenicity of an inactivated whole cell tuberculosis vaccine booster in adults primed with BCG: A randomized, controlled trial of DAR-901.
    PLoS One. 2017;12:e0175215.
    PubMed     Abstract available


  849. LEMPP JM, Zajdowicz MJ, Hankinson AL, Toney SR, et al
    Assessment of the QuantiFERON-TB Gold In-Tube test for the detection of Mycobacterium tuberculosis infection in United States Navy recruits.
    PLoS One. 2017;12:e0177752.
    PubMed     Abstract available


  850. OPERARIO DJ, Koeppel AF, Turner SD, Bao Y, et al
    Prevalence and extent of heteroresistance by next generation sequencing of multidrug-resistant tuberculosis.
    PLoS One. 2017;12:e0176522.
    PubMed     Abstract available


  851. CHOI SR, Britigan BE, Moran DM, Narayanasamy P, et al
    Gallium nanoparticles facilitate phagosome maturation and inhibit growth of virulent Mycobacterium tuberculosis in macrophages.
    PLoS One. 2017;12:e0177987.
    PubMed     Abstract available


  852. MOHR E, Daniels J, Beko B, Isaakidis P, et al
    DOT or SAT for Rifampicin-resistant tuberculosis? A non-randomized comparison in a high HIV-prevalence setting.
    PLoS One. 2017;12:e0178054.
    PubMed     Abstract available


  853. ABAYE GE, Abebe T, Worku A, Tolessa D, et al
    Detection of Mycobacterium tuberculosis from the stool of HIV sero-positive individuals suspected of pulmonary tuberculosis.
    PLoS One. 2017;12:e0177529.
    PubMed     Abstract available


  854. ZHANG L, Cheng X, Bian S, Song Y, et al
    Utility of Th1-cell immune responses for distinguishing active tuberculosis from non-active tuberculosis: A case-control study.
    PLoS One. 2017;12:e0177850.
    PubMed     Abstract available


  855. XIAO Y, Yu S, Xue Q, Lang S, et al
    A scoring system to effectively evaluate central nervous system tuberculosis in patients with military tuberculosis.
    PLoS One. 2017;12:e0176651.
    PubMed     Abstract available


  856. MICHELSEN SW, Soborg B, Diaz LJ, Hoff ST, et al
    The dynamics of immune responses to Mycobacterium tuberculosis during different stages of natural infection: A longitudinal study among Greenlanders.
    PLoS One. 2017;12:e0177906.
    PubMed     Abstract available


  857. LIM CH, Chen HH, Chen YH, Chen DY, et al
    The risk of tuberculosis disease in rheumatoid arthritis patients on biologics and targeted therapy: A 15-year real world experience in Taiwan.
    PLoS One. 2017;12:e0178035.
    PubMed     Abstract available


  858. QADER G, Hamim A, Sayedi M, Rashidi M, et al
    Addressing tuberculosis control in fragile states: Urban DOTS experience in Kabul, Afghanistan, 2009-2015.
    PLoS One. 2017;12:e0178053.
    PubMed     Abstract available


  859. KUMAR NP, Moideen K, Dolla C, Kumaran P, et al
    Prediabetes is associated with the modulation of antigen-specific Th1/Tc1 and Th17/Tc17 responses in latent Mycobacterium tuberculosis infection.
    PLoS One. 2017;12:e0178000.
    PubMed     Abstract available


  860. NENASHEVA T, Nikolaev A, Diykanov D, Sukhanova A, et al
    The introduction of mesenchymal stromal cells induces different immunological responses in the lungs of healthy and M. tuberculosis infected mice.
    PLoS One. 2017;12:e0178983.
    PubMed     Abstract available


  861. LI D, He W, Chen B, Lv P, et al
    Primary multidrug-resistant tuberculosis versus drug-sensitive tuberculosis in non-HIV-infected patients: Comparisons of CT findings.
    PLoS One. 2017;12:e0176354.
    PubMed     Abstract available


  862. USTERO PA, Kay AW, Ngo K, Golin R, et al
    School and household tuberculosis contact investigations in Swaziland: Active TB case finding in a high HIV/TB burden setting.
    PLoS One. 2017;12:e0178873.
    PubMed     Abstract available


  863. KHAN MS, Hutchison C, Coker RJ
    Risk factors that may be driving the emergence of drug resistance in tuberculosis patients treated in Yangon, Myanmar.
    PLoS One. 2017;12:e0177999.
    PubMed     Abstract available


  864. PUCKEN VB, Knubben-Schweizer G, Dopfer D, Groll A, et al
    Evaluating diagnostic tests for bovine tuberculosis in the southern part of Germany: A latent class analysis.
    PLoS One. 2017;12:e0179847.
    PubMed     Abstract available


  865. WANG L, Li R, Xu C, Zhang H, et al
    The Global Fund in China: Multidrug-resistant tuberculosis nationwide programmatic scale-up and challenges to transition to full country ownership.
    PLoS One. 2017;12:e0177536.
    PubMed     Abstract available


  866. HUANG LK, Wang HH, Lai YC, Chang SC, et al
    The impact of glycemic status on radiological manifestations of pulmonary tuberculosis in diabetic patients.
    PLoS One. 2017;12:e0179750.
    PubMed     Abstract available


  867. JIAO W, Blackmore NJ, Nazmi AR, Parker EJ, et al
    Quaternary structure is an essential component that contributes to the sophisticated allosteric regulation mechanism in a key enzyme from Mycobacterium tuberculosis.
    PLoS One. 2017;12:e0180052.
    PubMed     Abstract available


  868. KAR R, Nangpal P, Mathur S, Singh S, et al
    bioA mutant of Mycobacterium tuberculosis shows severe growth defect and imparts protection against tuberculosis in guinea pigs.
    PLoS One. 2017;12:e0179513.
    PubMed     Abstract available


  869. ABRAHAM PR, Pathak N, Pradhan G, Sumanlatha G, et al
    The N-terminal domain of Mycobacterium tuberculosis PPE17 (Rv1168c) protein plays a dominant role in inducing antibody responses in active TB patients.
    PLoS One. 2017;12:e0179965.
    PubMed     Abstract available


  870. DUNCAN C, Jamieson FB, Troudt J, Izzo L, et al
    Whole transcriptomic and proteomic analyses of an isogenic M. tuberculosis clinical strain with a naturally occurring 15 Kb genomic deletion.
    PLoS One. 2017;12:e0179996.
    PubMed     Abstract available


  871. MEYER AJ, Atuheire C, Worodria W, Kizito S, et al
    Sputum quality and diagnostic performance of GeneXpert MTB/RIF among smear-negative adults with presumed tuberculosis in Uganda.
    PLoS One. 2017;12:e0180572.
    PubMed     Abstract available


  872. OPERARIO DJ, Koeppel AF, Turner SD, Bao Y, et al
    Correction: Prevalence and extent of heteroresistance by next generation sequencing of multidrug-resistant tuberculosis.
    PLoS One. 2017;12:e0181284.
    PubMed     Abstract available


  873. BALSEIRO A, Altuzarra R, Vidal E, Moll X, et al
    Assessment of BCG and inactivated Mycobacterium bovis vaccines in an experimental tuberculosis infection model in sheep.
    PLoS One. 2017;12:e0180546.
    PubMed     Abstract available


  874. WUBULI A, Li Y, Xue F, Yao X, et al
    Seasonality of active tuberculosis notification from 2005 to 2014 in Xinjiang, China.
    PLoS One. 2017;12:e0180226.
    PubMed     Abstract available


  875. LI S, Liu B, Peng M, Chen M, et al
    Diagnostic accuracy of Xpert MTB/RIF for tuberculosis detection in different regions with different endemic burden: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0180725.
    PubMed     Abstract available


  876. IDH J, Andersson B, Lerm M, Raffetseder J, et al
    Reduced susceptibility of clinical strains of Mycobacterium tuberculosis to reactive nitrogen species promotes survival in activated macrophages.
    PLoS One. 2017;12:e0181221.
    PubMed     Abstract available


  877. ONYEDUM CC, Alobu I, Ukwaja KN
    Prevalence of drug-resistant tuberculosis in Nigeria: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0180996.
    PubMed     Abstract available


  878. MAGEE MJ, Sun YV, Brust JCM, Shah NS, et al
    Polymorphisms in the vitamin D receptor gene are associated with reduced rate of sputum culture conversion in multidrug-resistant tuberculosis patients in South Africa.
    PLoS One. 2017;12:e0180916.
    PubMed     Abstract available


  879. SIMA BT, Belachew T, Abebe F
    Knowledge, attitude and perceived stigma towards tuberculosis among pastoralists; Do they differ from sedentary communities? A comparative cross-sectional study.
    PLoS One. 2017;12:e0181032.
    PubMed     Abstract available


  880. KO Y, Song J, Lee SY, Moon JW, et al
    Does repeated pleural culture increase the diagnostic yield of Mycobacterium tuberculosis from tuberculous pleural effusion in HIV-negative individuals?
    PLoS One. 2017;12:e0181798.
    PubMed     Abstract available


  881. JEON AB, Obregon-Henao A, Ackart DF, Podell BK, et al
    2-aminoimidazoles potentiate ss-lactam antimicrobial activity against Mycobacterium tuberculosis by reducing ss-lactamase secretion and increasing cell envelope permeability.
    PLoS One. 2017;12:e0180925.
    PubMed     Abstract available


  882. EVANS D, Schnippel K, Govathson C, Sineke T, et al
    Treatment initiation among persons diagnosed with drug resistant tuberculosis in Johannesburg, South Africa.
    PLoS One. 2017;12:e0181238.
    PubMed     Abstract available


  883. MYLLYMAKI H, Niskanen M, Oksanen KE, Sherwood E, et al
    Identification of novel antigen candidates for a tuberculosis vaccine in the adult zebrafish (Danio rerio).
    PLoS One. 2017;12:e0181942.
    PubMed     Abstract available


  884. HANIFA Y, Fielding KL, Chihota VN, Adonis L, et al
    A clinical scoring system to prioritise investigation for tuberculosis among adults attending HIV clinics in South Africa.
    PLoS One. 2017;12:e0181519.
    PubMed     Abstract available



  885. Correction: A scoring system to effectively evaluate central nervous system tuberculosis in patients with miliary tuberculosis.
    PLoS One. 2017;12:e0182713.
    PubMed     Abstract available


  886. SHETE PB, Ravindran R, Chang E, Worodria W, et al
    Evaluation of antibody responses to panels of M. tuberculosis antigens as a screening tool for active tuberculosis in Uganda.
    PLoS One. 2017;12:e0180122.
    PubMed     Abstract available


  887. SZKWARKO D, Hirsch-Moverman Y, Du Plessis L, Du Preez K, et al
    Child contact management in high tuberculosis burden countries: A mixed-methods systematic review.
    PLoS One. 2017;12:e0182185.
    PubMed     Abstract available


  888. GETAHUN B, Nkosi ZZ
    Is directly observed tuberculosis treatment strategy patient-centered? A mixed method study in Addis Ababa, Ethiopia.
    PLoS One. 2017;12:e0181205.
    PubMed     Abstract available


  889. SERI B, Koffi A, Danel C, Ouassa T, et al
    Prevalence of pulmonary tuberculosis among prison inmates: A cross-sectional survey at the Correctional and Detention Facility of Abidjan, Cote d'Ivoire.
    PLoS One. 2017;12:e0181995.
    PubMed     Abstract available


  890. RIVIERE J, Le Strat Y, Hendrikx P, Dufour B, et al
    Cost-effectiveness evaluation of bovine tuberculosis surveillance in wildlife in France (Sylvatub system) using scenario trees.
    PLoS One. 2017;12:e0183126.
    PubMed     Abstract available


  891. FONSECA BPFE, Silva MVPD, Araujo KM, Sampaio RB, et al
    Network analysis for science and technology management: Evidence from tuberculosis research in Fiocruz, Brazil.
    PLoS One. 2017;12:e0181870.
    PubMed     Abstract available


  892. MALEKINEJAD M, Parriott A, Viitanen AP, Horvath H, et al
    Yield of community-based tuberculosis targeted testing and treatment in foreign-born populations in the United States: A systematic review.
    PLoS One. 2017;12:e0180707.
    PubMed     Abstract available


  893. FARLEY JE, Ndjeka N, Kelly AM, Whitehouse E, et al
    Evaluation of a nurse practitioner-physician task-sharing model for multidrug-resistant tuberculosis in South Africa.
    PLoS One. 2017;12:e0182780.
    PubMed     Abstract available


  894. MANDALAKAS AM, Ngo K, Alonso Ustero P, Golin R, et al
    BUTIMBA: Intensifying the Hunt for Child TB in Swaziland through Household Contact Tracing.
    PLoS One. 2017;12:e0169769.
    PubMed     Abstract available


  895. LIU H, Zheng R, Wang P, Yang H, et al
    IL-37 Confers Protection against Mycobacterial Infection Involving Suppressing Inflammation and Modulating T Cell Activation.
    PLoS One. 2017;12:e0169922.
    PubMed     Abstract available


  896. HAMEED S, Moganeradj K, Mahmood N, McHugh TD, et al
    Sequence analysis of the rifampicin resistance determining region (RRDR) of rpoB gene in multidrug resistance confirmed and newly diagnosed tuberculosis patients of Punjab, Pakistan.
    PLoS One. 2017;12:e0183363.
    PubMed     Abstract available


  897. TRIPP L, Sawchuk LA
    Insights into secular trends of respiratory tuberculosis: The 20th century Maltese experience.
    PLoS One. 2017;12:e0183296.
    PubMed     Abstract available


  898. ADAMU AL, Aliyu MH, Galadanci NA, Musa BM, et al
    Deaths during tuberculosis treatment among paediatric patients in a large tertiary hospital in Nigeria.
    PLoS One. 2017;12:e0183270.
    PubMed     Abstract available


  899. SUBBARAMAN R, Thomas BE, Sellappan S, Suresh C, et al
    Tuberculosis patients in an Indian mega-city: Where do they live and where are they diagnosed?
    PLoS One. 2017;12:e0183240.
    PubMed     Abstract available


  900. CASTRO-GARZA J, Garcia-Jacobo P, Rivera-Morales LG, Quinn FD, et al
    Detection of anti-HspX antibodies and HspX protein in patient sera for the identification of recent latent infection by Mycobacterium tuberculosis.
    PLoS One. 2017;12:e0181714.
    PubMed     Abstract available


  901. JONES A, Pitts M, Al Dulayymi JR, Gibbons J, et al
    New synthetic lipid antigens for rapid serological diagnosis of tuberculosis.
    PLoS One. 2017;12:e0181414.
    PubMed     Abstract available


  902. REYES-ALDASORO CC
    The proportion of cancer-related entries in PubMed has increased considerably; is cancer truly "The Emperor of All Maladies"?
    PLoS One. 2017;12:e0173671.
    PubMed     Abstract available


  903. KIMARO GD, Mfinanga S, Simms V, Kivuyo S, et al
    The costs of providing antiretroviral therapy services to HIV-infected individuals presenting with advanced HIV disease at public health centres in Dar es Salaam, Tanzania: Findings from a randomised trial evaluating different health care strategies.
    PLoS One. 2017;12:e0171917.
    PubMed     Abstract available


  904. HUERGA H, Ferlazzo G, Bevilacqua P, Kirubi B, et al
    Incremental Yield of Including Determine-TB LAM Assay in Diagnostic Algorithms for Hospitalized and Ambulatory HIV-Positive Patients in Kenya.
    PLoS One. 2017;12:e0170976.
    PubMed     Abstract available


  905. CHIACCHIO T, Delogu G, Vanini V, Cuzzi G, et al
    Immune characterization of the HBHA-specific response in Mycobacterium tuberculosis-infected patients with or without HIV infection.
    PLoS One. 2017;12:e0183846.
    PubMed     Abstract available


  906. HOCHBERG NS, Sarkar S, Horsburgh CR Jr, Knudsen S, et al
    Comorbidities in pulmonary tuberculosis cases in Puducherry and Tamil Nadu, India: Opportunities for intervention.
    PLoS One. 2017;12:e0183195.
    PubMed     Abstract available


  907. SINGH BK, Sharma SK, Sharma R, Sreenivas V, et al
    Diagnostic utility of a line probe assay for multidrug resistant-TB in smear-negative pulmonary tuberculosis.
    PLoS One. 2017;12:e0182988.
    PubMed     Abstract available


  908. ESPINOSA-CUETO P, Magallanes-Puebla A, Castellanos C, Mancilla R, et al
    Dendritic cells that phagocytose apoptotic macrophages loaded with mycobacterial antigens activate CD8 T cells via cross-presentation.
    PLoS One. 2017;12:e0182126.
    PubMed     Abstract available


  909. HAIMOVICH JS, Venkatesh AK, Shojaee A, Coppi A, et al
    Discovery of temporal and disease association patterns in condition-specific hospital utilization rates.
    PLoS One. 2017;12:e0172049.
    PubMed     Abstract available


  910. HATTHAKAROON C, Pharkjaksu S, Chongtrakool P, Suwannakarn K, et al
    Molecular epidemiology of cryptococcal genotype VNIc/ST5 in Siriraj Hospital, Thailand.
    PLoS One. 2017;12:e0173744.
    PubMed     Abstract available


  911. BRUFFAERTS N, Vluggen C, Roupie V, Duytschaever L, et al
    Virulence and immunogenicity of genetically defined human and porcine isolates of M. avium subsp. hominissuis in an experimental mouse infection.
    PLoS One. 2017;12:e0171895.
    PubMed     Abstract available


  912. BAGUMA R, Penn-Nicholson A, Smit E, Erasmus M, et al
    Application of a whole blood mycobacterial growth inhibition assay to study immunity against Mycobacterium tuberculosis in a high tuberculosis burden population.
    PLoS One. 2017;12:e0184563.
    PubMed     Abstract available


  913. MARANGU D, Mwaniki H, Nduku S, Maleche-Obimbo E, et al
    Stakeholder perspectives for optimization of tuberculosis contact investigation in a high-burden setting.
    PLoS One. 2017;12:e0183749.
    PubMed     Abstract available


  914. PHILLIPS BL, Gautam US, Bucsan AN, Foreman TW, et al
    LAG-3 potentiates the survival of Mycobacterium tuberculosis in host phagocytes by modulating mitochondrial signaling in an in-vitro granuloma model.
    PLoS One. 2017;12:e0180413.
    PubMed     Abstract available


  915. KHAPARDE S, Raizada N, Nair SA, Denkinger C, et al
    Scaling-up the Xpert MTB/RIF assay for the detection of tuberculosis and rifampicin resistance in India: An economic analysis.
    PLoS One. 2017;12:e0184270.
    PubMed     Abstract available


  916. TKACHUK AP, Gushchin VA, Potapov VD, Demidenko AV, et al
    Multi-subunit BCG booster vaccine GamTBvac: Assessment of immunogenicity and protective efficacy in murine and guinea pig TB models.
    PLoS One. 2017;12:e0176784.
    PubMed     Abstract available


  917. GETAHUN B, Nkosi ZZ
    Satisfaction of patients with directly observed treatment strategy in Addis Ababa, Ethiopia: A mixed-methods study.
    PLoS One. 2017;12:e0171209.
    PubMed     Abstract available


  918. CLOUSE K, Blevins M, Lindegren ML, Yotebieng M, et al
    Low implementation of Xpert MTB/RIF among HIV/TB co-infected adults in the International epidemiologic Databases to Evaluate AIDS (IeDEA) program.
    PLoS One. 2017;12:e0171384.
    PubMed     Abstract available


  919. MONTANE E, Barriocanal AM, Arellano AL, Valderrama A, et al
    Pilot, double-blind, randomized, placebo-controlled clinical trial of the supplement food Nyaditum resae(R) in adults with or without latent TB infection: Safety and immunogenicity.
    PLoS One. 2017;12:e0171294.
    PubMed     Abstract available


  920. KUMAR NP, Moideen K, Viswanathan V, Sivakumar S, et al
    Heightened circulating levels of antimicrobial peptides in tuberculosis-Diabetes co-morbidity and reversal upon treatment.
    PLoS One. 2017;12:e0184753.
    PubMed     Abstract available


  921. CUI JY, Liang HW, Pan XL, Li D, et al
    Characterization of a novel panel of plasma microRNAs that discriminates between Mycobacterium tuberculosis infection and healthy individuals.
    PLoS One. 2017;12:e0184113.
    PubMed     Abstract available


  922. BLANCO-GUILLOT F, Delgado-Sanchez G, Mongua-Rodriguez N, Cruz-Hervert P, et al
    Molecular clustering of patients with diabetes and pulmonary tuberculosis: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0184675.
    PubMed     Abstract available


  923. BLOCH-INFANGER C, Battig V, Kremo J, Widmer AF, et al
    Increasing prevalence of infectious diseases in asylum seekers at a tertiary care hospital in Switzerland.
    PLoS One. 2017;12:e0179537.
    PubMed     Abstract available


  924. SALAME FM, Ferreira MD, Belo MT, Teixeira EG, et al
    Knowledge about tuberculosis transmission and prevention and perceptions of health service utilization among index cases and contacts in Brazil: Understanding losses in the latent tuberculosis cascade of care.
    PLoS One. 2017;12:e0184061.
    PubMed     Abstract available


  925. SENGHORE M, Otu J, Witney A, Gehre F, et al
    Whole-genome sequencing illuminates the evolution and spread of multidrug-resistant tuberculosis in Southwest Nigeria.
    PLoS One. 2017;12:e0184510.
    PubMed     Abstract available


  926. ZHANG C, Ruan Y, Cheng J, Zhao F, et al
    Comparing yield and relative costs of WHO TB screening algorithms in selected risk groups among people aged 65 years and over in China, 2013.
    PLoS One. 2017;12:e0176581.
    PubMed     Abstract available


  927. ABONGOMERA C, Ritmeijer K, Vogt F, Buyze J, et al
    Development and external validation of a clinical prognostic score for death in visceral leishmaniasis patients in a high HIV co-infection burden area in Ethiopia.
    PLoS One. 2017;12:e0178996.
    PubMed     Abstract available


  928. TAVARES AM, Fronteira I, Couto I, Machado D, et al
    HIV and tuberculosis co-infection among migrants in Europe: A systematic review on the prevalence, incidence and mortality.
    PLoS One. 2017;12:e0185526.
    PubMed     Abstract available


  929. LARSON EC, Novis CL, Martins LJ, Macedo AB, et al
    Mycobacterium tuberculosis reactivates latent HIV-1 in T cells in vitro.
    PLoS One. 2017;12:e0185162.
    PubMed     Abstract available


  930. BONADONNA LV, Saunders MJ, Zegarra R, Evans C, et al
    Why wait? The social determinants underlying tuberculosis diagnostic delay.
    PLoS One. 2017;12:e0185018.
    PubMed     Abstract available


  931. MUSA BM, Adamu AL, Galadanci NA, Zubayr B, et al
    Trends in prevalence of multi drug resistant tuberculosis in sub-Saharan Africa: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0185105.
    PubMed     Abstract available


  932. SHIM EJ, Lee KM, Kim EJ, Kim HG, et al
    CT pattern analysis of necrotizing and nonnecrotizing lymph nodes in Kikuchi disease.
    PLoS One. 2017;12:e0181169.
    PubMed     Abstract available


  933. SHIN HJ, Kim TO, Oh HJ, Park HY, et al
    Impact of diabetes mellitus on indeterminate results of the QuantiFERON TB Gold In-Tube test: A propensity score matching analysis.
    PLoS One. 2017;12:e0181887.
    PubMed     Abstract available


  934. LETH C, Varadharajan A, Mester P, Fischaleck M, et al
    Matrixlysis, an improved sample preparation method for recovery of Mycobacteria from animal tissue material.
    PLoS One. 2017;12:e0181157.
    PubMed     Abstract available


  935. EMUKULE GO, Spreeuwenberg P, Chaves SS, Mott JA, et al
    Estimating influenza and respiratory syncytial virus-associated mortality in Western Kenya using health and demographic surveillance system data, 2007-2013.
    PLoS One. 2017;12:e0180890.
    PubMed     Abstract available


  936. SHIN HJ, Franco LH, Nair VR, Collins AC, et al
    A baculovirus-conjugated mimotope vaccine targeting Mycobacterium tuberculosis lipoarabinomannan.
    PLoS One. 2017;12:e0185945.
    PubMed     Abstract available


  937. TYLER AD, Randell E, Baikie M, Antonation K, et al
    Application of whole genome sequence analysis to the study of Mycobacterium tuberculosis in Nunavut, Canada.
    PLoS One. 2017;12:e0185656.
    PubMed     Abstract available


  938. MEKONNEN E, Bekele E
    An ancestral human genetic variant linked to an ancient disease: A novel association of FMO2 polymorphisms with tuberculosis (TB) in Ethiopian populations provides new insight into the differential ethno-geographic distribution of FMO2*1.
    PLoS One. 2017;12:e0184931.
    PubMed     Abstract available


  939. YU EA, John SH, Tablante EC, King CA, et al
    Host transcriptional responses following ex vivo re-challenge with Mycobacterium tuberculosis vary with disease status.
    PLoS One. 2017;12:e0185640.
    PubMed     Abstract available


  940. BOIREAU C, Dufour B, Praud A
    The importance of communication in promoting voluntary participation in an experimental trial: A qualitative study based on the assessment of the gamma-interferon test for the diagnosis of bovine tuberculosis in France.
    PLoS One. 2017;12:e0185799.
    PubMed     Abstract available


  941. WANG X, Jiang H, Wang X, Liu H, et al
    ESMPE: A combined strategy for school tuberculosis prevention and control proposed by Dalian, China.
    PLoS One. 2017;12:e0185646.
    PubMed     Abstract available


  942. THERON A, Roth RL, Hoppe H, Parkinson C, et al
    Differential inhibition of adenylylated and deadenylylated forms of M. tuberculosis glutamine synthetase as a drug discovery platform.
    PLoS One. 2017;12:e0185068.
    PubMed     Abstract available


  943. MAILANKODY S, Dangeti GV, Soundravally R, Joseph NM, et al
    Cerebrospinal fluid matrix metalloproteinase 9 levels, blood-brain barrier permeability, and treatment outcome in tuberculous meningitis.
    PLoS One. 2017;12:e0181262.
    PubMed     Abstract available


  944. MICHEL AL, Lane EP, de Klerk-Lorist LM, Hofmeyr M, et al
    Experimental Mycobacterium bovis infection in three white rhinoceroses (Ceratotherium simum): Susceptibility, clinical and anatomical pathology.
    PLoS One. 2017;12:e0179943.
    PubMed     Abstract available


  945. ELLIS CK, Rice S, Maurer D, Stahl R, et al
    Use of fecal volatile organic compound analysis to discriminate between non-vaccinated and BCG-Vaccinated cattle prior to and after Mycobacterium bovis challenge.
    PLoS One. 2017;12:e0179914.
    PubMed     Abstract available


  946. RICE JP, Seifert M, Moser KS, Rodwell TC, et al
    Performance of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis and rifampin resistance in a low-incidence, high-resource setting.
    PLoS One. 2017;12:e0186139.
    PubMed     Abstract available


  947. RENIERS G, Blom S, Lieber J, Herbst AJ, et al
    Tuberculosis mortality and the male survival deficit in rural South Africa: An observational community cohort study.
    PLoS One. 2017;12:e0185692.
    PubMed     Abstract available


  948. PATI S, Swain S, Metsemakers J, Knottnerus JA, et al
    Pattern and severity of multimorbidity among patients attending primary care settings in Odisha, India.
    PLoS One. 2017;12:e0183966.
    PubMed     Abstract available


  949. MINDU C, Lopez-Varela E, Alonso-Menendez Y, Mausse Y, et al
    Caretakers' perspectives of paediatric TB and implications for care-seeking behaviours in Southern Mozambique.
    PLoS One. 2017;12:e0182213.
    PubMed     Abstract available


  950. SCHECHTER MC, Buac K, Adekambi T, Cagle S, et al
    Neutrophil extracellular trap (NET) levels in human plasma are associated with active TB.
    PLoS One. 2017;12:e0182587.
    PubMed     Abstract available


  951. RASOAHANITRALISOA R, Rakotosamimanana N, Stucki D, Sola C, et al
    Evaluation of spoligotyping, SNPs and customised MIRU-VNTR combination for genotyping Mycobacterium tuberculosis clinical isolates in Madagascar.
    PLoS One. 2017;12:e0186088.
    PubMed     Abstract available


  952. HIJIKATA M, Keicho N, Duc LV, Maeda S, et al
    Spoligotyping and whole-genome sequencing analysis of lineage 1 strains of Mycobacterium tuberculosis in Da Nang, Vietnam.
    PLoS One. 2017;12:e0186800.
    PubMed     Abstract available


  953. SCHNEEFELD M, Busche T, Geffers R, Kalinowski J, et al
    The transcriptional regulator LysG (Rv1985c) of Mycobacterium tuberculosis activates lysE (Rv1986) in a lysine-dependent manner.
    PLoS One. 2017;12:e0186505.
    PubMed     Abstract available


  954. CHAN SL, Chua APG, Aminkeng F, Chee CBE, et al
    Association and clinical utility of NAT2 in the prediction of isoniazid-induced liver injury in Singaporean patients.
    PLoS One. 2017;12:e0186200.
    PubMed     Abstract available


  955. KAPWATA T, Morris N, Campbell A, Mthiyane T, et al
    Spatial distribution of extensively drug-resistant tuberculosis (XDR TB) patients in KwaZulu-Natal, South Africa.
    PLoS One. 2017;12:e0181797.
    PubMed     Abstract available


  956. HSIAO CY, Chiu HY, Wang TS, Tsai TF, et al
    Serial QuantiFERON-TB Gold testing in patients with psoriasis treated with ustekinumab.
    PLoS One. 2017;12:e0184178.
    PubMed     Abstract available


  957. BELLO G, Faragher B, Sanudi L, Namakhoma I, et al
    The effect of engaging unpaid informal providers on case detection and treatment initiation rates for TB and HIV in rural Malawi (Triage Plus): A cluster randomised health system intervention trial.
    PLoS One. 2017;12:e0183312.
    PubMed     Abstract available


  958. MUNOZ L, Gonzalez L, Soldevila L, Dorca J, et al
    QuantiFERON(R)-TB Gold In-Tube for contact screening in BCG-vaccinated adults: A longitudinal cohort study.
    PLoS One. 2017;12:e0183258.
    PubMed     Abstract available


  959. HAVLICEK J, Rivera-Milla E, Slickers P, Andres S, et al
    An application of competitive reporter monitored amplification (CMA) for rapid detection of single nucleotide polymorphisms (SNPs).
    PLoS One. 2017;12:e0183561.
    PubMed     Abstract available


  960. ALTET N, Latorre I, Jimenez-Fuentes MA, Maldonado J, et al
    Assessment of the influence of direct tobacco smoke on infection and active TB management.
    PLoS One. 2017;12:e0182998.
    PubMed     Abstract available


  961. AGIZEW T, Boyd R, Ndwapi N, Auld A, et al
    Peripheral clinic versus centralized laboratory-based Xpert MTB/RIF performance: Experience gained from a pragmatic, stepped-wedge trial in Botswana.
    PLoS One. 2017;12:e0183237.
    PubMed     Abstract available


  962. CHENG AC, Yang KY, Chen NJ, Hsu TL, et al
    CLEC9A modulates macrophage-mediated neutrophil recruitment in response to heat-killed Mycobacterium tuberculosis H37Ra.
    PLoS One. 2017;12:e0186780.
    PubMed     Abstract available


  963. VINNARD C, Ravimohan S, Tamuhla N, Pasipanodya J, et al
    Pyrazinamide clearance is impaired among HIV/tuberculosis patients with high levels of systemic immune activation.
    PLoS One. 2017;12:e0187624.
    PubMed     Abstract available


  964. KAWATSU L, Uchimura K, Ohkado A
    Trend and treatment status of latent tuberculosis infection patients in Japan - Analysis of Japan TB Surveillance data.
    PLoS One. 2017;12:e0186588.
    PubMed     Abstract available


  965. CARCELEN M, Abascal E, Herranz M, Santanton S, et al
    Optimizing and accelerating the assignation of lineages in Mycobacterium tuberculosis using novel alternative single-tube assays.
    PLoS One. 2017;12:e0186956.
    PubMed     Abstract available


  966. NGABONZIZA JCS, Diallo AB, Tagliani E, Diarra B, et al
    Half of rifampicin-resistant Mycobacterium tuberculosis complex isolated from tuberculosis patients in Sub-Saharan Africa have concomitant resistance to pyrazinamide.
    PLoS One. 2017;12:e0187211.
    PubMed     Abstract available


  967. XU L, Chen J, Innes AL, Li L, et al
    Prescription practice of anti-tuberculosis drugs in Yunnan, China: A clinical audit.
    PLoS One. 2017;12:e0187076.
    PubMed     Abstract available


  968. CAMPBELL JR, Johnston JC, Sadatsafavi M, Cook VJ, et al
    Cost-effectiveness of post-landing latent tuberculosis infection control strategies in new migrants to Canada.
    PLoS One. 2017;12:e0186778.
    PubMed     Abstract available


  969. FELDACKER C, Pintye J, Jacob S, Chung MH, et al
    Continuing professional development for medical, nursing, and midwifery cadres in Malawi, Tanzania and South Africa: A qualitative evaluation.
    PLoS One. 2017;12:e0186074.
    PubMed     Abstract available


  970. DANYUTTAPOLCHAI J, Kittimunkong S, Nateniyom S, Painujit S, et al
    Implementing an isoniazid preventive therapy program for people living with HIV in Thailand.
    PLoS One. 2017;12:e0184986.
    PubMed     Abstract available


  971. HERZMANN C, Ernst M, Lange C, Stenger S, et al
    Pulmonary immune responses to Mycobacterium tuberculosis in exposed individuals.
    PLoS One. 2017;12:e0187882.
    PubMed     Abstract available


  972. HE X, Cao M, Mahapatra T, Du X, et al
    Burden of tuberculosis in Xinjiang between 2011 and 2015: A surveillance data-based study.
    PLoS One. 2017;12:e0187592.
    PubMed     Abstract available


  973. ARMSTRONG-HOUGH M, Turimumahoro P, Meyer AJ, Ochom E, et al
    Drop-out from the tuberculosis contact investigation cascade in a routine public health setting in urban Uganda: A prospective, multi-center study.
    PLoS One. 2017;12:e0187145.
    PubMed     Abstract available


  974. ONYANGO DO, Yuen CM, Cain KP, Ngari F, et al
    Reduction of HIV-associated excess mortality by antiretroviral treatment among tuberculosis patients in Kenya.
    PLoS One. 2017;12:e0188235.
    PubMed     Abstract available


  975. HEMINGWAY C, Berk M, Anderson ST, Wright VJ, et al
    Childhood tuberculosis is associated with decreased abundance of T cell gene transcripts and impaired T cell function.
    PLoS One. 2017;12:e0185973.
    PubMed     Abstract available


  976. PATEL S, Paulsen C, Heffernan C, Saunders D, et al
    Tuberculosis transmission in the Indigenous peoples of the Canadian prairies.
    PLoS One. 2017;12:e0188189.
    PubMed     Abstract available


  977. SHEWADE HD, Jeyashree K, Mahajan P, Shah AN, et al
    Effect of glycemic control and type of diabetes treatment on unsuccessful TB treatment outcomes among people with TB-Diabetes: A systematic review.
    PLoS One. 2017;12:e0186697.
    PubMed     Abstract available


  978. RANZANI OT, Rodrigues LC, Waldman EA, Carvalho CRR, et al
    Estimating the impact of tuberculosis anatomical classification on treatment outcomes: A patient and surveillance perspective analysis.
    PLoS One. 2017;12:e0187585.
    PubMed     Abstract available


  979. ANDRES M, Gohring-Zwacka E, Fiebig L, Priwitzer M, et al
    Integration of molecular typing results into tuberculosis surveillance in Germany-A pilot study.
    PLoS One. 2017;12:e0188356.
    PubMed     Abstract available


  980. AL-RIFAI RH, Pearson F, Critchley JA, Abu-Raddad LJ, et al
    Association between diabetes mellitus and active tuberculosis: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0187967.
    PubMed     Abstract available


  981. SOTGIU G, Falzon D, Hollo V, Kodmon C, et al
    Determinants of site of tuberculosis disease: An analysis of European surveillance data from 2003 to 2014.
    PLoS One. 2017;12:e0186499.
    PubMed     Abstract available


  982. SON HJ, Sung H, Park SY, Kim T, et al
    Diagnostic performance of the (1-3)-beta-D-glucan assay in patients with Pneumocystis jirovecii compared with those with candidiasis, aspergillosis, mucormycosis, and tuberculosis, and healthy volunteers.
    PLoS One. 2017;12:e0188860.
    PubMed     Abstract available


  983. DOAN TN, Eisen DP, Rose MT, Slack A, et al
    Interferon-gamma release assay for the diagnosis of latent tuberculosis infection: A latent-class analysis.
    PLoS One. 2017;12:e0188631.
    PubMed     Abstract available


  984. MCMURTREY C, Harriff MJ, Swarbrick GM, Duncan A, et al
    T cell recognition of Mycobacterium tuberculosis peptides presented by HLA-E derived from infected human cells.
    PLoS One. 2017;12:e0188288.
    PubMed     Abstract available


  985. SUN Y, Chen J, Li J, Xu Y, et al
    Novel approach based on one-tube nested PCR and a lateral flow strip for highly sensitive diagnosis of tuberculous meningitis.
    PLoS One. 2017;12:e0186985.
    PubMed     Abstract available


  986. LATORRE I, Minguez S, Carrascosa JM, Naves J, et al
    Immune-mediated inflammatory diseases differently affect IGRAs' accuracy for latent tuberculosis infection diagnosis in clinical practice.
    PLoS One. 2017;12:e0189202.
    PubMed     Abstract available


  987. MAVE V, Kinikar A, Kagal A, Nimkar S, et al
    Isoniazid concentrations in hair and plasma area-under-the-curve exposure among children with tuberculosis.
    PLoS One. 2017;12:e0189101.
    PubMed     Abstract available


  988. LAVANIA S, Anthwal D, Bhalla M, Singh N, et al
    Direct detection of Mycobacterium tuberculosis rifampin resistance in bio-safe stained sputum smears.
    PLoS One. 2017;12:e0189149.
    PubMed     Abstract available


  989. FLICK RJ, Munthali A, Simon K, Hosseinipour M, et al
    Assessing infection control practices to protect health care workers and patients in Malawi from nosocomial transmission of Mycobacterium tuberculosis.
    PLoS One. 2017;12:e0189140.
    PubMed     Abstract available


  990. KIMUDA SG, Andia-Biraro I, Egesa M, Bagaya BS, et al
    Use of QuantiFERON(R)-TB Gold in-tube culture supernatants for measurement of antibody responses.
    PLoS One. 2017;12:e0188396.
    PubMed     Abstract available


  991. JONSSON J, Westman A, Bruchfeld J, Sturegard E, et al
    A borderline range for Quantiferon Gold In-Tube results.
    PLoS One. 2017;12:e0187313.
    PubMed     Abstract available


  992. SINGH B, Saqib M, Gupta A, Kumar P, et al
    Autophagy induction by Mycobacterium indicus pranii promotes Mycobacterium tuberculosis clearance from RAW 264.7 macrophages.
    PLoS One. 2017;12:e0189606.
    PubMed     Abstract available


  993. GRANDJEAN L, Gilman RH, Iwamoto T, Koser CU, et al
    Convergent evolution and topologically disruptive polymorphisms among multidrug-resistant tuberculosis in Peru.
    PLoS One. 2017;12:e0189838.
    PubMed     Abstract available


  994. PITTALIS S, Piselli P, Contini S, Gualano G, et al
    Socioeconomic status and biomedical risk factors in migrants and native tuberculosis patients in Italy.
    PLoS One. 2017;12:e0189425.
    PubMed     Abstract available


  995. BANDA HT, Thomson R, Mortimer K, Bello GAF, et al
    Community prevalence of chronic respiratory symptoms in rural Malawi: Implications for policy.
    PLoS One. 2017;12:e0188437.
    PubMed     Abstract available


  996. YU G, Ye B, Chen D, Zhong F, et al
    Comparison between the diagnostic validities of Xpert MTB/RIF and interferon-gamma release assays for tuberculous pericarditis using pericardial tissue.
    PLoS One. 2017;12:e0188704.
    PubMed     Abstract available


  997. VAN DER HEIJDEN EMDL, Chileshe J, Vernooij JCM, Gortazar C, et al
    Immune response profiles of calves following vaccination with live BCG and inactivated Mycobacterium bovis vaccine candidates.
    PLoS One. 2017;12:e0188448.
    PubMed     Abstract available


  998. KIM Y, Kim BK, Choi HJ, Ryu SW, et al
    Lessons learned from continued TB outbreaks in a high school.
    PLoS One. 2017;12:e0188076.
    PubMed     Abstract available


  999. WAI PP, Shewade HD, Kyaw NTT, Kyaw KWY, et al
    Patients with MDR-TB on domiciliary care in programmatic settings in Myanmar: Effect of a support package on preventing early deaths.
    PLoS One. 2017;12:e0187223.
    PubMed     Abstract available


    January 2016
  1000. BASTOS HN, Osorio NS, Castro AG, Ramos A, et al
    A Prediction Rule to Stratify Mortality Risk of Patients with Pulmonary Tuberculosis.
    PLoS One. 2016;11:e0162797.
    PubMed     Abstract available


  1001. FAGUNDEZ G, Perez-Freixo H, Eyene J, Momo JC, et al
    Treatment Adherence of Tuberculosis Patients Attending Two Reference Units in Equatorial Guinea.
    PLoS One. 2016;11:e0161995.
    PubMed     Abstract available


  1002. AYUBI E, Doosti-Irani A, Sanjari Moghaddam A, Sani M, et al
    The Clinical Usefulness of Tuberculin Skin Test versus Interferon-Gamma Release Assays for Diagnosis of Latent Tuberculosis in HIV Patients: A Meta-Analysis.
    PLoS One. 2016;11:e0161983.
    PubMed     Abstract available


  1003. MORISHITA F, Yadav RP, Eang MT, Saint S, et al
    Mitigating Financial Burden of Tuberculosis through Active Case Finding Targeting Household and Neighbourhood Contacts in Cambodia.
    PLoS One. 2016;11:e0162796.
    PubMed     Abstract available


  1004. SSENGOOBA W, Respeito D, Mambuque E, Blanco S, et al
    Do Xpert MTB/RIF Cycle Threshold Values Provide Information about Patient Delays for Tuberculosis Diagnosis?
    PLoS One. 2016;11:e0162833.
    PubMed     Abstract available


  1005. MEHTA S, Das M, Laxmeshwar C, Jonckheere S, et al
    Linezolid-Associated Optic Neuropathy in Drug-Resistant Tuberculosis Patients in Mumbai, India.
    PLoS One. 2016;11:e0162138.
    PubMed     Abstract available


  1006. AULD E, Lin J, Chang E, Byanyima P, et al
    HIV Infection Is Associated with Shortened Telomere Length in Ugandans with Suspected Tuberculosis.
    PLoS One. 2016;11:e0163153.
    PubMed     Abstract available


  1007. FORST J, Brown TA
    Inability of 'Whole Genome Amplification' to Improve Success Rates for the Biomolecular Detection of Tuberculosis in Archaeological Samples.
    PLoS One. 2016;11:e0163031.
    PubMed     Abstract available


  1008. KHALID R, Afzal M, Khurshid S, Paracha RZ, et al
    Fusion Molecules of Heat Shock Protein HSPX with Other Antigens of Mycobacterium tuberculosis Show High Potential in Serodiagnosis of Tuberculosis.
    PLoS One. 2016;11:e0163349.
    PubMed     Abstract available


  1009. NARENDRAN G, Kavitha D, Karunaianantham R, Gil-Santana L, et al
    Role of LTA4H Polymorphism in Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome Occurrence and Clinical Severity in Patients Infected with HIV.
    PLoS One. 2016;11:e0163298.
    PubMed     Abstract available


  1010. TURINAWE K, Vandebriel G, Lowrance DW, Uwinkindi F, et al
    Operating Characteristics of a Tuberculosis Screening Tool for People Living with HIV in Out-Patient HIV Care and Treatment Services, Rwanda.
    PLoS One. 2016;11:e0163462.
    PubMed     Abstract available


  1011. WERGELAND I, Assmus J, Dyrhol-Riise AM
    Cytokine Patterns in Tuberculosis Infection; IL-1ra, IL-2 and IP-10 Differentiate Borderline QuantiFERON-TB Samples from Uninfected Controls.
    PLoS One. 2016;11:e0163848.
    PubMed     Abstract available


  1012. STREATA I, Weiner J 3rd, Iannaconne M, McEwen G, et al
    The CARD9 Polymorphisms rs4077515, rs10870077 and rs10781499 Are Uncoupled from Susceptibility to and Severity of Pulmonary Tuberculosis.
    PLoS One. 2016;11:e0163662.
    PubMed     Abstract available


  1013. CHANDA-KAPATA P, Kapata N, Masiye F, Maboshe M, et al
    Health Seeking Behaviour among Individuals with Presumptive Tuberculosis in Zambia.
    PLoS One. 2016;11:e0163975.
    PubMed     Abstract available


  1014. NASREEN S, Shokoohi M, Malvankar-Mehta MS
    Prevalence of Latent Tuberculosis among Health Care Workers in High Burden Countries: A Systematic Review and Meta-Analysis.
    PLoS One. 2016;11:e0164034.
    PubMed     Abstract available


  1015. CHOI HG, Choi S, Back YW, Park HS, et al
    Mycobacterium tuberculosis Rv2882c Protein Induces Activation of Macrophages through TLR4 and Exhibits Vaccine Potential.
    PLoS One. 2016;11:e0164458.
    PubMed     Abstract available


  1016. OMBURA IP, Onyango N, Odera S, Mutua F, et al
    Prevalence of Drug Resistance Mycobacterium Tuberculosis among Patients Seen in Coast Provincial General Hospital, Mombasa, Kenya.
    PLoS One. 2016;11:e0163994.
    PubMed     Abstract available


  1017. MASINI EO, Mansour O, Speer CE, Addona V, et al
    Using Survival Analysis to Identify Risk Factors for Treatment Interruption among New and Retreatment Tuberculosis Patients in Kenya.
    PLoS One. 2016;11:e0164172.
    PubMed     Abstract available


  1018. LEE SH, Kwon AM, Yang HC, Lee SK, et al
    Longitudinal Lung Function Decrease in Subjects with Spontaneous Healed Pulmonary Tuberculosis.
    PLoS One. 2016;11:e0164039.
    PubMed     Abstract available


  1019. BLANKLEY S, Graham CM, Turner J, Berry MP, et al
    The Transcriptional Signature of Active Tuberculosis Reflects Symptom Status in Extra-Pulmonary and Pulmonary Tuberculosis.
    PLoS One. 2016;11:e0162220.
    PubMed     Abstract available


  1020. ZURCHER K, Zwahlen M, Ballif M, Rieder HL, et al
    Influenza Pandemics and Tuberculosis Mortality in 1889 and 1918: Analysis of Historical Data from Switzerland.
    PLoS One. 2016;11:e0162575.
    PubMed     Abstract available


  1021. SANAIE A, Mergenthaler C, Nasrat A, Seddiq MK, et al
    An Evaluation of Passive and Active Approaches to Improve Tuberculosis Notifications in Afghanistan.
    PLoS One. 2016;11:e0163813.
    PubMed     Abstract available


  1022. GURJAV U, Outhred AC, Jelfs P, McCallum N, et al
    Whole Genome Sequencing Demonstrates Limited Transmission within Identified Mycobacterium tuberculosis Clusters in New South Wales, Australia.
    PLoS One. 2016;11:e0163612.
    PubMed     Abstract available


  1023. FLETCHER R, Jones JD, Shah NS
    Treatment of Active Tuberculosis in Chicago, 2008-2011: The Role of Public Health Departments.
    PLoS One. 2016;11:e0164162.
    PubMed     Abstract available


  1024. MCLAREN ZM, Schnippel K, Sharp A
    A Data-Driven Evaluation of the Stop TB Global Partnership Strategy of Targeting Key Populations at Greater Risk for Tuberculosis.
    PLoS One. 2016;11:e0163083.
    PubMed     Abstract available


  1025. MATHEW B, Hobrath JV, Ross L, Connelly MC, et al
    Screening and Development of New Inhibitors of FtsZ from M. Tuberculosis.
    PLoS One. 2016;11:e0164100.
    PubMed     Abstract available


  1026. JO YS, Park JH, Lee JK, Heo EY, et al
    Discordance between MTB/RIF and Real-Time Tuberculosis-Specific Polymerase Chain Reaction Assay in Bronchial Washing Specimen and Its Clinical Implications.
    PLoS One. 2016;11:e0164923.
    PubMed     Abstract available



  1027. Correction: The Clinical Usefulness of Tuberculin Skin Test versus Interferon-Gamma Release Assays for Diagnosis of Latent Tuberculosis in HIV Patients: A Meta-Analysis.
    PLoS One. 2016;11:e0165143.
    PubMed     Abstract available


  1028. XIE J, Codd C, Mo K, He Y, et al
    Differential Adverse Event Profiles Associated with BCG as a Preventive Tuberculosis Vaccine or Therapeutic Bladder Cancer Vaccine Identified by Comparative Ontology-Based VAERS and Literature Meta-Analysis.
    PLoS One. 2016;11:e0164792.
    PubMed     Abstract available


  1029. OSPINA JE, Orcau A, Millet JP, Ros M, et al
    Epidemiology of Tuberculosis in Immigrants in a Large City with Large-Scale Immigration (1991-2013).
    PLoS One. 2016;11:e0164736.
    PubMed     Abstract available


  1030. MCCALLUM AD, Nyirenda D, Lora W, Khoo SH, et al
    Perceptions of Research Bronchoscopy in Malawian Adults with Pulmonary Tuberculosis: A Cross-Sectional Study.
    PLoS One. 2016;11:e0165734.
    PubMed     Abstract available


  1031. CHOI H, Chon HR, Kim K, Kim S, et al
    Clinical and Laboratory Differences between Lymphocyte- and Neutrophil-Predominant Pleural Tuberculosis.
    PLoS One. 2016;11:e0165428.
    PubMed     Abstract available


  1032. ZHOU F, Xu X, Wu S, Cui X, et al
    Influence of HLA-DRB1 Alleles on the Variations of Antibody Response to Tuberculosis Serodiagnostic Antigens in Active Tuberculosis Patients.
    PLoS One. 2016;11:e0165291.
    PubMed     Abstract available


  1033. STREATA I, Weiner J Rd, Iannaccone M, McEwen G, et al
    Correction: The CARD9 Polymorphisms rs4077515, rs10870077 and rs10781499 Are Uncoupled from Susceptibility to and Severity of Pulmonary Tuberculosis.
    PLoS One. 2016;11:e0165853.
    PubMed     Abstract available


  1034. PEREZ-PORCUNA TM, Pereira-da-Silva HD, Ascaso C, Malheiro A, et al
    Prevalence and Diagnosis of Latent Tuberculosis Infection in Young Children in the Absence of a Gold Standard.
    PLoS One. 2016;11:e0164181.
    PubMed     Abstract available


  1035. ALVARO-MECA A, Diaz A, de Miguel Diez J, Resino R, et al
    Environmental Factors Related to Pulmonary Tuberculosis in HIV-Infected Patients in the Combined Antiretroviral Therapy (cART) Era.
    PLoS One. 2016;11:e0165944.
    PubMed     Abstract available


  1036. BERHANU R, Schnippel K, Mohr E, Hirasen K, et al
    Early Outcomes Of Decentralized Care for Rifampicin-Resistant Tuberculosis in Johannesburg, South Africa: An Observational Cohort Study.
    PLoS One. 2016;11:e0164974.
    PubMed     Abstract available


  1037. BEKKER A, Schaaf HS, Draper HR, Kriel M, et al
    Tuberculosis Disease during Pregnancy and Treatment Outcomes in HIV-Infected and Uninfected Women at a Referral Hospital in Cape Town.
    PLoS One. 2016;11:e0164249.
    PubMed     Abstract available


  1038. MOHAMMED S, Glennerster R, Khan AJ
    Impact of a Daily SMS Medication Reminder System on Tuberculosis Treatment Outcomes: A Randomized Controlled Trial.
    PLoS One. 2016;11:e0162944.
    PubMed     Abstract available


  1039. SARKER M, Barua M, Guerra F, Saha A, et al
    Double Trouble: Prevalence and Factors Associated with Tuberculosis and Diabetes Comorbidity in Bangladesh.
    PLoS One. 2016;11:e0165396.
    PubMed     Abstract available


  1040. LIM CH, Lin CH, Chen DY, Chen YM, et al
    One-Year Tuberculosis Risk in Rheumatoid Arthritis Patients Starting Their First Tumor Necrosis Factor Inhibitor Therapy from 2008 to 2012 in Taiwan: A Nationwide Population-Based Cohort Study.
    PLoS One. 2016;11:e0166339.
    PubMed     Abstract available


  1041. KARAT AS, Omar T, von Gottberg A, Tlali M, et al
    Autopsy Prevalence of Tuberculosis and Other Potentially Treatable Infections among Adults with Advanced HIV Enrolled in Out-Patient Care in South Africa.
    PLoS One. 2016;11:e0166158.
    PubMed     Abstract available


  1042. CHUANG PH, Wu MH, Fan SY, Lin KY, et al
    Population-Based Drug Resistance Surveillance of Multidrug-Resistant Tuberculosis in Taiwan, 2007-2014.
    PLoS One. 2016;11:e0165222.
    PubMed     Abstract available


  1043. AIBANA O, Acharya X, Huang CC, Becerra MC, et al
    Nutritional Status and Tuberculosis Risk in Adult and Pediatric Household Contacts.
    PLoS One. 2016;11:e0166333.
    PubMed     Abstract available


  1044. LIU Z, Gao Y, Yang H, Bao H, et al
    Impact of Hypoxia on Drug Resistance and Growth Characteristics of Mycobacterium tuberculosis Clinical Isolates.
    PLoS One. 2016;11:e0166052.
    PubMed     Abstract available


  1045. CHEN DY, Li JP, Chen YM, Liao TL, et al
    Elevated Neopterin Levels Are Associated with Increased Tuberculosis Risk in Rheumatoid Arthritis Patients with QuantiFERON Conversion during Biologic Therapy.
    PLoS One. 2016;11:e0166301.
    PubMed     Abstract available


  1046. NOSOVA EY, Zimenkov DV, Khakhalina AA, Isakova AI, et al
    A Comparison of the Sensititre MycoTB Plate, the Bactec MGIT 960, and a Microarray-Based Molecular Assay for the Detection of Drug Resistance in Clinical Mycobacterium tuberculosis Isolates in Moscow, Russia.
    PLoS One. 2016;11:e0167093.
    PubMed     Abstract available


  1047. FATIMA R, Qadeer E, Yaqoob A, Haq MU, et al
    Extending 'Contact Tracing' into the Community within a 50-Metre Radius of an Index Tuberculosis Patient Using Xpert MTB/RIF in Urban, Pakistan: Did It Increase Case Detection?
    PLoS One. 2016;11:e0165813.
    PubMed     Abstract available


  1048. SMITH GC, Delahay RJ, McDonald RA, Budgey R, et al
    Model of Selective and Non-Selective Management of Badgers (Meles meles) to Control Bovine Tuberculosis in Badgers and Cattle.
    PLoS One. 2016;11:e0167206.
    PubMed     Abstract available


  1049. BRONNER MURRISON L, Martinson N, Moloney RM, Msandiwa R, et al
    Tobacco Smoking and Tuberculosis among Men Living with HIV in Johannesburg, South Africa: A Case-Control Study.
    PLoS One. 2016;11:e0167133.
    PubMed     Abstract available


  1050. NIETO R LM, Mehaffy C, Creissen E, Troudt J, et al
    Virulence of Mycobacterium tuberculosis after Acquisition of Isoniazid Resistance: Individual Nature of katG Mutants and the Possible Role of AhpC.
    PLoS One. 2016;11:e0166807.
    PubMed     Abstract available


  1051. NUGENT G, Yockney IJ, Whitford EJ, Cross ML, et al
    Field Trial of an Aerially-Distributed Tuberculosis Vaccine in a Low-Density Wildlife Population of Brushtail Possums (Trichosurus vulpecula).
    PLoS One. 2016;11:e0167144.
    PubMed     Abstract available


  1052. MODI S, Cavanaugh JS, Shiraishi RW, Alexander HL, et al
    Performance of Clinical Screening Algorithms for Tuberculosis Intensified Case Finding among People Living with HIV in Western Kenya.
    PLoS One. 2016;11:e0167685.
    PubMed     Abstract available


  1053. JIANG F, Huang W, Wang Y, Tian P, et al
    Nucleic Acid Amplification Testing and Sequencing Combined with Acid-Fast Staining in Needle Biopsy Lung Tissues for the Diagnosis of Smear-Negative Pulmonary Tuberculosis.
    PLoS One. 2016;11:e0167342.
    PubMed     Abstract available


  1054. GUERRINI V, Subbian S, Santucci P, Canaan S, et al
    Experimental Evolution of Mycobacterium tuberculosis in Human Macrophages Results in Low-Frequency Mutations Not Associated with Selective Advantage.
    PLoS One. 2016;11:e0167989.
    PubMed     Abstract available


  1055. HUNDIE GB, Woldemeskel D, Gessesse A
    Evaluation of Direct Colorimetric MTT Assay for Rapid Detection of Rifampicin and Isoniazid Resistance in Mycobacterium tuberculosis.
    PLoS One. 2016;11:e0169188.
    PubMed     Abstract available


  1056. BAEZ-SALDANA R, Delgado-Sanchez G, Garcia-Garcia L, Cruz-Hervert LP, et al
    Isoniazid Mono-Resistant Tuberculosis: Impact on Treatment Outcome and Survival of Pulmonary Tuberculosis Patients in Southern Mexico 1995-2010.
    PLoS One. 2016;11:e0168955.
    PubMed     Abstract available


  1057. YEH JJ, Wang YC, Lin CC, Lin CL, et al
    Association of Respiratory Tuberculosis with Incident Bone Fracture: Bridging the Tuberculosis Airway Infection and the Osteoporotic Bone.
    PLoS One. 2016;11:e0168673.
    PubMed     Abstract available


  1058. LAHEY T, Laddy D, Hill K, Schaeffer J, et al
    Immunogenicity and Protective Efficacy of the DAR-901 Booster Vaccine in a Murine Model of Tuberculosis.
    PLoS One. 2016;11:e0168521.
    PubMed     Abstract available


  1059. ZHANG F, Xu C, Ning L, Hu F, et al
    Exploration of Serum Proteomic Profiling and Diagnostic Model That Differentiate Crohn's Disease and Intestinal Tuberculosis.
    PLoS One. 2016;11:e0167109.
    PubMed     Abstract available


  1060. CABRERA-GAYTAN DA, Niebla-Fuentes MD, Padilla-Velazquez R, Valle-Alvarado G, et al
    Association of Pulmonary Tuberculosis and HIV in the Mexican Institute of Social Security, 2006-2014.
    PLoS One. 2016;11:e0168559.
    PubMed     Abstract available


  1061. SUN Q, Wei W, Sha W
    Potential Role for Mycobacterium tuberculosis Specific IL-2 and IFN-gamma Responses in Discriminating between Latent Infection and Active Disease after Long-Term Stimulation.
    PLoS One. 2016;11:e0166501.
    PubMed     Abstract available


  1062. DEKHIL N, Meftahi N, Mhenni B, Ben Fraj S, et al
    MDR-TB Outbreak among HIV-Negative Tunisian Patients followed during 11 Years.
    PLoS One. 2016;11:e0153983.
    PubMed     Abstract available


  1063. KJAERGAARD J, Stensballe LG, Birk NM, Nissen TN, et al
    Lack of a Negative Effect of BCG-Vaccination on Child Psychomotor Development: Results from the Danish Calmette Study - A Randomised Clinical Trial.
    PLoS One. 2016;11:e0154541.
    PubMed     Abstract available


  1064. TAI MS, Sharma VK
    Role of Transcranial Doppler in the Evaluation of Vasculopathy in Tuberculous Meningitis.
    PLoS One. 2016;11:e0164266.
    PubMed     Abstract available


  1065. BIAN S, Zhang Y, Zhang L, Shi X, et al
    Diagnostic Value of Interferon-gamma Release Assays on Pericardial Effusion for Diagnosis of Tuberculous Pericarditis.
    PLoS One. 2016;11:e0165008.
    PubMed     Abstract available


  1066. WEI W, Wei-Sheng Z, Ahan A, Ci Y, et al
    The Characteristics of TB Epidemic and TB/HIV Co-Infection Epidemic: A 2007-2013 Retrospective Study in Urumqi, Xinjiang Province, China.
    PLoS One. 2016;11:e0164947.
    PubMed     Abstract available


  1067. MENG Q, Sayin I, Canaday DH, Mayanja-Kizza H, et al
    Immune Activation at Sites of HIV/TB Co-Infection Contributes to the Pathogenesis of HIV-1 Disease.
    PLoS One. 2016;11:e0166954.
    PubMed     Abstract available


  1068. HESLOP R, Bojang AL, Jarju S, Mendy J, et al
    Changes in Host Cytokine Patterns of TB Patients with Different Bacterial Loads Detected Using 16S rRNA Analysis.
    PLoS One. 2016;11:e0168272.
    PubMed     Abstract available


  1069. GILBERT JA, Shenoi SV, Moll AP, Friedland GH, et al
    Cost-Effectiveness of Community-Based TB/HIV Screening and Linkage to Care in Rural South Africa.
    PLoS One. 2016;11:e0165614.
    PubMed     Abstract available


  1070. BROPHY JC, Hawkes MT, Mwinjiwa E, Mateyu G, et al
    Survival Outcomes in a Pediatric Antiretroviral Treatment Cohort in Southern Malawi.
    PLoS One. 2016;11:e0165772.
    PubMed     Abstract available


  1071. KILALE AM, Ngadaya E, Muhumuza J, Kagaruki GB, et al
    Who Has Mycobacterial Disease? A Cross Sectional Study in Agropastoral Communities in Tanzania.
    PLoS One. 2016;11:e0153711.
    PubMed     Abstract available


  1072. HANIFA Y, Fielding KL, Chihota VN, Adonis L, et al
    Diagnostic Accuracy of Lateral Flow Urine LAM Assay for TB Screening of Adults with Advanced Immunosuppression Attending Routine HIV Care in South Africa.
    PLoS One. 2016;11:e0156866.
    PubMed     Abstract available


  1073. VELEN K, Lewis JJ, Charalambous S, Page-Shipp L, et al
    Household HIV Testing Uptake among Contacts of TB Patients in South Africa.
    PLoS One. 2016;11:e0155688.
    PubMed     Abstract available


  1074. MEGHJI J, Simpson H, Squire SB, Mortimer K, et al
    A Systematic Review of the Prevalence and Pattern of Imaging Defined Post-TB Lung Disease.
    PLoS One. 2016;11:e0161176.
    PubMed     Abstract available


  1075. SHENAI S, Ronacher K, Malherbe S, Stanley K, et al
    Bacterial Loads Measured by the Xpert MTB/RIF Assay as Markers of Culture Conversion and Bacteriological Cure in Pulmonary TB.
    PLoS One. 2016;11:e0160062.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: